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ABSTRACT 
Multiple Sclerosis (MS) is a degenerative disease and a common cause of 
disability in adults. 85% of people with MS (pwMS) are initially diagnosed with 
relapsing remitting MS (RRMS), which involves discreet periods of relapses 
and remission of symptoms. Over time, most, but not all, pwMS transition to 
secondary progressive MS (SPMS), which is characterised by a gradual 
accumulation of disability. Little research to date has explored the experience 
of this transition. Nine pwMS and seven MS health professionals (HPs) were 
interviewed to explore pwMS’ experiences, coping and needs during this 
transition. Four major themes were identified using Thematic Analysis (Braun 
& Clarke, 2006); ‘is this really happening?’, ‘becoming a reality’, ‘a life of 
struggle’, and ‘brushing oneself off and moving on’. Findings suggest a 
process of moving from uncertainty towards confirmation of one’s diagnostic 
label, the experience of which was influenced, in part, by the attitudes and 
approaches of HPs themselves.  Understanding pwMS’ experiences of the 
transition is essential if clinicians are to provide pwMS with appropriate 
support during the transition. Several possible implications for theory and 
practice were put forward. 
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CHAPTER 1: INTRODUCTION 
 
Introduction to Multiple Sclerosis 
Multiple Sclerosis (MS) is a degenerative disease of the Central Nervous 
System, and a common cause of disability in adults (Coles, 2009).   
Approximately 2.5 million people worldwide are affected by MS, with the 
majority diagnosed between the ages of 20-40 (Compston & Coles, 2008). 
Symptoms vary across individuals, and may include fatigue, sensory loss, as 
well as difficulties with balance, walking, vision, bladder and bowel control, 
memory and concentration (Compston & Coles, 2008). There is no cure for 
MS, and the disease course is unpredictable and varies between individuals.  
As MS has a limited effect on life expectancy (Burgess, 2010), most people 
with MS (pwMS) will live with the condition for a long time and accumulate 
irreversible disability (Confavreux, 2008).   
MS poses numerous challenges for both physical and psychological well-
being, including unpleasant symptoms, treatment regimes and drug side-
effects, as well as disruption to life goals, employment and relationships 
(Dennison, Moss-Morris & Chalder, 2009).  Meta-analytic evidence indicates 
that pwMS have higher rates of depression than both the general population, 
and people with other chronic illnesses (Schubert & Foliart, 1993), as well as 
heightened anxiety (Zorzon et al., 2001), and low subjective well-being and 
quality of life (Benito-Leon, Morales, Rivera-Navarro & Mitchell, 2003). In spite 
of this, a substantial number of pwMS manage to adapt well to living with the 
illness (Antonak & Livneh, 1995). 
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For ease of classification, three standard clinical subtypes of MS have been 
described (Lubin & Reingold, 1996; NICE, 2003): primary progressive MS 
(PPMS); relapsing remitting MS (RRMS), and secondary progressive MS 
(SPMS).  Whilst PPMS involves a gradual worsening of MS symptoms from 
the initial onset of MS, RRMS is characterised by periods where symptoms 
appear for at least 24 hours (i.e. a relapse), following which one recovers 
either partially or entirely, with a lack of disease progression between relapses 
(Lubin & Reingold, 1996).  In contrast, SPMS is typically defined as 
deterioration independent of relapses for 6 months or more, which follows an 
initial RRMS course (Lublin & Reingold, 1996).  
 
Transition from RRMS to SPMS 
85% of pwMS are initially diagnosed with RRMS (Lublin & Reingold, 1996). 
Although there is no cure, disease modifying drugs (DMDs) may reduce the 
number of relapses that pwMS experience, and the severity and duration of 
relapses may be managed via steroid treatment (NICE, 2003).  Within 
approximately three decades of the onset of RRMS, 65-90% of pwMS will 
transition to SPMS (Compston & Coles, 2008; Trojano, Paolicelli, Bellacosa & 
Cataldo, 2003).  Whilst many people with SPMS no longer experience 
relapses, some still experience them with little subsequent recovery, and 
undergo a gradual worsening of the baseline between relapses over time 
(Lubin & Reingold, 1996).  DMDs are generally ineffective at slowing disease 
progression in SPMS (e.g. Panitch, Miller, Paty & Weinshenker, 2004; Cohen 
et al., 2002). As a result, guidelines from the Association of British 
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Neurologists (2007) recommend that DMDs are stopped in patients with 
SPMS who do not experience relapses, given their potential negative side-
effects (Lonergan et al., 2009).  Hence, the transition to SPMS may involve 
withdrawal of previous treatments, and a significant reduction in potential 
treatment options. Although this transition is common, it does not occur in all 
pwMS (Kalb, 2000).  Furthermore, given the variability of the disease, 
diagnostic criteria for SPMS are not always easily applied in clinical practice, 
leading to delays in reclassifying patients with SPMS (Sand, Krieger, Farrell & 
Miller, 2014).  SPMS is associated with poorer quality of life (e.g. McNulty, 
Livneth & Wilson, 2004), and heightened rates of depression and anxiety 
(Mohr et al., 1999) compared with other forms of MS.  
Although research has examined the experiences of pwMS diagnosed with 
RRMS and of those living with established SPMS, little research has explored 
the experience of transitioning from RRMS to SPMS.  This is a unique 
transition for a number of reasons. Firstly, it tends to be subtle, and is 
generally not a distinct phase in itself, often being confirmed in retrospect 
(Sand et al., 2014). Anecdotal evidence also suggests that the common, yet 
not inevitable, occurrence of the transition may lead pwMS to hope that they 
may escape it. This may result in a shattering of such hope on being 
reclassified (Kalb, 2000). Furthermore, this transition presents its own range 
of challenges given its inherent shift from a form of MS involving relapses 
interspersed with periods of wellness, to a progressive and irreversible form of 
the illness associated with a reduction in treatment options (Smith, 2009; 
Kalb, 2000). Anecdotal evidence suggests that the transition is associated 
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with a strong emotional reaction, which may include grief, anxiety, despair and 
anger (Kalb, 2000). In light of the above, there has been a recent call for 
research exploring the experiences and needs of pwMS as they transition to 
SPMS, to enable provision of adequate support for pwMS through this 
process (Wilson & Hartland, 2012).   
Given a relative lack of research examining the experience of the transition to 
SPMS, this chapter will begin with an overview of existing qualitative literature 
examining the experience of living with MS, including the perceived needs, 
coping and adjustment associated with the following stages of the disease: (i) 
being diagnosed and living with RRMS; (ii) living with SPMS; (iii) living with 
MS across the disease trajectory.  Given the in-depth insight into individuals’ 
experiences provided by qualitative literature (Spencer, Ritchie, Lewis & 
Dillon, 2003), inclusion of these studies is aimed at enriching the reader’s 
understanding of the experiences of pwMS. This is crucial, given the potential 
relevance of such findings for the transition to SPMS. Furthermore, this 
overview will highlight gaps in current knowledge regarding the experience of 
the transition.  Following this, a model of psychological adjustment to MS will 
be outlined.  Subsequently, an overview of the only study to date to have 
explored the experience of transitioning from RRMS to SPMS will be 
provided.  Finally, a justification for adopting a qualitative approach for the 
current study will be presented, and the research aims will be outlined. 
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Experience of being diagnosed and living with RRMS 
Miller (1997) explored the experience of living with RRMS, including the 
receipt of a MS diagnosis, using hermeneutic phenomenology. Many 
participants described feeling relieved on receipt of their diagnosis due to 
discovering that their symptoms were not due to a fatal illness. Other themes 
included uncertainty due to the unpredictability of this stage of the disease, 
fear, loss, and concealment of one’s disease given a lack of understanding 
within society about MS.  Coping was facilitated through maintaining a sense 
of hope in relation to one’s condition. Participants highlighted the value of 
receiving information about self-management, maintaining independence and 
accessing care.  This study had a number of weaknesses including insufficient 
description of the methods of data collection and analysis. On the other hand, 
this study was strengthened by its inclusion of member checking1 (Spencer et 
al., 2003), and the use of participants’ quotations to support the findings.  
Similarly, Koopman and Schweitzer (1999) found that receipt of diagnosis was 
associated with feelings of devastation and isolation. Relief was not 
described, however.  These authors extended Miller’s (1997) results by 
demonstrating that the pre-diagnostic phase where pwMS had been 
experiencing symptoms was associated with a heightened sense of confusion 
and worry about the meaning of one’s symptoms. Similar to Miller, this study 
found that the post-diagnostic phase was characterised by a combination of 
uncertainty and hope.  The quality of this phenomenological, qualitative study 
                                                 
1
 Member checking refers to a process of verifying the accuracy of qualitative data analysis (e.g. 
codes, themes) with members of the group from whom the data were originally obtained (e.g. 
Spencer et al., 2003). 
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was enhanced by its use of both face-to-face and telephone interviews with 
each of the five participants, as well as through its illustration of the 
conclusions by a substantial amount of data (Mays & Pope, 1995).   
Likewise, Johnson (2003) found that the pre-diagnostic period was one of 
anxiety due to uncertainty about the meaning of one’s symptoms. Receipt of 
diagnosis was associated with shock and devastation, as well as isolation and 
abandonment, which was both due to the diagnosis itself as well as a sense 
of professionals withdrawing at this point due to little cause for immediate 
treatment.  While the majority of participants described dissatisfaction with 
how this stage of their disease had been managed, a minority described 
satisfaction with their experience.  As in Miller’s (1997) study, a number of 
participants also described relief on receiving their diagnosis, and emphasised 
the value of receiving sufficient information and advice to support them 
through their adjustment.  The quality of this study was strengthened by its 
inclusion of participants’ quotes (Mays & Pope, 1995), and the use of member 
checking (Spencer et al., 2003), but was compromised by its reliance on 
participants’ recall of their experiences which occurred up to 33 years 
previously, and its insufficient description of its methods of data analysis 
(Spencer et al., 2003). 
Like Johnson (2003), Solari  (2007) found varying degrees of satisfaction 
among pwMS regarding the experience of diagnosis communication. These 
ranged from acceptable to poor, with the period around the MS diagnosis 
being regarded as crucial in terms of how pwMS experienced their disease. 
All participants indicated that they would prefer their diagnosis to be 
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communicated to them unambiguously as soon as it was available.  Solari 
and colleagues recommended improvements such as provision of an 
appropriate setting for diagnosis communication (e.g. private, sufficient time), 
tailoring of information for each individual, direction towards other sources of 
information (e.g. websites) and continuity of care. Recommendations 
regarding provision of adequate information are reminiscent of 
recommendations from previous studies (e.g. Miller, 1997; Johnson, 2003).   
This study was strengthened by its inclusion of participant quotes (Mays & 
Pope, 1995) and the use of member checking.  
As in previous studies (e.g. Miller, 1997), Malcolmson, Lowe-Strong and 
Dunwoody (2008) found that receipt of diagnosis was commonly associated 
with relief. This study also described the experience of one individual who, in 
contrast to other studies, experienced no relief, but instead a sense of fear 
and lowered self-esteem, which suggests a range of potential responses to 
the receipt of a diagnosis across individuals. Findings also indicated that self-
management techniques such as proactivity were found to be helpful in 
coping with this adjustment. This study used thematic analysis to analyse its 
results (n = 13). Although only one data collection method was used, the 
quality of this study was enhanced by the use of member checking, as well as 
substantial reporting of participant quotes throughout the article, supporting 
the credibility of the findings (Greenhalgh, 1997). 
Using thematic content analysis, Edwards, Barlow and Turner (2008) found 
that the period between the onset of initial symptoms and receipt of a MS 
diagnosis was long and difficult for most of their participants, which was partly 
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due to difficulty in getting medical professionals to investigate their symptoms. 
Some participants were disbelieved by medical professionals, which left them 
feeling bitter and angry. Following this, many pwMs experienced 
dissatisfaction with the way in which their diagnosis was communicated to 
them, with some describing the manner in which this was carried out as 
‘unsympathetic’ and ‘casual’.  As in other studies (e.g. Miller, 1997; Johnson, 
2003), participants experienced both devastation and relief on receiving their 
diagnosis, which was often followed by uncertainty and anxiety about their 
future.  Most participants indicated that they were not provided with sufficient 
information or advice about managing MS at the time of diagnosis. In contrast, 
a minority of participants reported being satisfied with the information and 
treatment that they had received, as in other studies (e.g. Johnson, 2003). 
Some participants felt that it is important for pwMS to accept that there are 
limited treatments available for MS.   This study obtained its data via 24 semi-
structured telephone interviews.  Its limitations included its reliance on 
retrospective recall, with some participants having received their diagnosis up 
to 37 years previously, and insufficient description of the method of data 
analysis (Spencer et al., 2003). Furthermore, as the majority of participants 
were white females, confidence in the applicability of the results to men and 
other ethnicities is limited. The quality of this study was enhanced however 
through the inclusion of rich examples of raw data. 
The findings of Dennison, Yardley, Devereux and Moss-Morris (2010) 
reflected those of previous studies (e.g. Miller, 1997; Johnson, 2003), in that 
the receipt of a MS diagnosis was often associated with feeling distressed and 
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overwhelmed, but it could be managed through maintaining positivity and the 
use of practical strategies (e.g. adapting one’s activities) to maintain a sense 
of normality. This study used thematic analysis to examine the lived 
experience of adjusting to the early stages of MS, and recruited thirty 
participants in total. Results suggested that with time, many participants 
reached a point of acceptable quality of life and emotional well-being in spite 
of their MS. However, this seemingly positive adjustment was described as 
being under constant threat from MS, with many participants indicating that 
their successful adjustment was dependent on the absence of severe 
symptoms or relapses.  While some participants found seeking support and 
advice from other pwMS to be helpful, others described avoiding this avenue 
in order to avoid reminders of the consequences of the possible worsening of 
their MS.  This study had a number of limitations, including the use of only 
one data collection method, and its reliance on retrospective recall. The 
quality of this study was strengthened by its inclusion of substantial participant 
quotes. 
In summary, the period between the onset of symptoms and the receipt of an 
initial MS diagnosis may be characterised by anxiety about the meaning of 
symptoms, and some individuals may struggle to have their symptoms 
considered seriously by health professionals.  Such findings raise questions 
about the experiences of pwMS in the period leading up to a reclassification of 
SPMS, such as whether pwMS are aware of changes in their disease pattern, 
and what sense they make of this.  Such questions are salient given the 
common, yet not inevitable nature of the transition, as well as the fact that 
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pwMS would have already have been living with MS for some time before 
being reclassified.  The impact of such factors on pwMS’ ability to detect 
changes in their disease pattern and the meaning that they attribute to such 
changes remains to be explored.   
As demonstrated, receipt of the RRMS diagnosis may be associated with 
feelings of relief, shock, fear, uncertainty, and isolation. Given increased 
certainty regarding irreversible accrual of disability associated with SPMS, in 
contrast with the uncertainty associated with the fluctuating RRMS course 
(Kalb, 2000), how pwMS make sense of the reclassification merits 
exploration. Such investigation is also warranted in light of potential for the 
non-occurrence of the transition, which, according to anecdotal evidence, may 
lead pwMS to view the reclassification as bad luck (Kalb, 2000).  The above 
findings also suggested that as time passes, some individuals may learn to 
cope and maintain an acceptable quality of life in RRMS, but that this may be 
dependent on the absence of severe symptoms.  Given the trajectory of 
irreversible disability associated with SPMS, this result raises questions about 
how pwMS cope with the transition from RRMS to SPMS.  
The studies above suggested a need for improved provision of high quality 
information tailored for each individual, and sufficient protected time for 
communication of the diagnosis. Ongoing professional support delivered by 
knowledgeable and empathic professionals, was identified as crucial for 
people with RRMS in order to support relapse management and to avoid 
feelings of abandonment. The extent to which such needs are met in relation 
to the transition to SPMS, and whether additional needs specific to this 
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transition exist, warrant investigation. 
 
Experience of living with SPMS 
Two qualitative studies to date have examined the experiences of living with 
established SPMS.  The first of these, Olsson, Lexell and Soderberg (2008), 
used phenomenological hermeneutic interpretation to explore the experience 
of ten women living with SPMS. The two themes which emerged were ‘living 
with an unrecognisable body’ (Olsson et al., 2008, p. 424), including loss of 
control over one’s body and feeling directed by one’s MS, and ‘trying to 
maintain power’ (Olsson et al., 2008, p. 424), such as by seeking information 
to reduce the unpredictability of their disease, and striving to maintain one’s 
work role.  This study was strengthened by its inclusion of rich examples of 
raw data, although its inclusion of only female participants may compromise 
the applicability of the results to men with SPMS.   
Following this, Olsson, Skar and Soderberg (2010) explored the meaning of 
feeling well in women with SPMS. They found that in spite of living with the 
challenging consequences of SPMS, participants reported being able to feel 
well through finding a pace for their daily life where they could perform 
ordinary tasks, and through feeling needed and understood by others, so that 
their MS was not their dominant experience.  Additionally, participants 
described the cultivation of an inner strength and resolve to feel well in spite 
of their disease as helpful.  Similar to Dennison et al. (2010), wellness was 
strongly related to the severity of one’s symptoms and their impact on one’s 
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degree of disability on a given day.  This study used the same methodology 
and was subject to the same strengths and limitations as the previous study 
(i.e. Olsson et al., 2008). 
Given the focus of these studies on living with established disability, the value 
of exploring pwMS’ prior adjustment from RRMS is highlighted. For instance, it 
remains unclear how pwMS reach such a point of coping with established 
disability, and whether adjustment to one’s condition begins prior to, during, or 
following the transition from RRMS.  This is salient given that, in advance of 
the transition, pwMS would have already been living with MS, albeit in a 
different form. Furthermore, given the loss of control over one’s body 
described in relation to living with established SPMS, it remains unclear how 
pwMS make sense of, and respond to, the changes in their disease pattern 
prior to being reclassified. 
 
Experiences, coping and needs across the disease trajectory 
Whilst the previously reviewed studies focused on the experiences of living 
with specific stages of MS, a number of studies have explored experiences of 
MS in general, by including participants at various stages of the disease 
trajectory. Many of these findings echoed the results of studies in relation to 
RRMS and SPMS, reviewed above.  For instance, similar to Olsson et al. 
(2010), Kirkpatrick-Pinson, Ottens and Fisher (2009) examined successful 
coping with MS by interviewing ten women who self-reported as coping well 
with the disease in spite of its associated challenges. As in Olsson’s study, 
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successful coping was facilitated by provision of information about MS, as well 
as the availability of good support systems, including support groups in the 
progressive phase of the disease. This study was strengthened by inclusion of 
participant quotes, but weakened by a lack of member checking (Mays & 
Pope, 1995). 
Also echoing the results of previously reviewed studies (Olsson et al., 2010; 
Dennison et al., 2010), Fleming-Courts, Buchanan and Werstlein (2004) found 
that while living with MS presented a range of challenges for all ten 
participants, they demonstrated a capacity to meet such challenges through 
refocusing their priorities, and careful planning of their activities. As in 
previous studies regarding RRMS and SPMS (e.g. Solari et al., 2007; Olsson 
et al., 2008), participants emphasised the value of being listened to, and 
provision of information about their condition. The quality of this study was 
compromised a lack of member checking of the data (Mays & Pope, 1995). 
Theme validation was increased, however, through investigator triangulation 
of themes2 (Green & Thorogood, 2004). 
Similarly, in their exploration of the experiences of pwMS across the disease 
trajectory, Wollin, Yates and Kristjanson (2006) identified four themes which 
reflected many of the findings reported previously.  Receipt of the MS 
diagnosis was associated with disbelief and devastation, echoing the findings 
of Edwards (2008) and Dennison et al. (2010), discussed above.  The next 
theme of losses and forced life choices reflected the findings of other studies 
                                                 
2
 Investigator triangulation involves using multiple investigators to review the findings, which can 
provide a check on selective interpretation and illuminate blind spots in analysis.  
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(e.g. Reynolds & Prior, 2003; Fleming-Courts et al., 2004), as did the third 
theme of difficulty in accessing services and information (e.g. Johnson, 2003).  
The final theme was that of cycles of grief, accommodating change, following 
which relief is found. This theme was somewhat reflective of the findings of 
Reynolds and Prior (2003), who described acknowledgement of one’s 
difficulties as an important stage in the process of adjustment and coping.  
This study was weakened by its reliance on retrospective recall from many 
years earlier. 
As demonstrated, many of the findings in relation to living with MS across the 
disease trajectory echoed those regarding living with RRMS and SPMS. 
However, a number of studies exploring MS across the disease trajectory built 
upon previously reviewed findings regarding RRMS and SPMS.  For instance, 
Reynolds and Prior (2003) interviewed twenty-seven women at various stages 
of MS, and used an interpretative phenomenological approach to explore their 
strategies for living with MS.  Living with MS was described as a continuous 
process of negotiation between negative and positive forces. As in previously 
reviewed studies (e.g. Olsson et al., 2010), coping was facilitated through 
looking after one’s health, maintaining positive relationships, engaging in 
meaningful occupations, and adapting tasks to meet one’s current level of 
functioning where necessary. This study built on the previous findings, 
however, by identifying additional means of coping, such as through actively 
valuing positive life experiences, clarifying one’s values, and finding benefit in 
adversity. For some, MS was viewed as an opportunity for personal growth. 
Acknowledgement of one’s difficulties, at least to oneself, was reported as an 
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important turning point for many participants, following which they were able 
to move forward with their lives. Although helpful, it was acknowledged that 
such coping strategies did not eliminate the impact of MS on participants’ 
lives, which has been reported by other studies (e.g. Koopman & Schweitzer, 
1999).  This was a high quality study with well-described analysis methods 
(Mays & Pope, 1995), and inclusion of participants’ quotations, providing 
evidence for the researchers’ interpretations (Greenhalg, 1997). 
Whilst previous studies gathered data from pwMS alone, two studies 
incorporated the insights of multiple stakeholders (e.g. carers, health 
professionals) into their investigation of the experiences of pwMS. For 
instance, Edmonds et al. (2007) included the perspectives of both pwMS and 
carers in exploring the issues for people severely affected by MS.  Their 
results suggested that pwMS are concerned with losses and changes 
stemming from their MS, particularly in relation to declining independence and 
physical functioning, and changes in personal relationships. This theme of 
losses has been reported by previously reviewed studies (e.g. Wollin et al., 
2006). The experience of loss and change emerged as continuous and 
evolving right across the disease trajectory. Although there was an insufficient 
description of the qualitative analytic method and a lack of member checking 
of the data, the study was strengthened by its inclusion of participant quotes. 
Similarly, Golla, Galushko, Pfaff and Voltz (2012) explored healthcare 
professionals’ (HPs) perceptions of the unmet needs of pwMS using content 
analysis. Results indicated that unmet needs included support for family and 
friends, with some participants highlighting the need for relatives and friends 
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of pwMS to be provided with psychological support and information about the 
disease course. Other unmet needs stemmed from deficits in communication 
among HPs, resulting in pwMS sometimes not being provided with adequate 
individualised information and advice. Challenges with managing everyday 
life, and maintaining continuity of one’s roles in life were also reported. This 
study built further on previous studies, by highlighting a number of challenges 
faced by HPs (e.g. time pressure), which inhibited their ability to meet the 
needs of pwMS. These results also indicated that many HPs felt insufficiently 
equipped when breaking bad news to pwMS. The quality of this study was 
compromised by its insufficient description of its analytic method, but 
strengthened by its inclusion of a heterogeneous sample of HPs, which may 
have enhanced the generalizability of the findings. 
In summary, studies exploring the experience of living with MS across the 
disease trajectory echoed many of the previously reviewed studies in relation 
to RRMS and SPMS. However, some of these studies built upon previously 
reviewed findings, by suggesting that some pwMS may learn to cope with 
their illness through finding benefit and meaning in everyday life, and by 
viewing living with MS as an opportunity for personal growth.  Such findings 
also indicated the potential value of acknowledging one’s difficulties in being 
able to move forward with one’s life.  Provision of support for pwMS’ friends 
and family emerged as a need that had not been reported previously. These 
findings also indicated a number of challenges faced by HPs in providing 
adequate support for pwMS. Whilst such findings highlighted difficulties faced 
by pwMS across the disease trajectory, it remains unclear to what extent such 
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findings apply to the specific experience of transitioning from RRMS to SPMS.   
 
Coping and Adjustment in MS 
Given the range of challenges posed to pwMS’ well-being, and variability in 
how they cope with such challenges described above, the coping and 
adjustment of pwMS has captured the attention of numerous researchers.  
Dennison, Moss-Morris and Chalder (2009) carried out a systematic review of 
72 studies examining psychological factors associated with adjustment in MS. 
Adjustment outcomes, in the context of this review, included psychological 
and emotional well-being, quality of life, and the subjective impact of MS on 
life domains.  They subsequently proposed a model of psychological 
adjustment to MS, based on this review. In accordance with the cognitive 
behavioural model (Beck, 1976), Dennison et al.'s model suggests that early 
life experiences and an individual's personality provide the basis for beliefs 
about oneself and others.  Such beliefs, in turn, influence one's values, goals 
and behaviour. According to this model, changes such as the receipt of a MS 
diagnosis, experiencing a relapse, or disease progression, lead to disruption 
of one's emotional equilibrium and quality of life. Emotional distress arising 
from such disruption is expected at this point, according to the model.  This 
reflects the qualitative findings outlined above regarding pwMS’ experience of 
the initial diagnosis of MS (e.g. Koopman and Schweitzer, 1999; Johnson, 
2003; Dennison et al., 2010). This model suggests that if prolonged, such 
disruption and distress lead to adjustment difficulties.  In line  with Lazarus 
and Folkman's (1984) influential stress-coping model, Dennison et al.'s model 
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posits that appraisal of one's MS is associated with adjustment outcome.  
Appraisals of MS as stressful and threatening, rather than controllable or a 
challenge, is linked with worse adjustment according to this model.  Given the 
inevitable deterioration and frequent withdrawal of DMDs associated with 
SPMS, exploration of pwMS’ appraisal of the transition is warranted. 
Also in accordance with Lazarus and Folkman (1984), Dennison et al. (2009) 
propose that one's choice of coping strategies is linked with adjustment 
outcome. Their model differentiates between a variety coping strategies 
associated with successful and unsuccessful coping. Coping strategies, in this 
context, are regarded as conscious efforts that individuals make to manage 
stressors. Coping through emotion-focused strategies such as wishful thinking 
or avoidance, and experiencing uncertainty about one's MS emerged as 
having a strong evidence base for their link with poor adjustment. Other 
factors such as the presence of dysfunctional cognitions and cognitive errors, 
unhelpful illness representations, unhelpful beliefs about pain, helplessness, 
and perceived barriers to health behaviours emerged as having a modest 
evidence base for their link with unsuccessful adjustment, according to their 
review.   
In line with Lazarus and Folkman's (1984) model, Dennison et al. (2009) 
proposed that coping through the use of positive reappraisal and problem-
focused strategies (i.e. strategies aimed at altering the source of one's stress) 
were strongly associated with better adjustment in MS.  This echoes the 
qualitative findings reviewed above in relation to coping with RRMS through 
proactivity (e.g. Malcolmson et al., 2008), as well as the reported usefulness 
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of information to support self-management in RRMS (e.g. Miller, 1997). Better 
adjustment was also strongly linked with perceived social support, and coping 
through seeking social support. This is somewhat reflective of the above 
qualitative findings in relation to coping with SPMS (Olsson et al., 2010), and 
MS across the disease trajectory (Kirkpatrick-Pinson et al., 2009).  According 
to Dennison et al.’s (2009) review, perceived control and self-efficacy in 
relation to one's MS and life more generally, maintaining optimism, hope, 
benefit-finding, and acceptance of one's illness were modestly associated with 
better adjustment. Several of these factors are reflected in the qualitative 
literature reviewed above, including coping through benefit-finding (Reynolds 
& Prior, 2003), acceptance of one's MS (Edwards et al., 2008; Wollin et al., 
2006), and maintaining a sense of hope (Miller, 1997; Koopman and 
Schweitzer, 1999). Limitations of Dennison et al.'s review include the inclusion 
of methodologically weak studies, and a potential for bias of the results due to 
the exclusion of studies which were not published in peer-reviewed journals.  
Such factors may have compromised the validity of the model described 
above.  However, Dennison, Moss-Morris, Silber, Galea and Chalder (2010) 
found support for this model in relation to the early stages of MS. In particular, 
they found that cognitive and behavioural factors (e.g. unhelpful appraisals, 
degree of acceptance of MS, catastrophising, coping through avoidance) 
accounted for 37.1% (p<.001) of variance in distress. In contrast, illness 
severity only accounted for 2.2% of the variance in distress.  These authors 
acknowledged that experimental and longitudinal research is required to 
explore causality.    
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Dennison et al. (2009) argued that the extent to which the above 
psychological factors are linked to disease exacerbation or progression 
requires investigation. Hence, the extent to which this model applies to the 
transition from RRMS to SPMS remains to be explored. Such investigation is 
crucial, given research indicating that psychological factors often better 
predict individual variation in adjustment compared to illness factors 
(Dennison et al., 2010; Thomas et al., 2006).  Furthermore, unlike illness 
factors, psychological factors may be modified through psychological 
intervention (Dennison et al., 2009). Hence, insight into the coping and 
adjustment of pwMS in relation to the transition may enable identification of 
potential avenues for psychological intervention aimed at enhancing their 
psychological well-being at this stage. 
 
Transitioning from RRMS to SPMS 
No published research to date has examined the experience of transitioning 
from RRMS to SPMS.  An unpublished Masters of Science (MSc) dissertation 
(Hourihan, 2013) is the only study to have explored this topic to date. This 
study used Interpretative Phenomenological Analysis (IPA) to analyse its data.  
Similar to studies exploring the experience of receiving a diagnosis of RRMS 
(e.g. Edwards et al., 2008), Hourihan found that pwMS were aware of a 
change in their condition before receiving a reclassification of SPMS. In spite 
of this, the re-classification was unexpected, and associated with fear and a 
sense of abandonment by professionals, reminiscent of the experiences of 
being diagnosed with RRMS (e.g. Johnson, 2003). However, Hourihan argued 
28 
 
that feelings of abandonment may be further exacerbated at the onset of 
SPMS due to declining frequency of doctors’ appointments, which may stem 
from feelings of powerlessness among HPs to make a positive difference in 
the progressive stages of the illness.  Hourihan also indicated a lack of 
knowledge among pwMS about the disease trajectory, which may have 
contributed to their shock on being reclassified with SPMS.   
As in previously reviewed studies (e.g. Miller, 1997), Hourihan’s study 
suggested that pwMS value psychological support and provision of sufficient 
and accessible information by professionals to support them in coping with 
this adjustment.  Hourihan also found that there was a lack of information 
available to pwMS on being reclassified with SPMS.  Furthermore, the 
process of gaining information about disability benefits was described as 
arduous.  MS peer support was described as helpful at this stage of the 
disease trajectory, as was coping through positive relationships with family 
and friends, where available.   
This was a small study, with only five participants, and there is no published 
research to verify the findings.  Although Hourihan identified a number of 
unmet needs of pwMS during the transition it did not explore barriers to 
meeting such needs.  Additionally there was little investigation of pwMS’ 
coping and adjustment in response to the transition, aside from seeking social 
support. Finally, although Hourihan found that all participants had noticed 
changes in their disease pattern prior to being reclassified, this study did not 
explore how pwMS responded to, or made sense of such changes.  
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The current study 
This study aimed to build on Hourihan’s (2013) work through gaining a more 
thorough understanding of the experiences of pwMS throughout the transition 
to SPMS, from when they first noticed changes in their disease pattern to the 
period following the reclassification of SPMS where people made sense of 
this news.  It aimed to explore the coping and needs of pwMS throughout the 
transition, and to identify barriers to meeting such needs in order to illuminate 
ways forward. It was hoped that this would be achieved through interviewing a 
slightly larger number of pwMS, as well as by incorporating the perspectives 
of specialist MS health professionals (HPs).  A growing body of qualitative 
literature in healthcare has explored the perspectives of HPs in combination 
with those of patients in examining the issues faced by patients and 
healthcare services (e.g. Pooley et al., 2001; Lester et al., 2005; Pinnock et 
al., 2011; Golla et al., 2012; Brown et al., 2013).  These studies revealed high 
levels of agreement between patients and HPs, as well as highlighting 
tensions between what patients want and what services are able to provide.  
Golla et al. (2012) argued that inclusion of HPs may contribute towards 
identification of barriers to meeting patients’ needs, illuminating ways forward.   
Golla et al. (2012) also highlighted the value of including specialist HPs’ 
perspectives on the experiences of pwMS given their substantial direct 
contact with pwMS.  They argued that including multiple stakeholder 
perspectives is essential for gaining a holistic view of patient experiences. 
Their findings revealed that HPs not only displayed excellent insight into the 
experiences of pwMS, but that HPs identified a broader range of relevant 
issues than pwMS themselves, such as in relation to patients’ unmet needs.  
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Hence, it was hoped that inclusion of HPs in the current study would lead to 
generation of a wider range of themes related to pwMS’ experiences than by 
interviewing pwMS alone. It was also hoped that inclusion of HPs would 
contribute to identification of unmet needs of pwMS during this transition, and 
the barriers to meeting such needs. 
 
Rationale for Adopting a Qualitative Approach 
There is now a significant body of literature on the use of qualitative 
methodologies in healthcare research, particularly in the study of chronic 
illness (e.g. Barbour, 1999; Charles & Walters, 1998; Williams, 1999, 2000). 
Qualitative methodologies aim to explore phenomena from the perspective of 
those being studied, and strive to provide an in-depth understanding of 
people’s experiences (Spencer et al., 2003).  This is in contrast to quantitative 
methodologies which do not fully embrace the participant’s viewpoint, due to 
their inherent imposing of the researcher’s assumptive framework (Macran et 
al., 1999).  The use of qualitative methodologies is helpful in areas where 
there has been little previous research, and where quantitative methodologies 
may prematurely limit the breadth of one’s exploration (Lyons & Coyle, 2007).  
Given that this study aimed to explore the experiences of people who had 
transitioned from RRMS to SPMS, and in light of the limited amount of 
previous research in this specific area, a qualitative approach was deemed 
more appropriate.    
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Research Questions 
The current study aimed to investigate the following questions. This was 
achieved by interviewing both pwMS and HPs: 
1) How do pwMS experience transitioning from RRMS to SPMS? 
2) How do pwMS cope with this transition? 
3) What are the needs of pwMS during this transition, and the barriers to 
these? 
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CHAPTER 2: METHODOLOGY 
 
SAMPLE SIZE 
The sample consisted of 16 participants, comprising nine people with MS 
(pwMS), and seven health professionals (HPs) (see Tables 1 and 2). All 
participants were recruited from a neurological and neurosurgical hospital in 
London.  There is currently a lack of consensus regarding sample size for 
Thematic Analysis (TA).  The sample size of 16 was within the range of 
sample sizes in published qualitative studies that used TA to explore the 
experiences of pwMS (Malcomson et al., 2008; Edwards et al., 2008; 
Dennison et al., 2010).  The sample size was also comparable to studies that 
used TA as outlined by Braun and Clarke (2006) (e.g. Brown, Whittingham, 
Sofronoff, & Boyd, 2013; Fielden, Sillence, & Little, 2011). Guest, Bunce and 
Johnson (2006) found that six to twelve participants is sufficient to reach a 
point of data saturation when using TA. Given that the current study aimed to 
reach a point of data saturation within the time constraints of the project, the 
sample size of 16 was regarded as sufficient for achieving this aim.    
 
INCLUSION CRITERIA/ EXCLUSION CRITERIA 
People with MS 
Awareness of reclassification of SPMS 
Participant awareness of a confirmed reclassification of SPMS following a 
previous diagnosis of RRMS was required. Such information was recorded in 
participants’ medical notes.  Participant awareness of their reclassification 
was required to eliminate any risk of distress caused by the researcher 
inadvertently revealing a diagnosis that they may not have been aware of.  
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Up to 24 months post-reclassification 
Initial inclusion criteria required that participants would be interviewed within 
twelve months of their reclassification of SPMS in order to minimize the 
effects of recall bias.  However, due to difficulties with recruiting sufficient 
numbers, this criterion was later extended to 24 months post-reclassification. 
 
Fluent in English 
Given the reliance of qualitative approaches such as TA on participants’ 
expression through language, it was decided that participants would need to 
speak English fluently. 
 
Not experiencing onset of a new comorbid condition 
PwMS experiencing onset of a new comorbid condition were excluded in 
order to avoid interference of the impact of the additional condition on their 
recall of the experience of transitioning from RRMS to SPMS. 
 
Health Professionals 
MS Specialist Health Professionals 
A range of MS specialist HPs (three MS Specialist Consultants, one 
Consultant Neurologist, two MS Specialist nurses, and one MS Specialist 
Physiotherapist) who had worked with pwMS who transitioned from RRMS to 
SPMS were recruited given their substantial contact with pwMS and insight 
into their experiences.   
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Table 1: Participant demographics – pwMS 
Participant Time since 
onset of MS 
symptoms 
Time since 
MS 
diagnosis 
Time since 
last 
relapse 
Severity of 
last relapse 
Time since 
reclassification 
of SPMS 
Indoor mobility 
1 10 years 5 years  48 months Severe 12 months Walks unaided 
2 30 years 30 years 33 months Moderate 5 months Walks using stick/frame, or 
holds onto furniture/somebody 
3 11 years 11 years 24 months Severe 1 month Walks using stick/frame, or 
holds onto furniture/somebody 
4 18 years 8 years 24 months Moderate 12 months Walk unaided 
5 4 years 2 years 24 months Mild 1 month Walks using stick/frame, or 
holds onto furniture/somebody 
6 29 years 10 years 12 months Mild 3 months Walks using stick/frame, or 
holds onto furniture/somebody 
7 25 years 25 years 2 months Severe 24 months Walks using stick/frame, or 
holds onto furniture/somebody 
8 22 years 9 years 20 years Severe 21 months Walks using stick/frame, or 
holds onto furniture/somebody 
9 20 years 17 years 24 months Moderate 6 months Walks using stick/frame, or 
holds onto furniture/somebody 
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Table 1: Participant demographics – pwMS (continued) 
Participant Gender Age Ethnicity Marital 
status 
Number of 
dependents 
Education 
level 
Employment 
status 
Occupation Interview 
duration 
(minutes) 
1 Male 49 Indian Married 0 Degree Full-time 
employed 
Test Analyst 22 
2 Female 58 White Married 0 Degree Part-time work Community 
Matron 
42 
3 Female 44 White Divorced 1 Diploma Retired Nursery school 
teacher  
26 
4 Female 52 White Married 3 Degree Part-time work Researcher 44 
5 Female 51 White Divorced 0 Diploma Permanently 
sick/disabled 
Salesperson  65 
6 Female 43 White Cohabiting 1 Higher 
National 
Diploma 
Permanently 
sick/disabled 
HR coordinator  62 
7 Female 44 White Married 0 Degree Permanently 
sick/disabled 
Social worker   81 
8 Male 68 White Married 0 Higher 
National 
Diploma 
Retired Electrical 
engineer 
21 
9 Female 50 White Single 0 Degree Retired Therapist  36 
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Table 2: Participant demographics – HPs 
Participant Gender Age Ethnicity Occupation Time 
working 
with 
pwMS 
Number of patients they had worked 
with who had transitioned from 
RRMS to SPMS 
Interview 
duration 
(minutes) 
1 Female 35 Other 
Asian 
MS Specialist 
Consultant 
9 years >50 36 
2 Female 29 White MS Specialist 
Nurse 
15 
months 
11-50 26 
3 Male 58 White Consultant 
Neurologist 
30 
years 
>50 18 
4 Female 40 White MS Specialist 
Nurse 
7 years                  >50 48 
5 Male 43 White MS Specialist 
Consultant 
15 
years 
>50 30 
6 Female 42 White MS Specialist 
Physiotherapist 
15 
years 
>50 30 
7 Male 41 Indian MS Specialist 
Consultant 
14 
years 
>50 20 
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RECRUITMENT 
 
All participants were recruited from a neurological and neurosurgical hospital 
in London. Participants were recruited via purposive sampling, whereby they 
were sought out deliberately according to specific inclusion criteria relevant to 
the objectives of this study.  This approach is consistent with the findings of 
Guest et al. (2006), whose investigation regarding the minimum number of 
participants required for data saturation in TA, discussed above, was based 
on the use of purposive sampling. 
 
Recruitment of pwMS 
Over approximately 5 months, MS clinic staff (MS consultants and MS nurses) 
identified pwMS who met the inclusion and exclusion criteria.  Participants 
who met these criteria were invited to take part by their clinician during routine 
clinic appointments. They were provided with a Participant Invitation Letter 
(Appendix A), Information Sheet (Appendix C), and a pre-paid return 
envelope.  Interested participants had the option of contacting the researcher 
via telephone using the contact details provided on the Information Sheet.  
Alternatively, if they preferred the researcher to telephone them, participants 
could complete a tear off slip at the end of the Information Sheet, which was 
posted to the researcher’s university department using the pre-paid envelope.  
When speaking to the primary researcher, candidates were given the 
opportunity to ask any questions, and if they agree to be interviewed, a time 
and place was arranged. All pwMS who responded decided to take part. 
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Recruitment of HPs 
HPs were recruited at a service-wide meeting, during which the researcher 
carried out a presentation about the study. Participant Invitation Letters 
(Appendix B), Information Sheets (Appendix D), and pre-paid envelope were 
distributed following the presentation.  Participants indicated their interest in 
participating either in person following the meeting, or contacted the 
researcher via the contact details provided on the Information Sheet.  Once 
again, when speaking to the primary researcher, candidates were given the 
opportunity to ask any questions, and if they agree to be interviewed, a time 
and place was arranged. 
 
 
INTRODUCTION TO THEMATIC ANALYSIS 
Thematic Analysis (TA) is a method for identifying and analysing patterns of 
meaning within data (Braun & Clarke, 2006).  Although previously described 
as a poorly defined, yet widely employed qualitative method (Boyatzis, 1998; 
Braun & Clarke, 2006), TA has recently received recognition as a method in 
its own right (Braun & Clarke, 2006). As indicated by Braun and Clarke, many 
of the past criticisms of TA stem from a lack of clear guidelines for how to 
employ this method. These authors served to remedy this lack of clarity by 
establishing a series of clearly defined phases through which researchers 
must pass in order to carry out TA. These are discussed in detail below (see 
‘Data Analysis’).   
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TA stems from the much older tradition of content analysis (CA), with which it 
shares many of its procedures and principles. CA is an approach for 
determining the frequency of particular categories within data, such as 
specific words or images. CA has received criticism for its often exclusive 
reliance on frequency outcomes, as well as its removal of codes from their 
context, hence reducing their meaning (Silverman, 1993).  TA was developed, 
in part, to move beyond CA’s focus on solely observable material, towards 
consideration of implicit and latent structures within data (Merton, 1975).  
Hence, this method is capable of illuminating both the manifest and latent 
factors contributing to an issue.  It is used not only to minimally organise and 
describe data, but also often includes an interpretation of aspects of the 
research topic (Boyatzis, 1998). 
TA is a flexible approach, in that it can adopt an inductive or ‘bottom up’ 
approach (e.g. Frith & Gleeson, 2004), or a deductive, ‘top down’ approach 
(e.g. Boyatzis, 1998). Its flexibility also means that it is not tied to any pre-
existing theories or epistemological assumptions.  TA can be an essentialist 
or ‘naïve’ realist method, which assumes that data is a simple and direct 
representation of reality, although Braun and Clarke (2006) indicated that they 
themselves do not subscribe to such a position. TA is also capable of 
adopting perspectives at the other end of the continuum, namely 
constructionist or relativist standpoints, which assume that meaning and 
experience are constructed through language as opposed to being inherent. 
Finally, TA can also adopt positions which fall in between these two poles, by 
adopting phenomenological or critical realist perspectives (e.g. Willig, 2013). 
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Whilst the former is concerned with the quality of subjective experience, the 
latter assumes that data is not a direct mirror of reality, but requires 
interpretation in order to further our understanding of phenomena. According 
to Braun and Clarke (2006), whichever position is adopted, it is important that 
researchers make their assumptions explicit.  
 
ADOPTING AN INDUCTIVE APPROACH 
As stated above, the flexibility of TA enables researchers to adopt either an 
inductive or deductive approach. The former is a data-driven approach which 
involves analysing the data without trying to fit it into pre-existing coding 
frames or pre-conceptions. Hence the researcher is guided by the data itself, 
from which themes are derived. Deductive approaches tend to be driven by 
the researcher’s theoretical interests rather than the data itself, and therefore 
are not as capable of generating rich descriptions of the overall data as 
inductive approaches (Braun & Clarke, 2006). In light of a lack of research 
exploring the transition to SPMS, as well as the aims of this study, an 
inductive approach was chosen, as it was regarded as a more suitable means 
of gaining an in-depth and thorough understanding of people’s experiences.  
Inductive TA is commonly used in studies exploring the experiences and 
meanings of individuals (e.g. Brown et al., 2013; Frith & Gleeson, 2004).  
 
EPISTEMOLOGICAL POSITION 
The current study adopted a critical realist approach (Willig, 2013), which sits 
firmly between the opposing poles of essentialism or realism and 
constructionism or relativism.  This approach assumes that although data are 
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capable of revealing the nature of reality, it is not a direct, ‘mirror-like’ 
reflection of such reality. Instead, interpretation is required in order to further 
one’s understanding of the underlying influences that impact on the 
phenomena of interest. Such influences include social, physiological, and 
psychological processes, which may be outside participants’ awareness.  This 
choice of epistemological position reflected a desire to incorporate the 
experiences and insights of participants, the meanings attached to the 
experiences of pwMS, as well as acknowledging the impact of their wider 
context on these meanings. It was felt that this position acknowledged both 
the reality of MS symptoms, as well as the influence that broader socio-
cultural factors have on the experiences of pwMS.  This position was in line 
with the reasoning behind the inclusion of HPs, given their potential to offer 
broader insights onto the factors impacting on patients’ experiences than 
patients themselves (Golla et al., 2012).  Although TA has been described as 
a flexible position in terms of choice of epistemological position, it has been 
suggested that this approach is suited to adopting a critical realist position 
(Harper, 2011). 
 
RATIONALE FOR CHOOSING THEMATIC ANALYSIS 
TA was chosen as the most appropriate method of analysis given the lack of 
research specifically addressing the unique transition from RRMS to SPMS. In 
light of this, it was decided that an approach which identified themes within 
participants’ understanding would provide scope for further investigation in the 
future.  
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TA was also chosen due to its flexibility regarding its epistemological and 
theoretical stance, enabling the adoption of a critical realist perspective, as 
discussed above.  Furthermore, the inherent flexibility of this approach means 
that it is suited to studies which gather and integrate data from multiple 
stakeholders (e.g. Wong et al., 2014; Brown et al., 2013; Jarrett et al., 1999).   
TA is commonly used as a method for exploring people’s experiences (e.g. 
Brown et al., 2013; Fielden et al., 2011; Dennison et al., 2010), as it capable 
of providing rich, detailed and complex accounts of data (Braun & Clarke, 
2006).  
Adopting TA also enabled the researcher to explore process related 
questions, such as how pwMS experienced the transition from RRMS to 
SPMS.  Given the time constraints of a DClinPsych, this would not have been 
possible using longitudinal or quantitative methods. 
Finally, previous qualitative research within the area of MS has employed TA 
(e.g. Dennison et al., 2010), specific guidelines on how to carry out this 
method were available, and the researcher had access to supervision and 
training in TA. 
 
THEMATIC ANALYSIS COMPARED TO OTHER METHODS 
TA was chosen as the analytic method after careful consideration of how the 
research question could be best answered.  A number of other methods were 
considered, but deemed less appropriate than TA for the requirements of this 
study.  
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Discursive approaches (DA) overlap with TA in that they involve a search for 
patterns or themes across an entire data set.  However, DA place significant 
emphasis on the construction of social phenomena through language (Willig, 
2008), as well as the performance aspects of speech.  As a result, there is 
less emphasis on gaining an understanding of the ‘true’ nature of peoples’ 
experiences.  Although the current study acknowledged the impact of 
linguistic, socio-cultural and historical factors on peoples’ experiences, it did 
not regard approaches which viewed participants as merely discursive agents 
as in line with the research aims. 
Like DA, Foucauldian Discourse Analysis (FDA) does not seek to understand 
the true nature of phenomena, but rather how particular versions of such 
phenomena are constructed through language (Willig, 2013). This particular 
approach focuses on how power and culture contribute to the construction of 
dominant discourses, and explores how these discourses relate to peoples’ 
feelings and behaviour (Willig, 2008).  It could have been interesting to have 
focused primarily on the discourses that exist around the transition from 
RRMS to SPMS. This was decided against however, given that this study 
aimed to understand the experiences of pwMS, and to identify ways to inform 
intervention in the real world (Willig, 1999).  
Grounded Theory (GT) was also considered as a potential approach. This 
method focuses on peoples’ responses to social situations, and how their 
behaviour, in turn, influences social processes.  Although GT has recently 
been applied to experiential questions, its overall aim is to identify the social 
processes which underlie and account for such experiences, and to develop 
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theories of such processes (Charmaz, 2006).  The generation of a theoretical 
model of social processes was not the focus of this research, given its primary 
aim of understanding people’s experiences of transitioning from RRMS to 
SPMS.   
Interpretative Phenomenological Analysis (IPA) is another approach that was 
considered, given that it is used for exploring participants’ subjective 
experiences in substantial detail (McLeod, 2001). The primary focus of 
phenomenological research, including IPA, is to gain a better understanding 
of how participants experience the world, often without furthering our 
understanding of the broader factors which shape such experiences, or how 
they relate to external reality (Willig, 2013). Through adopting a critical realist 
approach, TA offered an avenue not just for exploring the reality of pwMS’ 
experiences, but also enabled incorporation of the broader socio-cultural 
factors which contribute to these experiences. IPA involves relatively small 
sample sizes and emphasises idiography rather than generalizability (Smith et 
al., 2009). Given that this study aimed for its results to form the basis of 
interventions for pwMS, an approach such as TA, which involved larger 
sample sizes than IPA, was regarded as more appropriate as it was more 
likely to lead to a point of data saturation (Guest et al., 2006). Furthermore, as 
IPA requires a relatively homogenous sample of participants who are ‘experts’ 
in the experience being investigated, TA was regarded as more appropriate 
given this study’s inclusion of HPs.   
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ETHICAL CONSIDERATIONS 
The study received full ethical approval from the Nottingham 2 – East 
Midlands research ethics committee (Appendix E) and the Psychology 
Department, Royal Holloway, University of London (Appendix F).  The NHS 
Research and Development department at the site of recruitment also granted 
approval for the research to take place (Appendix G).  A substantial 
amendment was later agreed to in order to better facilitate recruitment 
(Appendix H). 
 
Informed Consent 
All participants were over 18 years old and deemed to have capacity.  By 
providing suitable candidates with an invitation letter and information sheet, 
participants were able to decide in their own time about whether to participate, 
and only if interested did they make themselves known to the researcher.  
The information sheet outlined the purpose of the research, what participation 
would involve, the risks and benefits of participating, that it was voluntary, the 
right to withdraw, and how confidentiality and anonymity would be applied. In 
the case of pwMS, candidates were informed that their decision regarding 
participation would not have any impact on their receipt of medical care. 
Informed consent was gained for participation, as well as for recording of the 
interview and the possibility that verbatim extracts could be included in the 
final report.  Participants completed a consent form (Appendices I and J), 
which was countersigned by the researcher. Participants were offered a 
signed copy, and a copy was placed in their medical record. 
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Confidentiality 
The information sheet explained how confidentiality would be applied. This 
was reiterated to participants when gaining informed consent before each 
interview.  Participants were informed of the limits of confidentiality, such that 
disclosure of risk could result in confidentiality being broken. In the case of 
pwMS, participants were informed that their GPs would be notified of their 
participation via letter (Appendix K).  Before participating, they were asked to 
give written consent for this to happen when completing the consent form. 
Participants were assigned an identification number to ensure anonymity.  All 
identifying information was removed when transcribing the data. All data was 
stored securely in a locked cabinet, and electronic data was stored on an 
encrypted USB memory stick which adhered to NHS confidentiality standards.  
 
Risks 
It was hoped that participants would benefit from having an opportunity to 
speak openly about their experiences during the interview.  Given that pwMS 
were recruited from routine MS clinics where their needs would have already 
been thoroughly assessed, it was not expected that further discussion of the 
reclassification of SPMS would be any more distressing than discussing their 
condition at a clinical interview.  However it was acknowledged that the 
interview process had the potential to raise issues that were sensitive and 
distressing for both pwMS and HPs. Potential distress was minimised in 
several ways. Firstly, service user involvement in the development of the 
interview schedule helped to ensure that its wording and structure was 
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sufficiently sensitive and conducive towards the development of rapport 
between researcher and participant. Secondly, participants were informed of 
their right not to answer any question that they wished, and to withdraw their 
participation at any time. Thirdly, the researcher employed their therapeutic 
skills to respond to any participant distress in a sensitive and empathetic 
manner.  All interviews were conducted in a private setting in order that 
participants felt comfortable when discussing potentially sensitive issues.  
Participants were provided with an opportunity for verbal debriefing at the end 
of each interview. They were provided with a debriefing sheet following their 
participation which included an overview of the purpose of the study, the 
researcher’s contact details and, in the case of pwMS, contact details of 
support agencies (Appendices L and M).  In the event that further support was 
necessary, it was agreed that the researcher would either notify the 
participant’s MS team, or discuss with the participant alternative sources of 
support. No participants required this follow-up. 
 
DATA COLLECTION 
Data was gathered via individual face to face, semi-structured interviews, as 
is common in TA (Wilkinson et al., 2004). Given the nature of the research 
question, this was regarded as the most appropriate method of data collection 
as it allowed participants to generate rich and detailed data. Interviews with 
HPs occurred at their place of work, while interviews with pwMS took place at 
their homes.  Given that many pwMS experience difficulty with mobility, this 
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form of data collection enabled pwMS to participate in this study within the 
comfort of their own homes. 
The interview schedules (Appendices N and O) were developed using 
published guidance (Willig, 2013), based on relevant literature, and further 
developed through discussions with research supervisors, fellow qualitative 
researchers, and service users (see Service User Involvement). Each of the 
questions in the interview schedule for HPs mirrored those for pwMS, in that 
they asked HPs about the experiences of pwMS. For instance, whilst pwMS 
were asked ‘How did you deal with the impact of this reclassification?’, HPs 
were asked ‘How do you think pwMS deal with the impact of this 
reclassification?’.  The interview schedule was used in a flexible manner, 
enabling the researcher to ask follow-up questions regarding interesting and 
unanticipated issues that were brought up. Many of the initial questions were 
open and exploratory (e.g. ‘Can you tell me what it was like to receive a 
reclassification of SPMS?’), which allowed participants to provide detailed 
accounts of what was important to them. Interviews lasted between 22 and 81 
minutes for pwMS, and 18 to 48 minutes for HPs.  Interviews were audio 
recorded and subsequently transcribed verbatim by the researcher who 
removed all identifying information. 
In order to contextualise the interview, a demographic questionnaire was 
administered for both pwMS (Appendix P) and HPs (Appendix Q). As with the 
interview schedule, this questionnaire was based on relevant literature and 
developed further through discussions with research supervisors and peers. 
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SERVICE USER INVOLVEMENT 
Two patients with MS who were receiving treatment at the hospital where the 
research was based were asked by their clinician to provide feedback on the 
information sheet and interview schedule. Feedback was integrated into the 
development of these items prior to their use in the study. 
 
DATA ANALYSIS 
The data was analysed using TA as outlined by Braun and Clarke (2006), and 
guided by supervision from a Senior Lecturer in Health Psychology 
experienced in qualitative research. Qualitative software (NVivo 10) was used 
to assist the researcher in managing and organising the data. The stages of 
analysis were as follows. 
Familiarising oneself with the data: All interviews were transcribed by the 
researcher. Transcribing is regarded as an excellent way for researchers to 
begin familiarising themselves with qualitative data (Riessman, 1993). Some 
researchers argue that the process of transcribing is an important phase of 
data analysis in itself, through which the researcher may develop a thorough 
understanding of the data, and through which meanings can be generated 
(Bird, 2005; Lapadat & Lindsay, 1999). After the data was transcribed, the 
researcher further immersed themselves in the data by reading the entire 
dataset a number of times so that patterns of meaning could begin to emerge. 
The recordings were also listened to several times to ensure the accuracy of 
the transcription.  During this phase the researcher took notes and marked 
ideas for coding which they returned to in later phases of the analysis. 
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Generating initial codes: Once the researcher had sufficiently familiarised 
themselves with the data, initial codes were generated.  Codes are defined as 
‘the most basic segment, or element, of the raw data or information that can 
be assessed in a meaningful way regarding the phenomenon’ (Boyatzis, 
1998, p. 63). In light of the inductive approach adopted, coding was aimed at 
simply capturing the meaning contained within data segments, as opposed to 
approaching the data with any pre-existing coding frame.  This process 
involved giving equal attention to the entire dataset, to identify features of the 
data that were of interest, including both semantic and latent content. Initial 
coding revealed substantial overlap between data for pwMS and HPs. 
Following review and discussion with the research supervisor it was therefore 
decided to code the data for pwMS and HPs together as a whole, as in other 
similar studies (e.g. Brown et al., 2013). Given the time constraints of this 
project, separate coding of HP and pwMS data would not have enabled 
reaching a point of data saturation (Guest et al., 2006). Data extracts 
reflecting each code were collated, ensuring that enough of the surrounding 
data was retained in order to retain context (Bryman, 2001).  Data extracts 
were coded as many times as was necessary to ensure that each code 
contained all relevant extracts. 
Searching for themes:  Once the entire dataset had been coded, similar or 
related codes were then organised into potential themes.  All initial codes 
relevant to the research questions were combined into themes. Braun and 
Clarke (2006) also recommend the development of thematic maps to facilitate 
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the generation of themes. These enabled the researcher to consider 
relationships between themes (Appendix R). 
Reviewing themes:  Candidate themes were then reviewed and refined. This 
involved considering whether the collated extracts formed a coherent pattern 
within each theme.  If not, the theme was revised. This was done either by 
renaming the theme, combining overlapping themes, creating a new theme in 
the case of diverse themes, relocating extracts that did not fit into another 
existing theme, or discarding them from the analysis.  This process was 
repeated until all the candidate themes formed a coherent pattern.  Following 
this, the validity of each theme was assessed in relation to the entire dataset.  
This process also allowed for coding of any additional data within themes that 
had been missed in previous coding stages. This process of reviewing and 
refining codes was repeated until a satisfactory thematic map had been 
developed that adequately reflected the dataset (Appendix R). 
Defining and naming themes:   Collated data extracts within each theme were 
then reviewed in order to identify what particular aspect of the data they 
captured.  Themes, including both overarching themes and sub-themes, were 
then defined and named accordingly. Where possible, participants’ own words 
were used as theme labels.  Care was taken to ensure that theme definitions 
and names sufficiently captured the essence of each theme, and adequately 
distinguished them from the other themes. Consideration was also made in 
terms of how each theme related to the overall story that was evident in the 
data. In addition, care was taken to develop short but punchy names that 
captured the essence of each theme. 
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Producing the report: The final stage of report production involved selecting 
examples of transcript to illustrate elements of the themes. These extracts 
clearly identified issues within each theme, and presented a clear example of 
each point that was made. 
 
QUALITY IN THEMATIC ANALYSIS 
Qualitative researchers have for some time been engaged in discussions 
regarding how to assess validity and quality in their research. While the 
criteria used to judge the scientific value of quantitative research are not 
meaningful when applied to qualitative research, evaluating the quality of 
qualitative research is still essential in order that it can make claims and be 
clinically applicable (Yardley, 2008). 
Generic criteria for conducting good qualitative research have been drawn up 
(e.g. Henwood & Pidgeon, 1992; Elliott et al., 1999; Parker, 2004; Yardley, 
2000; 2008), which can be applied to TA (Braun & Clarke, 2006). For 
instance, according to Yardley (2000), qualitative research should 
demonstrate the following: 
 
Sensitivity to Context 
Attention was paid to existing research and theory in the generation of the 
research aims, and considered throughout the analysis.  The involvement of 
service-users in the development of the research, and inclusion of verbatim 
extracts helped to ensure sensitivity to the perspectives and socio-cultural 
context of participants. The researcher strove to maintain an awareness of 
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their own characteristics and assumptions throughout the research process 
(see Researcher As a Person-In-Context), and reflected on these in their 
discussions with the research supervisor about analysis and writing up. 
 
Commitment and Rigour 
To facilitate in-depth engagement with the research topic, the researcher 
observed a specialist MS clinic at the research site which was dedicated to 
supporting pwMS through the transition phase. This enabled the researcher to 
develop a detailed and real-world insight into the context of such clinics, 
including management of the transition phase. To ensure rigour, the 
researcher attended lectures on TA, and consulted published literature to 
develop their knowledge and skills.  The rationale for choosing TA and the 
characteristics of the sample are outlined above, which aim to highlight the 
appropriateness of the sample and technique. 
 
Transparency and Coherence 
To ensure transparency, a clear and detailed account of the sample, design, 
procedures and analysis have been discussed above. In order to allow 
readers to follow how the analysis process took place, details of initial coding 
have been included for a section of a transcript (Appendix S).  Regular 
consultation with both supervisors took place, one of whom has expertise in 
the area of MS and one in qualitative analysis.  Peer supervision was used 
throughout the research process in which sections of the transcripts were co-
analysed to enable the researcher to gain multiple perspectives and facilitate 
cross validation. To provide a credibility check (Elliott et al., 1999) an entire 
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individual transcript was analysed by a fellow qualitative researcher (Appendix 
T), which enabled discussion and agreement of themes.  Candidate names 
for themes were also discussed in peer supervision and with the supervisor in 
order that they could be checked for ‘fit’ with the quotes assigned to them. 
Like Braun and Clarke (2006), Yardley (2000) emphasised the importance of 
providing a clear and convincing argument for how the research was carried 
out, which has been discussed in previous sections. 
 
Impact and Importance   
This aspect highlights the importance of contributing to existing theory and 
understanding regarding the research topic. The aims and unique contribution 
of this research were discussed in the Introduction. The Results and 
Discussion sections will attend to how the findings provide unique and novel 
accounts of the experience of transitioning from RRMS to SPMS, and how 
this may contribute towards psychological theory and practice. 
 
Braun and Clarke (2006) devised a 15-point checklist for good quality TA, 
which is displayed in Table 3 on the following page (Braun & Clarke, 2006, p. 
96): 
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Table 3: Braun and Clarke’s checklist for good quality TA (Braun & Clarke, 2006, p. 96) 
Process No. Criteria 
Transcription 1 The data have been transcribed to an appropriate level of detail, and the transcripts have been checked 
against the tapes for ‘accuracy’. 
Coding 2 Each data item has been given equal attention in the coding process. 
 3 Themes have not been generated from a few vivid examples (an anecdotal approach), but instead the 
coding process has been thorough, inclusive and comprehensive. 
 4 All relevant extracts for each theme have been collated. 
 5 Themes have been checked against each other and back to the original data set. 
 6 Themes are internally coherent, consistent, and distinctive. 
Analysis 7 Data have been analysed – interpreted, made sense of – rather than just paraphrased or described. 
 8 Analysis and data match each other – the extracts illustrate the analytic claims. 
 9 Analysis tells a convincing and well-organised story about the data and topic. 
 10 A good balance between analytic narrative and illustrative extracts is provided. 
Overall 11 Enough time has been allocated to complete all phases of the analysis adequately, without rushing a phase 
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or giving it a once-over-lightly. 
 12 The assumptions about, and specific approach to, thematic analysis are clearly explicated. 
 13 There is good fit between what you claim you do, and what you show you have done – i.e. described 
method and reported analysis are consistent. 
 14 The language and concepts used in the report are consistent with the epistemological position of the 
analysis. 
 15 The researcher is positioned as active in the research process; themes do not just ‘emerge’. 
 
 57 
 
Care was taken to ensure that each of these criteria were met, as outlined 
under ‘Data Analysis’ above. For instance, all interviews were listened to 
several times to ensure accuracy of transcription.  To ensure that no data or 
potential codes had been missed, the researcher reviewed the raw data 
several times. Input from a second coder served to further ensure the 
inclusivity and thorough nature of the coding process. Themes and their 
associated data were reviewed and re-reviewed by the researcher, research 
supervisor and a group of fellow qualitative researchers to ensure their 
internal consistency, distinctiveness, and reflectiveness of the dataset. The 
process of coding and generating themes took place over a period of three 
months, which provided the researcher with sufficient time to carry out high 
quality analysis. As demonstrated, the underlying assumptions and analytic 
process have been clearly outlined. The choice of a critical realist position 
enabled the researcher to be positioned as an active agent in the research 
process, through engaging in interpretation of the data. 
 
RESEARCHER AS A PERSON-IN-CONTEXT 
I am a 30-year old white Irish Trainee Clinical Psychologist.  I am a healthy, 
able-bodied individual who has previously experienced a number of minor 
health complaints which, for some time, were outside of my control, and the 
control of the health professionals that I sought treatment from.  The impact of 
these conditions on my overall quality of life was minimal relative to that of 
chronic illnesses such as MS, but yet I can recall the frustration and distress I 
experienced when I was initially unable to alleviate such conditions.  These 
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experiences, coupled with insight into the experiences of one of my closest 
friends who has been living with a chronic illness for the past decade 
contributed to my interest in living and coping with chronic health conditions.  
Such interest is partly underpinned by a sense of relief and gratitude as a 
result of being able to regain my own health, and admiration for the resilience 
displayed by my friend in living with a life-long, challenging illness.  
My interest in MS specifically stemmed both from the aforementioned factors, 
as well as interactions that I had with a number of pwMS during my career 
prior to clinical training.  Although brief, such encounters highlighted the 
disempowering and degrading aspects of the disease. I strove to maintain 
awareness of this pre-conception throughout data collection and analysis.  I 
informed participants that I did not have previous research experience in MS, 
and that my clinical experience in this area was limited. This allowed me to 
carry out the research interviews from a position of naivety and curiosity, 
whilst positioning participants as experts of their experience.  I think that such 
positioning was conducive towards suspension of my own understandings 
and experiences.  Furthermore, I hope that the use of service user 
involvement and open questions allowed me to minimise my own 
assumptions when communicating with the participants. 
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CHAPTER 3: RESULTS 
Four main themes were generated from participants’ accounts. These are 
illustrated below, along with sub-themes (Table 3). Generation of these 
themes was influenced by several factors.  Firstly, they reflect what was 
central and prevalent across participants’ accounts.  Furthermore, in ensuring 
impact and importance (Yardley, 2000), the researcher maintained a focus on 
themes that were unique and relevant to the research aims, so as to capture 
the most salient and unique aspects of the transition to SPMS. 
Themes are presented as a narrative account of the data, as recommended 
by Braun and Clarke (2006).  Verbatim extracts from participants have been 
presented throughout. These were selected as they were felt to best capture 
the theme being described, enabling evaluation of the degree of ‘fit’ between 
the data and interpretation (Elliott et al., 1999). The number of participants 
contributing to each theme is presented in Table 3.   
To ensure a clear account, some quotes have been edited. The omission of 
non-relevant data is indicated by ‘.….’  When dialogue from the interviewer is 
included within quotes, this is indicated by ‘I’.   
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Table 4: List of Themes 
Theme Sub-Themes Number of 
participants 
contributing to the 
theme3 
1: Is this 
Really 
Happening? 
 Noticing a gradual decline 
 I couldn’t really make sense 
of it 
 Soldiering on 
 Preparing oneself 
 Limbo 
 I wish they had prepared me 
9 pwMS; 7 HPs 
7 pwMS; 6 HPs 
 
5 pwMS; 6 HPs 
6 pwMS; 7 HPs 
7 pwMS; 6 HPs 
6 pwMS; 7 HPs 
2: Becoming 
a Reality 
 Shock and devastation 
 It makes sense 
 Turning point 
 What does this mean? 
 It needs to be done in the 
right environment 
5 pwMS; 7 HPs 
7 pwMS; 5 HPs 
7 pwMS; 1 HP 
9 pwMS; 7 HPs 
8 pwMS; 5 HPs 
3: A life of 
struggle 
 It’s all downhill from here 
 This can’t be happening 
 One’s world just shrinks 
 Living with frustration 
8 pwMS; 7 HPs 
5 pwMS; 4 HPs 
8 pwMS; 4 HPs 
8 pwMS; 6 HPs 
4: Brushing 
oneself off 
and moving 
on 
 I accepted it because I’d 
already resigned myself to it 
 Living differently 
 Drawing on support 
 Doing all I can do and 
accepting the rest 
 Making the most of it 
5 pwMS; 4 HPs 
 
5 pwMS; 3 HPs 
8 pwMS; 7 HPs 
7 pwMS; 6 HPs 
 
8 pwMS; 5 HPs 
 
                                                 
3
 Numbers are out of a total of 9 pwMS and 7 HPs 
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THEME 1: IS THIS REALLY HAPPENING? 
Participant accounts indicated that before being reclassified with SPMS the 
majority of pwMS noticed changes in their disease pattern. Whilst there was 
some variation in how pwMS made sense of and responded to these 
changes, what was central to participant accounts was a lack of clarity about 
the meaning of these changes.  This theme captures this process of noticing 
changes in one’s disease pattern, and its associated lack of certainty.  It also 
captures the responses of some pwMS to such uncertainty through striving to 
make sense of such changes, and the struggles of some pwMS to face the 
potential for a reclassification of SPMS.   The title of this theme aims to 
encapsulate all of this: the reality of the changes in one’s condition, the 
associated uncertainty, and the varied responses of pwMS in trying to cope 
with, and make sense of, this uncertainty.   
 
Noticing a gradual decline 
The accounts of pwMS indicated that they had all noticed changes in their MS 
before being reclassified with SPMS.  This was also reflected by HPs. The 
changes were often described as a slow, gradual decline in one’s physical 
abilities as pwMS gradually lost control over their bodily functioning. The 
following quote captures the subtly evolving, yet conspicuous, nature of these 
changes: 
 
I noticed a gradual declining of my health, my ability to walk and 
balance, and I noticed that it was harder to, for example, walk in 
curves. I had to stop, walk in straight lines, turn, you know, each time, 
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stop and turn, and then walk, stop and turn and walk….. And 
sometimes, I mean, my legs would behave a bit like supermarket 
trolley wheels. They, kind of, didn’t go the direction I was walking in….. 
It’s gradually though - nothing happened very suddenly. PwMS 3 
 
Many pwMS described noticing, often in hindsight, that they had been 
struggling to carry out their usual activities. Given the gradual nature of their 
declining abilities, awareness of such a decline may have been more readily 
apparent via such retrospective observations: 
 
But, with hindsight I’ve noticed that each year there are things that I 
could have done fairly easily the previous year that I would now be 
struggling with this year. PwMS 6 
 
Several participants described becoming aware of a lack of “ups and downs” 
(pwMS 9) in their condition, which had characterised the RRMS phase. 
Instead, participants described a gradual and irreversible accumulation of 
disability: 
 
I did relapsing, but I didn’t do remitting….. if I did a relapse that was - 
that was where I stayed. Um, and nothing ever got any better. PwMS 4 
 
Some HPs added that family members would sometimes point out these 
changes to pwMS, further contributing to their awareness of such changes: 
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…their family members might start, um, to pick up on things, and will 
constantly reactivate the whole process of “Are you sure you’re ok?” 
That kind of thing… HP1 
 
I couldn’t really make sense of it 
Participants’ accounts captured how the period before the official 
reclassification was often characterised by uncertainty about the underlying 
cause or meaning of the changes described above. They described how such 
uncertainty stemmed, in part, from the subtle, transitory nature of the 
transition, making it difficult to determine if progression was, in fact, taking 
place: 
 
I think people do fluctuate from day to day, and week to week. So 
sometimes it takes some time for people - like a number of weeks or 
months, perhaps - to start to think about is this a slow progression, or is 
this that I’ve just had a bad few weeks? HP 6 
 
Many participants indicated that there was often no clear-cut line between 
RRMS and SPMS, and that even with hindsight it could be difficult to 
determine at what point one had transitioned into SPMS: 
 
I think it’s very hard to say when you cross the line… um… so there 
isn’t any difference. It’s a gradual declining, rather than anything very 
sudden. PwMS 3 
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Several participants described a lack of clarity about the underlying cause of 
the aforementioned changes in one’s disease pattern. Although they had 
noticed such changes, some pwMS were not aware of the potential for 
disease progression: 
 
…we do get patients who -  they’ll say that their symptoms have been 
getting worse for a few months, and it’s obviously not a relapse, but 
they might not realise that actually it’s just their condition deteriorating. 
HP 2 
 
This is further highlighted by the account of one pwMS, whose RRMS had 
previously been described as ‘Benign’4 by her MS team. As a result she 
thought that her deterioration was a consequence of nerve damage stemming 
from a previous relapse, and did not appear to have been aware of the 
possibility of SPMS: 
 
 … the sense I made of it was I think it’s because the first relapse, 
which was so bad, that compared to the rest of me, or the rest of my 
experience, um, I just thought it was nerve damage. PwMS 7 
 
Soldiering on 
This sub-theme captures how some pwMS struggled to face or acknowledge 
the underlying cause of the changes in their disease pattern and to seek 
                                                 
4
 Benign MS is a form of RRMS, still characterised by periods of relapse and remission, but involving 
relatively milder symptoms initially, or greater effects on one’s sensory experience compared with 
mobility.  
 65 
 
appropriate help.  It highlights how some pwMS responded to the uncertainty 
surrounding the changes in their condition by attempting to ignore or deny the 
possibility of transitioning to SPMS.  
A number of participants described how some pwMS attempted to attribute 
the changes in their disease pattern to causes other than a transition to 
SPMS, such as the effects of a relapse, or insufficient physiotherapy.  Their 
accounts suggested that this may have been due to a view of SPMS as the 
worst possible outcome: 
 
I thought that it was a relapse, and that they would get better….. I 
couldn’t face the fact that it would just - that that’s it. That’s too, kind of, 
a final thing. PwMS 9 
 
A number of participants also described how many pwMS at this stage 
struggled for some time without accessing support from services: 
 
I never went to the GP... I wasn't really in touch with anyone about it. 
PwMS 2 
 
… quite often there’ll be people that come to the attention here, that 
maybe have been floundering out in the community, that they weren’t 
known about..… that’s the difficulty.   HP 4 
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Preparing oneself 
This sub-theme captures how some pwMS responded to uncertainty 
regarding the meaning of the changes in their condition by psychologically 
bracing themselves for a reclassification of SPMS. This sub-theme also 
acknowledges a residual uncertainty stemming from a lack of confirmation of 
a reclassification. 
Although lacking in certainty about the meaning of the changes in one’s 
condition, a number of participants described a process of adjusting one’s 
mind-set in relation to one’s disease, in which pwMS acknowledged the 
possibility of a transition to SPMS: 
 
…sometimes I just thought I can’t move from my car, I’m just so tired. 
So I suppose the experience then… I was preparing myself thinking my 
MS is getting worse. PwMS 2 
 
As part of this process, some pwMS sought information about SPMS in order 
to further their understanding of it and prepare for what potentially lay ahead: 
 
…at that stage then you start looking at what to expect if you’re 
entering that phase. And that’s when I starting reading things about 
fatigue and heaviness in the legs….. I read up bits and I thought 
yes..… I think I am. PwMS 2  
 
PwMS and HPs indicated that this process of preparing oneself was often 
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accompanied by anxiety and dread about the possibility that one was 
transitioning to SPMS:  
  
 I: And what sense did you make of it - the fact that it was getting 
worse? 
  P: I must be….. I must have gone through the Relapsing Remitting - I 
must be at the Secondary Progressive stage, and this is going to get - 
you know, this is bad news. PwMS 4 
 
Limbo 
This sub-theme captures the consequences of interplay between some 
pwMS’ desire to receive clarification regarding the changes in their condition, 
and the challenges faced by HPs in reaching the level of certainty required to 
provide such clarification. The title of this sub-theme aims to encapsulate the 
uncertainty inherent in the resulting delay in clarification.  
Some pwMS sought clarification from their MS team regarding the changes in 
their disease pattern, and asked if such changes could be attributed to a 
transition to SPMS: 
And it’s not unusual for people with MS to actually ask me whether I 
think they’ve started progressing - started to enter the progressive 
phase. HP 5 
 
Many participants described reluctance on the part of HPs to officially 
reclassify patients with SPMS. This was viewed by several participants as 
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hindering one’s process of acceptance and adjustment to living with SPMS: 
 
 … you’re waiting all that time knowing in your head that I’m not getting 
better, but not being able to have that label….. it makes the acceptance 
process a lot longer, because you’re sitting there and not knowing for 
ages. HP 2  
 
A number of reasons for such delays in reclassifying pwMS were described by 
both HPs and pwMS.  They highlighted how the complex and ever-changing 
nature of MS may have posed challenges for MS consultants in determining 
whether pwMS met diagnostic criteria for SPMS: 
 
… there’s always been people who it looked like their MS was 
changing, they were going through that transition phase, and then 
suddenly they’re having very clear relapses again.  HP 4  
 
Such reluctance to reclassify patients also stemmed from concern regarding 
the psychological impact that such a reclassification could have on patients: 
 
… it is one of the main reasons why, um, clinicians are hesitant with 
giving a diagnosis of, um, transition, but it’s quite a devastating -  
there’s no way of lessening that blow once you do actually give it. HP 1 
 
One consultant described the difficult impact that reclassifying patients could 
have on HPs themselves, which may have further contributed to their 
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reluctance to reclassify pwMS until a sufficient degree of certainty had been 
reached:   
 
…the person delivering the news will be demonised. And, um, however 
much they don’t want to be in that role….. everyone wants to be 
liked….. wants to do something positive. And actually being in the role 
of a doctor often means you’re bringing quite negative things to a 
discussion… and it is not nice. Um, and it takes a while for people to 
recognise that, at some level, it’s not personal. HP 5 
 
Overall, this sub-theme captures the unresolved nature of the waiting period 
experienced by many pwMS in advance of being reclassified with SPMS.  
Although pwMS shed some light on the barriers to resolving this ‘limbo’ 
period, the added insights and perspectives of HPs provided further 
clarification regarding these issues. 
 
I wish they had prepared me 
In light of the above, this sub-theme captures the need to have sufficiently 
prepared pwMS for the potential transition, expressed by both pwMS and 
HPs. It links with the overall theme in its acknowledgement of the confusion 
and uncertainty experienced by many pwMS regarding their changing 
condition, and the role that education could have had in resolving this to some 
extent.  
Both pwMS and HPs described forewarning and education about SPMS as 
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important, but sometimes lacking, in preparing pwMS for the transition: 
 
 …what would be helpful is if the consultants or the medics had actually 
said well this is where it goes..… this is how it can go - steel yourself. 
PwMS 4 
 
A number of barriers to preparing pwMS for the transition were identified. 
Given that the transition is not inevitable, some HPs were reluctant to inform 
patients of its potential occurrence as they did not want to worry them: 
 
…when they’re Relapsing Remitting, you don’t want to really go on too 
much about Secondary Progression, because it’s a bit of a negative 
way of looking at things. You want to be optimistic, and you don’t want 
to emphasise that too much, because the patient will go away feeling 
very depressed. HP 7 
 
Furthermore, it may have been difficult for pwMS to take on board information 
about a potential transition to SPMS, particularly at an early stage of the 
disease: 
 
…it’s very difficult for someone to take that on board early on, um… 
and probably even when things are stable, because they don’t want to 
be reminded about it, and it’s natural to put, um, less palatable 
outcomes to one’s side… HP 5  
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In light of these challenges, several participants suggested that although 
preparatory education about the transition should be routinely provided, it 
ought to occur following the initial diagnosis of MS, after pwMS have had time 
to process the news of their diagnosis: 
 
I think at some level it should be introduced very early on as well, but 
not with the initial diagnosis - there’s enough to deal with there. But I 
think there may well be a role for follow up briefing sessions a year or 
two down the line when people are settled into where they are with the 
diagnosis, understand what that means for them, and now want to 
know what that means for the longer term. HP 5 
 
 
  
 72 
 
THEME 2: BECOMING A REALITY 
This theme encapsulates participants’ accounts of how, regardless of the 
extent to which pwMS expected it, the reclassification of SPMS served as a 
point of confirmation of one’s disease status.  It captures the shock and 
distress experienced by many pwMS on being reclassified, given prevalent 
understanding of SPMS.  It highlights how being reclassified provided often 
long-awaited clarification regarding the changes that pwMS had noticed in 
their disease pattern, and frequently served as a turning point towards greater 
acknowledgement of their condition.  This theme also acknowledges the 
importance of careful consideration on the part of HPs regarding how the 
reclassification was communicated, given its significance for pwMS, and the 
varying degrees to which they may have expected it.  The title of this theme 
aims to encapsulate all of this, through its capturing of the clarification and 
confirmation regarding one’s condition provided by the reclassification, and 
the implications of this. 
 
Shock and devastation 
This sub-theme captures participants’ accounts of shock, fear and a loss of 
hope experienced by many pwMS on being reclassified with SPMS.   Several 
pwMS described the reclassification as having arrived completely out of the 
blue.  The extent of the shock experienced by some pwMS was captured by 
one participant who referred to the reclassification as comparable to her initial 
diagnosis:  
   
 73 
 
Um, it was a shock. Once I’d sort of absorbed, processed the 
information it was a shock. It was a bit like hearing you’ve got MS for 
the first time, honestly.  PwMS 3 
 
This sense of shock was also described by several HPs: 
 
… then others it’s a complete, um, shock for them, and they had no 
idea, and it takes a lot of getting over, so. HP 2 
 
As demonstrated by the following quote, some pwMS hid their shock from the 
health professional who delivered it: 
  
I just shrugged it off, and ….. [ doctor] said to me at the time "how are 
you with this news?"  And I just said "yeah, yeah, I’m fine - it doesn’t 
change anything"  PwMS 3 
 
Several participants referred to a process of gradually coming to terms with 
the shock of the reclassification over time: 
 
… initially it may just be a mental block in not understanding what’s 
actually been discussed. It can take some time for them to… to 
process it. HP1 
 
Several participants described the reclassification as associated with a loss of 
hope in light of a lack of treatment options for SPMS. As a consequence many 
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pwMS may experience fear about their prognosis: 
 
… most people see the Secondary Progression as the bit that "oh 
they’re going to tell me to come off the drugs, and now there’s nothing 
else I can take for my MS… nothing else is going to slow it down," and 
they get really anxious about it. HP 4 
 
It makes sense 
For some pwMS, the reclassification helped to provide clarification about the 
changes that they had noticed in their disease pattern. A few pwMS described 
how their new diagnostic label felt more in line with their experience than their 
previous label of RRMS had: 
 
Um, it was kind of just… well, that makes sense more than up and 
down. It’s not up and down. It just made sense to me, in what was 
happening to me…… it just described the condition more. PwMS 9 
 
HPs also acknowledged how the reclassification may have enabled pwMS to 
make sense of their condition: 
 
Some of them, um, they’re quite happy to have that diagnosis because 
it helps them understand why their condition’s getting worse without 
having relapses, and why they’re feeling as bad as they do, whereas 
they’d been quite steady for a while just having relapses and then 
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going back to their normal. So, sometimes it’s nice to have a label for it. 
HP 2 
 
Some participants described how the reclassification served to confirm pwMS’ 
suspicions about the nature of their condition.  For some, the experience had 
been somewhat expected, and was described as not much of a shock: 
 
Secondary Progressive one was a bit like - it was more expected. It 
was more expected. It wasn’t really a huge shock.  PwMS 6 
  
Several participants’ accounts highlighted how although, for some, the 
reclassification was somewhat expected, it still served as a psychological 
blow: 
 
I don’t think it’s so unexpected for most people. But the other side of 
that is that it’s the last thing they want to hear. HP 3 
 
Turning point 
Several participants’ accounts highlighted how the reclassification served as a 
turning point for many pwMS, leading to greater acknowledgement of their 
MS.  A small number of participants described how they had not taken much 
heed of their initial diagnosis of MS, but when reclassified with SPMS they 
had begun to consider the implications of their condition on a new level: 
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… being told I had MS just washed over me.  I just ignored it. But uh, I 
didn’t feel the same when he told me it was Progressive. [I: In what 
way? How was it different?]  Um, it just felt more serious. Yeah, I 
thought I'd better start doing something about it. PwMS 8 
 
For instance, some participants described how the reclassification signalled a 
need to put safeguards in place for the future: 
 
I think it’s made me, eh, want to be more aware of what could happen. 
I’ve always, um, not wanted to know….. I didn’t want to know what was 
around that corner, and I suppose being reclassified I now want to 
know what’s around the corner so that I can be prepared for it. PwMS 3 
 
For many, the reclassification signalled a need to adjust one’s lifestyle in 
accordance with one’s degree of disability: 
 
I started then to rethink….. well I am now in Secondary Progressive 
MS… I have got to rethink my life. PwMS 2 
 
Some participants described how this turning point was accompanied by a 
sense of relief. This appeared to reflect the extent to which pwMS had been 
struggling with the deterioration in their condition up until that point, and the 
difficulty that they had been experiencing in fulfilling their roles.  The account 
of one pwMS suggested that the reclassification signalled a form of 
permission to withdraw from many of the roles that she had been struggling 
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with: 
 
… it was a relief because I was able to then rethink, and think well 
actually I can’t do all those things now, I know I can’t do all those 
things, and I’m not going to be able to do them. So I’ve had to redesign 
my social life.  PwMS 2 
 
The accounts of several participants highlighted how, even for those who had 
been expecting it, the reclassification provided confirmation about the need to 
make adjustments in one’s life.  In this sense, it served as a turning point at 
which pwMS felt it was at last appropriate to make the necessary 
adjustments: 
 
 I was ready for my wheelchair a long time ago. But it’s a big step to go in a 
wheelchair….. I think if the doctor would have confirmed to me earlier that 
I had, um, Secondary Progressive MS, I probably would have looked into 
those aids quicker….. I always thought if it’s Relapsing Remitting, what do 
I do with a wheelchair? I have to just give it back again. But then, when it’s 
confirmed you think, yeah, now I want all of this. PwMS 5 
 
What does this mean? 
Several participants highlighted the value of providing pwMS with information 
and support to enable them to negotiate life with SPMS.  This sub-theme links 
with the overall theme in its implicit acknowledgement of the significance of 
the reclassification of SPMS for pwMS, and the importance of factors 
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contributing to their experience of this process. 
Both pwMS and HPs emphasised the importance of providing pwMS with 
sufficient information about SPMS and its implications for their lives. This was 
described as often lacking, with some pwMS being left uncertain about the 
implications of their new diagnostic label. The accounts below suggest a 
sense of abandonment by professionals at this stage: 
 
I had one patient who, um, she got told by the registrar "oh you’re 
Secondary Progressive now," and that was it….. Didn’t get told 
anything about it, didn’t get told what it was, what it meant for her - 
nothing. HP 2 
 
Several pwMS and HPs highlighted the value of providing pwMS with a sense 
of hope about their prognosis. Participants identified a number of means 
through which this could be achieved, such as by emphasising the variability 
of SPMS, informing pwMS about potential future treatments, and presenting 
them with options for participation in clinical trials:  
 
… she was going to write to a couple of consultants to ask if I could 
join, um, some research programmes. So I actually did find that really 
reassuring, because I thought well….. she’s now saying there may be a 
disease modifying drug out there that can slow down the progression. 
PwMS 2 
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I certainly emphasise the variability, so that even though you’re….. in 
the Secondary Progressive phase, it’s still a very variable phase.  
Some people do get worse quite quickly, others plateau for a long time, 
so I focus on doing all you can to have as good an outcome as you 
can. HP 3 
 
Additionally, several participants highlighted the importance of signposting to 
sources of support to assist them with their current and future needs: 
 
I think they should give you a little bit more support, I suppose, with, 
um, pointing you in the right direction to somebody who can give you 
the advice that you need…… maybe more information about the kit 
that’s available to you -  either through social services, or through, you 
know, mobility shop type… PwMS 3 
 
Likewise, several participants, both pwMS and HPs, emphasised the value of 
follow-up support following the reclassification, both immediately following the 
reclassification (e.g. a debriefing session with a MS nurse), and in the weeks, 
months and years beyond.  This was regarded as important, in providing 
pwMS both with further information and emotional support, but often lacking 
compared to the initial diagnosis, once again contributing to a sense of 
abandonment by professionals: 
 
… rather than wandering out and queueing at the desk to make 
another appointment, I suppose it would be useful sometimes if 
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somebody was around to say….. "how are you doing? Is there anything 
you want to talk about?” Or “how can I help you?" ….. that would have 
been helpful. PwMS 2 
 
I think one of the big differences as well is that at diagnosis there is a 
lot of support there… there’s follow-up, um, nursing support….. there’s 
lots going on….. But then, I think a lot of them are just left to it when 
they get the Secondary Progressive diagnosis.  HP 2 
 
A number of HPs highlighted some of the challenges in providing pwMS with 
appropriate signposting and follow-up support.  These included lack of 
familiarity with pwMS’ local services, in terms of what is available, and local 
referral processes: 
 
I mean, one barrier for us here is that we’re a tertiary referral centre, so 
we see people from a massive geographical distance. And so the 
question is whether you follow them up here, or whether you try and 
link in with local support systems. But I think because you’re not 
practising in the locality, you don’t necessarily know all the systems 
that are there. So you’re having to work across barriers of, you know, 
who’s the MS nurse who works in Berkshire? And what hospital are 
they in? And how do I get a referral to that MS nurse? Is it the GP, or 
can I directly refer? HP 6 
 
In spite of the shortcomings and challenges described above, a small number 
 81 
 
of pwMS described a degree of satisfaction with some of the follow-up support 
and signposting provided. Once again, this highlights the importance of these 
factors in supporting pwMS through the reclassification process: 
 
I think the most helpful thing for me throughout this whole journey….. 
and the most comforting thing, has been having phone numbers for 
people you can contact, and know that they will come back to you.  
PwMS 6 
 
In light of the above, many participants described the availability of a 
specialised clinic aimed at supporting pwMS through the transition as helpful 
in addressing the needs of pwMS, in both the short- and long-term: 
 
… she referred me to the transitions clinic, which was really helpful, 
because it plugged me into loads of other things. PwMS 7 
 
It needs to be done in the right environment 
This sub-theme captures participants’ accounts of the importance of creating 
an appropriate space for delivering the news of the reclassification.  Whilst the 
focus of the previous sub-theme was on provision of information and support, 
this sub-theme concentrates on the environmental and interactional aspects 
of the reclassification process highlighted by participants. Like the previous 
sub-theme, this sub-theme links with the overall theme in its 
acknowledgement of the significance of the reclassification for pwMS in its 
focus on the implications of this. 
 82 
 
The accounts of several participants captured the importance delivering the 
news of the reclassification in an empathetic manner.  While some pwMS 
described how helpful their consultant’s empathy was during their 
reclassification, other pwMS and one HP, a MS nurse, described this as 
sometimes lacking: 
 
I think the medics need better training around communication and 
empathy. I think they don’t realise - they don’t think what that would 
mean to them if they were told that. HP 2 
 
A number of pwMS described the meeting in which they were reclassified as 
too brief, explaining that it did not allow them enough time for them to ask all 
their questions. This was also acknowledged by HPs: 
 
I didn’t have room to ask all the questions I needed to at the time. 
PwMS 7 
 
… sometimes their consultations are really rushed and they don’t get 
time to ask questions with the consultants. HP 2 
 
A few HPs and one pwMS acknowledged the challenges faced by HPs in 
allocating sufficient time for delivering the news of the reclassification, given 
service limitations: 
 
 83 
 
… the diagnosis is often delivered in an outpatient department, where 
our clinics are generally fairly heavily booked or overbooked, where, 
um, the news is broken in as sensitive a way as it possibly can be, but 
with full awareness that this person only has a limited amount of your 
time allocated to them…… it’s very difficult to carve out extra time to do 
that, even though you would want to. HP 5 
 
A number of participants highlighted the value of continuity of care when 
delivering the news of the reclassification of SPMS. This was regarded as 
important, as it could enable the development of familiarity and trust between 
patient and HP: 
 
… it can be through their MS nurse specialist. They may have built up 
a bond with one particular nurse specialist. In some centres they have 
their own dedicated nurse specialist who they get to know well, and 
they trust. Um, it’s best done by someone they know, really - who 
they’ve met before, ideally - who knows their condition. HP 7 
 
Continuity of care was also described as important in ensuring consistency in 
the information delivered to pwMS, so as to avoid conflicting messages: 
 
I think such discussions need to be led by the physicians who are in 
charge of patients, um, because obviously it’s a matter of trust..… if it’s 
done randomly by different people that trust is often lost, and so it’s 
important that such a sensitive topic is done by physicians….. or else 
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you can get into a lot of trouble where there is conflicting information…   
HP 1 
 
A number of participants highlighted the importance of the reclassification 
being delivered by sufficiently experienced HPs.  Experience was regarded as 
important, both for ensuring a correct diagnosis, and that the reclassification 
was delivered in an appropriate manner: 
 
… sometimes if patients are being seen by junior doctors there may be 
not an understanding of what’s going on, so it may be interpreted in a 
different fashion, or it may be interpreted more negatively than what a 
clinician who has seen a spectrum of disorders might….. experience is 
definitely needed on how to have this consultation. HP 1  
 
A small number of participants described privacy as valuable during 
communication of the reclassification. One pwMS recounted how the meeting 
in which she was reclassified was attended by a visiting doctor, which 
impacted on her ability to process the news in the meeting and provide 
genuine feedback to her consultant about its impact on her: 
 
I had a student doctor - no, a visiting doctor from … [hospital] who… 
[consultant] had asked to be in the room, and I’d said yes…… I think I 
just shrugged it off, and … [doctor] said to me at the time "how are you 
with this news?"… and I just said "yeah, yeah, I’m fine… it doesn’t 
change anything"….. had the visiting doctor not been in the room I may 
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have thought about it a bit more while I was in there….. I think having 
the visitor in the room probably wasn’t right for me personally. PwMS 3 
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THEME 3: A LIFE OF STRUGGLE 
This theme captures some of the challenges described in participants’ 
accounts of life following the reclassification itself, as well as some of the 
emotional and behavioural responses of pwMS. As the title of this theme 
suggests, the focus of this theme is on the struggles captured in many 
participants’ accounts of the transition, including its negative consequences 
for the lives of pwMS and their families. This theme also incorporates some of 
the emotional and behavioural responses of pwMS to the transition, which 
may have inadvertently compounded the extent to which they struggled with 
this process. 
 
It’s all downhill from here 
The title of this sub-theme aims to encapsulate some of the reactions to the 
transition described by participants, characterised by a sense of fear and 
dread about the future, and a gloomy resignation towards an inevitable 
decline in one’s condition.   
Some participants described a sense of giving up and resigning oneself to the 
loss of one’s abilities. Given the withdrawal of treatment associated with 
SPMS, participants described a view of SPMS as unstoppable, resulting in a 
loss of self-efficacy. This may have led some pwMS to have assumed a 
passive stance in relation to the deterioration of their condition: 
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… some give up hope ….. they don’t see that there’s much that they 
can do, so they say “oh physiotherapy’s not going to help me…” … 
there’s nothing for me now.   HP 2 
 
One HP described how, in response to a reclassification of SPMS, pwMS 
experienced anxiety about the implications of having SPMS on their ability to 
fulfil their roles in the future: 
 
I think people often worry about the future, and if they’ve got young 
children, how they’re going to fulfil that role as a parent.  HP 6 
 
Both HPs and pwMS described excessively dwelling on the implications of 
one’s condition, and catastrophizing about the future as unhelpful: 
 
I think dwelling too much on the worst case scenario is not going to be 
good. Um, so yeah, that’s probably not a good way to deal with it. HP 7 
 
Several participants described how some pwMS withdrew from others 
following the reclassification, and refused support: 
 
a lot of patients report that as the disease progresses they lose a lot of 
people around them, and I think that is partly because they won’t 
accept help, and they do push them away a bit. HP 2 
 
A number of pwMS and HPs highlighted how this may have stemmed from a 
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desire not to burden others: 
 
Umm, and then they don’t want to be a burden on their children 
etcetera.  There’s lots of baggage which surrounds it. HP 1 
 
One HP described how, for a particular pwMS, the future implications of 
having SPMS were so intolerable that she felt that she had no choice but to 
end her life: 
 
I had a really lovely, lovely lady who, eh, I saw in my old job who was 
quite desperate to end her life….. she decided that she could not live 
with the Secondary Progressive MS….. I think she made a conscious 
decision that she would die… so she just, bit by bit, stopped eating. 
And went, you know, went from being this, sort of, quite upbeat person 
sitting in the wheelchair… she’d had her first line treatment, she’d been 
on the tysabri infusions… and suddenly it went into Secondary 
Progressive, and she was quite adamant….. that she didn’t want to be 
granny in a wheelchair. And, nine months later her body just gave out 
ago. HP 4 
 
This can’t be happening 
This sub-theme focuses on participants’ accounts of the difficulty experienced 
by many pwMS in coming to terms with the irreversibility of SPMS.  A number 
of pwMS described struggling to accept the new stages of disability which 
accompanied their SPMS.  Their accounts often captured a sense of 
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resistance against letting go of previous activities and approaches, and 
making adjustments in line with the extent of their disability: 
 
… at some stage I’m going to have to look into getting a stair lift. I 
mean I’m resisting it…… if I can struggle up those stairs, I will. PwMS 4 
 
The accounts of several participants captured how, following the 
reclassification, some pwMS attempted to ignore the reality of their condition 
and tried to soldier on in spite of it: 
 
I had a chap….. he’s a black cab driver. And I would say even now, 
he’s probably still crawling across his gravel front lawn to climb into his 
taxi, which has been adapted, to go to work….. and you’ve got some 
people who will battle on, and battle on, and they’ll do things by, you 
know, like that chap….. literally crawling out across a gravel front drive 
to get into a taxi to then go to work. HP 4 
 
Some participants described high levels of distress which accompanied being 
confronted with new levels of disability, and all that it entailed.  One pwMS 
described difficulty integrating a new stage of disability into her self-concept: 
 
So like, when I started to use an intermittent self-catheterisation to go 
have a wee, um,  I was off sick from work for three weeks, because I 
was just like “I can’t ****ing do this! I’m not a disabled person. This is 
not me.”  PwMS 7 
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Some participants described efforts of pwMS to identify means of alleviating 
SPMS. These sometimes included invasive and potentially painful measures, 
which was likely to reflect the extent to which pwMS were struggling to accept 
the irreversibility of their condition: 
 
… they’re getting more desperate about the fact that they are getting 
more disabled, so they will try all the faddy things that are out there on 
the internet, be it the extreme diets, or, eh, I had somebody who went 
to Dubai and had their atlas bone - a bit of bone chipped out of their 
neck because somebody on the internet said that would stop their MS 
in its tracks. HP 4 
 
One pwMS described this response as “bargaining”, whose definition 
captured a degree of superstition inherent in its implication that engagement 
in certain practices will lead to an alleviation of her condition: 
 
 And I’ve done an awful lot of bargaining. I’ve done an awful lot of, you 
know, diets….. Bargaining means for me, um, well if I do this, then I’ll 
be better. PwMS 7 
 
A small number of participants described escapism from the reality of one’s 
condition through substance use, which is likely to have reflected the 
challenges faced by pwMS in accepting the reality of having SPMS:  
 
 91 
 
I would say a lot of them probably smoke and drink too much. I think 
there’s huge escapism with the help of cannabis. HP 4 
 
One’s world just shrinks 
The accounts of a number of participants captured increasing restriction in the 
lifestyles of pwMS arising from worsening disability associated with the 
transition. As a consequence, many pwMS described having to adopt a less 
active lifestyle, compared with their previous experience of RRMS: 
 
So now my life is very, very different….. I’ve withdrawn from all the 
groups I used to sing with. I didn’t take part in the festival this year….. I 
don’t go shopping now because I’m frightened I might fall. PwMS 2 
 
Such increasing restriction was also reflected by several participants who 
described difficulty with planning ahead, and a loss of spontaneity associated 
with the transition: 
 
 it just means that you can’t think oh well, you know, I can’t plan to do 
this in… go on holiday in X many months’ time because I’ll probably be 
better then. Because I know I won’t be. I’ll just be worse. PwMS 4 
 
A number of participants described how this heightened restriction limited 
their ability to engage in a social life, resulting in increased social isolation: 
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the lack of being able to go out and support. And the fatigue. I nap all 
the time, and that limits my - that has made me, um, not be sociable, 
perhaps when I would be. So that has really cut off a lot. PwMS 9 
 
Several participants described a sense of sadness arising from the 
consequences of this restriction. Their accounts captured a sense of grief 
regarding loss of one’s previous way of life: 
 
… you have to just say goodbye to the previous life, I think. To me, 
anyway, my spontaneous, quickly… I go for a trip here or there… that 
isn’t possible anymore. PwMS 5 
 
This was also reflected by HPs: 
 
I suspect, as with the initial diagnosis, that there’s a degree of grieving, 
um, for lost opportunities. HP 5 
 
Living with frustration 
Many participants described frustration in response to the transition, 
stemming from several sources.  The accounts of some participants 
highlighted frustration associated with the decline in one’s physical 
functioning, and the irreversibility of one’s condition: 
  
And now I can’t even say what’s frustrating me the most… the balance, 
or no muscles, because I have no more muscles left….. It isn’t going 
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anywhere.  It’s just going to stick around, the *******.      PwMS 5 
 
Some participants described frustration at the current lack of treatment 
options for SPMS: 
 
…“oh well, I’ve got Secondary Progressive so I can’t take anything 
anymore”..… people get very angry and get really frustrated about it. 
HP 4 
 
Several pwMS described barriers to meeting their practical needs since the 
reclassification, such as challenges involved in applying for benefits, blue 
badges, and so forth: 
 
… the bits and bobs - filling in forms, having to have appointments with 
people….. some of those things are quite stressful… processes that 
take forever to do are very stressful. PwMS 9 
 
Several pwMS described frustration at delays in service provision: 
 
Someone said they’re going to come around the house and see if it 
was suitable for me. But uh, I haven’t heard anything from them. PwMS 
8 
 
The accounts of some participants, both pwMS and HPs, highlighted the 
impact of service limitations on HPs’ abilities to provide pwMS with timely 
 94 
 
input: 
 
… the resources that you would require…..in terms of neurologists and 
MS nurses, eh, psychologists, and therapists…… it’s difficult to access 
any of these services in a timely, responsive manner. HP 3 
 
But you know that if you’ve been referred you’re not going to get an 
appointment next week..… because it’s so busy. PwMS 6 
  
 95 
 
THEME 4: BRUSHING ONESELF OFF AND MOVING ON 
The title of this theme aims to encapsulate the flexibility and resilience 
captured by many participants’ accounts of the responses of some pwMS to 
the reclassification. In this sense, it may be viewed as an opposing theme to 
Theme 3, whose focus was on the negative consequences of the transition, 
and the responses of pwMS which may have inadvertently further 
exacerbated their struggle. Whilst it is acknowledged that pwMS could move 
back and forth between the experiences captured in these two themes, or 
indeed experience them simultaneously, it was felt that this division of themes 
both reflected the content of participants’ accounts, and may prove useful for 
deriving conclusions and recommendations.  The current theme 
acknowledges the potential for initial responses of shock and devastation 
described in Theme 2, but focuses on the subsequent process of moving 
forward with one’s life, in spite of the transition.  It incorporates both the 
agency and flexibility of pwMS, in addition to the arguably more passive 
stance of accepting the irreversibility of SPMS. 
 
I accepted it because I’d already resigned myself to it 
This sub-theme encapsulates the buffering effect that adjustment to living with 
MS had against the impact of a reclassification of SPMS.  This links with the 
overall theme via its acknowledgement of the resilience of some pwMS, 
through capturing factors enabling their acceptance of the reclassification. 
Several participants indicated that the reclassification was often less of a 
shock compared to the initial diagnosis of MS.  Given that the reclassification 
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typically occurs several years after the initial diagnosis, pwMS may have 
become somewhat resigned to living with the disease and may have mentally 
prepared themselves for a worsening of their condition: 
 
Since then I’ve got older and I’ve nursed people with MS. So, I think it’s 
just natural to prepare myself over those years that I could get that bad. 
PwMS 2 
 
Several pwMS described having reached a point of acceptance of their 
condition which had taken place over the years since their initial diagnosis.  
They recounted how such acceptance of their MS enabled them to better 
adjust to living with SPMS: 
 
… there isn’t anything else to do but to accept it, and to be calm, and 
to… which I think only really does come once you’ve been used to 
having the disease.  PwMS 6 
 
Some participants spoke about how, by the time they were reclassified, they 
had built a knowledgebase about MS, and were familiar with MS services and 
professionals, which buffered them against the shock of the reclassification: 
  
I knew about MS then ..… I knew the MS nurses, I knew the hospital, I 
knew my infusion nurse, I knew I had people.  So it actually was a 
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softer diagnosis in all respects, because it was a….. I knew what I was 
dealing with.  PwMS 6 
 
This was also reflected by HPs: 
 
… going from Relapsing Remitting to Secondary Progressive, they 
should already have a knowledge base, if they’ve been appropriately 
treated and counselled by the nursing team in their centre that they’re 
followed up. So they should have come from a situation where they 
have a decent knowledgebase of MS. HP 7 
 
A number of participants spoke about how prior expectation of being 
reclassified with SPMS enabled some pwMS to accept the reclassification 
when it finally did occur. A few pwMS referred to a process of coming to terms 
with having SPMS long before they were officially reclassified: 
 
 …as these things get worse, you know, you’re kind of slowly having to 
accommodate it, and having to accept it, because you have no damn 
choice.  But it's not easy. So when you’re then told it’s Secondary 
Progressive you think well - yeah well, I’ve finally got to terms with all of 
this anyway.  So there’s a bit of a 'so what' about it….. I don’t welcome 
this news ….. life is really going to be horrible, but I’m not surprised. 
PwMS 4 
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Doing all I can do and accepting the rest 
This sub-theme captures participants’ descriptions of a balance between 
accepting one’s condition, and a focus on what one could control.  Indeed, 
several participants described having reached a point of acceptance of their 
condition, which involved letting go of their previous struggle against the 
disease.  As indicated by the previous sub-theme, for some, this process of 
acceptance had been taking place long before the reclassification.  However, 
other participants described this process of acceptance as taking place since 
the reclassification itself: 
 
since the summer of 2014, and I have kind of accepted my illness on a 
different level. I’m much, much, much more at peace with it than I was. 
PwMS 7 
 
Acceptance of one’s condition did not mean that pwMS adopted a passive 
stance in relation to the transition, however. On the contrary, a number of 
participants described focusing on doing as much as they could do to optimise 
their condition, whilst accepting what was outside of their control.  Several 
participants described focusing their attention and energy on symptom 
management and maximising functioning, through diet, exercise, 
physiotherapy, and so forth: 
 
I do go to the gym quite a lot, so I’m trying to do things to help my 
physical state, and I’ve been going up to [name of hospital] to see the 
physios… so to help with balance. PwMS 2 
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Some pwMS also found it helpful to educate themselves about SPMS, 
including potential treatment options: 
 
I think there’s some people who like to read, and like to use the internet 
for information, and use that as a means of coping. HP 6 
 
A number of participants described a balance between focusing one’s 
energies on what was within their control, whilst accepting what was outside 
of their control. This involved an acceptance of the limits of what one’s efforts 
could achieve in controlling the inevitable deterioration associated with SPMS: 
 
… once you’ve done everything you can do, and you really are sort of 
doing as much exercise as you can do, you’ve looked up where you 
should be with drugs, the medications, this, that and the other, there 
isn’t anything else to do but to accept it, and to be calm. PwMS 6 
 
Living differently 
This sub-theme captures the flexible and resourceful nature in which some 
pwMS responded to the transition, through adapting their lives in accordance 
with their current and projected levels of disability.  It links with the overall 
theme through its focus on the flexibility which characterised the responses of 
many pwMS described in participants’ accounts.  Its connection to the overall 
theme also lies in its capturing of the efforts of pwMS towards continued 
engagement in life as much as possible, albeit differently. Although often 
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described in positive terms, there was also a sense of inevitability and a lack 
of choice in some participants’ accounts of this response. This is likely to have 
reflected the overarching power of SPMS, against which pwMS and HPs had 
little control. 
Several pwMS described adapting their approach to everyday activities in line 
with their worsening disability: 
 
 I have adapted, so I have hoodie tops with zips. I don’t have cardigans 
with buttons that need to be done up. PwMS 7 
 
The helpfulness of adapting in such a way was also reflected by a number of 
HPs: 
 
I think helpful is where people remain active. You know, where, em, 
they’re not frightened to try and do the things they did before, but in a 
different way. HP 4 
 
Additionally, several participants spoke about modifying their physical 
environment and obtaining necessary equipment to meet their needs: 
 
 I’ve got a rail at the front of - at the front steps, which he put in. And I’ve 
got the stool there, which he got for me. He went around the house, 
and he got me a thing for - because I can’t stand up in the shower 
anymore - so he got me a bath board to sit on. PwMS 4 
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A number of participants also described identifying alternative hobbies to 
replace those that they were no longer able to do. Although sometimes 
described as difficult given the extent of one’s disability, there was a sense of 
necessity in participants’ accounts of this process: 
 
… you have to think of other things. And that’s been hard. That’s been 
really hard, actually, finding other things to do - that you can do, 
particularly when you’ve got numb hands and fingers, and stuff.  I 
mean I’m doing patchwork now… PwMS 6 
 
Drawing on support 
This sub-theme captures participants’ accounts of how some pwMS turned to 
others for support, both practical and emotional, in coping with the transition 
to SPMS.  In adapting to living with increasing disability, some pwMS 
described relying on friends and family for support with practical tasks that 
they were struggling with, or no longer able to do: 
 
I could walk the children to school, and I could pick them up, but I 
couldn’t do any more that day….. so I became dependent on, um, my 
eldest child going to get them. PwMS 4 
 
Both pwMS and HPs regarded the presence of a supportive social network as 
helpful in managing the emotional and psychological impact of the condition: 
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I think the people who go through that transition well generally have got 
a good support network, um, where there is genuinely a supportive 
family there, saying "you know, come on, it’s really not that bad, you 
know, we’re in this together." HP 4 
 
Peer support was also regarded as helpful, although sources of such support 
(e.g. groups) were sometimes lacking: 
  
I do think that patients value meeting up with each other and getting 
peer support.  I think, when we’ve put on education sessions for people 
I think they’ve possible gained more out of the peer support than they 
have from the information that we’ve given them. HP 6 
 
Making the most of it 
The title of this sub-theme aims to encapsulate participants’ accounts of 
optimising one’s present circumstances in spite of being reclassified with 
SPMS.  This includes encapsulation of the cultivation of positivity, gratitude 
and hope described by some pwMS when recounting their experiences of the 
transition to SPMS.    
A number of participants described taking each day in turn, and not focusing 
too far into the future as helpful in coping with the transition: 
 
… some people do just take the disease as it comes and just get on 
with their day to day life, and will take the change in diagnosis in the 
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same way, and they’ll just … whatever happens happens, and they’ll 
deal with it as it comes. HP 2 
 
Several participants described viewing SPMS as a mere label in the context of 
an overall progressive illness as helpful.  As captured below, viewing the 
reclassification in this way enabled pwMS not to worry too much about the 
meaning and implications of their new diagnostic category. Instead they were 
able to view it as a mere continuation of what they had already been 
experiencing: 
 
MS is progressive, no matter which way you do it. No matter if it’s 
Primary, Relapsing Remitting, Secondary… um… it’s all progressively 
deteriorating. And really the classification of it all doesn’t really mean a 
lot. PwMS 6 
 
Some participants explained that since being reclassified they had refrained 
from researching SPMS too much in order to avoid dwelling on what may lie 
ahead: 
  
And actually now I’ve been diagnosed, I haven’t actually gone in to look 
for any more research about it. I’ve just carried on. In a way, I don’t 
want to know too much about it… I’m carrying on.  PwMS 6 
 
A number of participants also spoke about holding onto positivity and hope 
about the future.  Whilst some described hope about being able to maintain 
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their current level of functioning for as long as possible, others referred to the 
potential for new treatments for SPMS as a source of hope: 
 
Well, for me personally, it’s all about looking to the future. And hope for 
the future, and drugs in the future. PwMS 6 
 
Several participants described a number of sources of gratitude in their lives, 
including a greater level of predictability associated with SPMS compared with 
RRMS, given the slow nature of progression.  Others described experiencing 
gratitude when comparing themselves to those with greater levels of disability 
than themselves: 
 
… there’s a little bit of me that thinks how lucky have I been, because 
I’ve got a friend who’s got Secondary Progressive MS and she’s just 
gone downhill quite quickly after being diagnosed. So I suppose I 
weigh it all up and think actually I’m very lucky. PwMS 2 
 
Several participants, including both pwMS and HPs, spoke about the 
helpfulness of making the most of one’s current level of functioning so as to 
not miss out on opportunities: 
 
I’ve still got to make the most of the time I’ve got while I can walk 
around and do things….. So I suppose I’m still using the same strategy 
as I used when I was first diagnosed. Do as much as you can while you 
can. PwMS 2 
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Some participants described doing what one is able to do, and taking 
pleasure in this exerting of one’s independence: 
 
I think doing things that one is able to do. Even like things that I can do, 
like making a cup of tea, is - when you can do something you do it - 
and anyone will tell you, when they’re limited in what they can do, 
usually, I think, they enjoy doing what they can do. PwMS 9 
 
Several participants spoke about not allowing one’s condition to take over 
their entire life. For instance, some spoke about striving towards a balance 
between managing one’s condition and enjoying a life beyond SPMS: 
 
I put myself on this autoimmune paleo-diet as recommended in that 
book in January….. And by then I kind of got to the point where I was 
thinking it would be quite nice actually, if I could have a friend around 
for dinner, or Sunday lunch, and we could have a bottle of wine.….. 
you’ve also got to enjoy life a bit, haven’t you? Otherwise, what’s the 
point of being here?.....you kind of got to find your own middle-ground. 
PwMS 7 
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CHAPTER 4: DISCUSSION 
Given the gaps in the existing literature, the current study aimed to explore 
the following research questions: 
 
1) How do pwMS experience transitioning from RRMS to SPMS? 
2) How do pwMS cope with this transition? 
3) What are the needs of pwMS during this transition, and the barriers 
to these? 
 
This chapter aims to summarise the findings of the current study and link 
these to the research aims.  The findings will also be discussed in relation to 
existing theory and research. Finally, the clinical implications, and limitations 
of this study will be outlined. 
 
Summary of Findings 
Four main themes were generated from participant accounts: 
 Is this really happening? 
 Becoming a reality 
 A life of struggle 
 Brushing oneself off and moving on 
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How do pwMS experience transitioning from RRMS to SPMS? 
In summary of the first research question, the period before reclassification of 
SPMS was characterised by pwMS noticing subtle changes in their disease 
pattern, and uncertainty regarding the meaning of such changes.  Regardless 
of the extent of pwMS’ expectations of SPMS, the reclassification served as a 
point of confirmation of one’s disease status, often associated with heightened 
acknowledgement of one’s current and projected levels of disability. This was 
frequently accompanied by shock and fear in relation to one’s prognosis.  
Following the reclassification, pwMS experienced uncertainty and anxiety 
about the future, increasing restriction, isolation and frustration. These 
experiences will now be discussed in greater detail, and in relation to existing 
theory and research. 
 
Uncertainty  
Uncertainty emerged as a key theme throughout the transition, both in 
advance of, and following the reclassification of SPMS.  Uncertainty in relation 
to one’s illness has been shown to be associated with poor adjustment in MS 
(e.g. MnNulty, Livneh, & Wilson, 2004).  Its emergence in the period before 
the reclassification, as pwMS gradually became aware of changes in their 
disease pattern, appeared to stem from the often subtle nature of such 
changes, inhibiting pwMS’ ability to make sense of these changes.  These 
results built on those of Hourihan (2013) who did not describe a sense of 
uncertainty in response to such changes. These findings are echoed by 
qualitative studies of pwMS’ experiences of the initial MS diagnosis however, 
 108 
 
which reported feelings of uncertainty about one’s diagnosis during the pre-
diagnostic phase of the disease (Koopman & Schweitzer, 1999; Johnson, 
2003; Edwards et al., 2008).  Compared to becoming aware of novel 
symptoms during the pre-diagnostic phase of MS, leading pwMS to seek 
professional support (e.g. Edwards et al., 2008), the subtle and transient 
nature of the changes during the transition made it difficult for some pwMS to 
be certain if their disease had in fact changed.  
Mishel’s (1988) theory of uncertainty in illness may serve to clarify the 
uncertainty associated with the pre-reclassification stage, described above.  
This theory resonates with Leventhal’s (1984) self-regulation model, which 
proposed that individuals tend to actively construct their own representations 
of their illness.  Mishel (1984) argued that uncertainty arises from situations 
where one is unable to assign a definite value to items or events and/or is 
unable to make accurate predictions regarding outcomes.  Mishel (1988) 
proposed that uncertainty stems from three components: symptom pattern, 
event familiarity, and event congruence. The term ‘symptom pattern’ refers to 
the degree of consistency of one’s symptoms, which determines one’s ability 
to detect a particular symptom pattern and attribute meaning to this.  The 
subtle, transitory nature of the changes described by participants is likely to 
have inhibited pwMS’ ability to detect a consistent pattern, and attribute 
meaning to such changes with much confidence. Establishing greater 
consistency as their disease progressed over time may have potentially 
increased pwMS’ ability to make sense of such changes, enabling them to 
consider the possibility that they were transitioning to SPMS.  
 109 
 
The second component of illness uncertainty, according to Mishel (1988), is 
‘event familiarity’, or the extent to which one is familiar with a particular 
symptom pattern. Familiarity, according to this theory, enables one to connect 
current events to previous similar experiences stored in memory, through 
which meaning may be derived. Given the novel nature of the SPMS pattern 
for pwMS, a lack of previous similar experiences with which to compare their 
current symptom pattern may have further contributed to uncertainty 
regarding the meaning of observed changes.  
Finally, ‘event congruence,’ according to Mishel, refers to the degree of 
consistency between one’s expectations, and current experience, of illness. 
High levels of congruence facilitate interpretation and understanding of one’s 
illness experience, whilst low levels inhibit such processes. Whilst some 
pwMS appeared unaware of the possibility of the transition, which may have 
stemmed from a lack of preparatory education (Hourihan, 2013), it is also 
plausible that knowledge of the fact that not all pwMS transition to SPMS may 
have resulted in low expectations of transitioning to SPMS among some 
pwMS.  In accordance with this theory, these factors are likely to have 
hindered pwMS’ ability to make sense of the changes in their disease pattern. 
Conversely, awareness of the common nature of this transition may have 
underpinned other pwMS’ expectations of it, enabling them to begin making 
sense of these changes, and attribute them to SPMS.  
As stated, uncertainty also emerged following the reclassification itself. This 
appeared to stem from the variable nature of SPMS, leading to uncertainty 
regarding one’s projected rate of deterioration, once again reflecting Mishel’s 
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(1984) conceptualisation described above.  Throughout the transition, 
uncertainty was often accompanied by anxiety.  According to Miceli and 
Castelfranchi’s (2005) conceptual framework, anxiety is an emotional 
response to uncertainty regarding the outcome of events, or one’s ability to 
handle a potential threat. Furthermore, perceived lack of control over potential 
threats has been linked to the establishment of anxiety (Barlow, 2002). Given 
pwMS’ uncertainty and lack of control over the course of their condition, these 
conceptualisations may serve to clarify participants’ accounts of anxiety that 
accompanied the uncertainty associated with the transition.   
The role of expectation 
As highlighted above, for some pwMS, the reclassification was completely 
unexpected, with some participants reporting a lack of pre-existing awareness 
of the potential for transitioning to SPMS.  These results reflect those of 
Hourihan (2013) who found that the majority of participants had not been 
expecting to be reclassified, and had not been aware of the potential for this.  
A lack of expectation of being reclassified was likely to have contributed to 
some pwMS’ feelings of shock on receipt of this news.  Feelings of shock in 
response to the initial diagnosis of MS have also been reported (e.g. Johnson, 
2003).  The degree of shock associated with the reclassification was 
sometimes described as comparable to that experienced at the initial MS 
diagnosis.  This may have stemmed from the extent of pwMS’ lack of 
expectation of being reclassified which, as discussed above, may have been 
underpinned by factors such as a lack of ‘event familiarity’ and ‘event 
congruence’ (Mishel, 1988), described above.  This may have stemmed from 
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a lack of sufficient preparatory education about the transition (Hourihan, 
2013).  
Whilst the reclassification was unexpected for some, for others it was more 
expected, and described as less of a shock.  Hence this study demonstrated a 
wider range of responses to the reclassification than Hourihan (2013), who 
found that the reclassification had been unexpected for all participants.  These 
results are reflected by research regarding the experience of the initial MS 
diagnosis, which indicated that prior suspicions of being diagnosed with MS 
appeared to mitigate against shock on being diagnosed (e.g. Johnson, 2003).  
Miceli and Castelfranchi (2005) suggest that by anticipating a negative 
outcome, individuals may be somewhat buffered against its occurrence, as 
one would have had already come to terms with it to some extent.  This may 
explain why some participants reported that they had not been particularly 
shocked in response to the reclassification. In spite of the mitigating effect of 
prior expectations, the news of the reclassification often still resulted in fear 
and distress among many pwMS. Similar emotions have been reported in 
response to the initial MS diagnosis (e.g. Johnson, 2003; Edwards et al., 
2008), and in response to the reclassification (Hourihan, 2013).  This 
suggests that prior expectations of SPMS may not entirely mitigate against 
negative emotional responses to the reclassification itself. This is likely to 
reflect the significance of the reclassification itself for pwMS, which will now 
be discussed.  
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The role of the diagnostic label 
For many pwMS the reclassification served as a turning point, enabling them 
to make sense of the changes in their disease pattern. This sense of 
clarification provided by the SPMS diagnosis was also reflected by Hourihan’s 
(2013) results.  According to Charmaz (1995), for those who have been 
struggling with chronic illness, provision of a diagnostic label may serve to 
legitimise one’s illness experience, and enable redefining of one’s illness.  
Legitimisation provided by diagnostic labels has also been reported elsewhere 
(e.g. Meyer, Leventhal & Gutmann, 1985).  Regardless of the extent of pwMS’ 
prior expectations of transitioning to SPMS, the reclassification signalled a 
need to acknowledge their condition, and make necessary adjustments. This 
latter finding was not reported by Hourihan (2013), and hence appears to be 
unique to the current study.  According to Charmaz (1995) once one’s illness 
has been redefined through receipt of a diagnosis, individuals may adapt to 
their condition through comparing their current and former degrees of 
impairment, revising their goals, and altering their identity in line with the 
degree of impairment stemming from their condition.  Charmaz argued that 
this forms part of the process of adapting to chronic illness.   
For some, the reclassification was accompanied by a sense of relief, which 
may have stemmed from legitimisation of the extent of one’s disability 
provided by the reclassification. For some, such legitimisation may have 
signalled a form of permission to relinquish many of the roles that pwMS had 
been struggling with up until the point of reclassification, and to make 
adjustments in line with the extent of their disability.  According to Charmaz 
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(1995) given the importance of goals linked to one’s identity, individuals will 
strive to maintain such goals until forced to relinquish them by the effects of 
chronic illness.  It is possible that pwMS’ previous hesitance to relinquish such 
roles may have been underpinned by Western societal values regarding the 
importance of activity and productivity (Murphy, 1995).  For some, the 
reclassification of SPMS appeared to signal sufficient reason for making such 
adjustments. Additionally, given the intolerable nature of uncertainty (Miceli & 
Castelfranchi, 2005), pwMS’ relief on being reclassified may have reflected 
the alleviation of uncertainty provided by the reclassification.  Although relief 
has been reported in response to the initial MS diagnosis (e.g. Edwards et al., 
2008), this was not reported by Hourihan (2013) in relation to the 
reclassification of SPMS.  Relief was also not included in Dennison et al.’s 
(2009) model of adjustment, which posited that critical events initially lead to 
distress and disruption of pwMS’ well-being.   
Loss and frustration 
The transition was also often accompanied by a sense of loss, stemming from 
the deterioration in pwMS’ ability to conduct their lives as before. In contrast 
with the periodic regaining of functioning associated with RRMS, the 
irreversible deterioration inherent in SPMS meant that many pwMS were 
forced to permanently withdraw from valued activities. As a result, many 
experienced heightened isolation, sadness and grief.  This finding reflects 
those of Hourihan (2013) who reported grief in response to loss of 
participation in meaningful activities as a result of the transition to SPMS.   A 
sense of loss has also been reported in response to the initial diagnosis of MS 
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(e.g. Miller, 1997), and in relation to living with MS across the disease 
trajectory (e.g. Wollin et al., 2006; Edmonds et al., 2007).  Grief is commonly 
regarded as a normal response to loss of physical function (Stewart & 
Shields, 1985), which may reflect consequent losses and revision of one’s 
goals and identity (Charmaz, 1995).   
Like Hourihan (2013), the current results demonstrated frustration among 
pwMS in response to the irreversibility of SPMS, the unwanted adjustments 
imposed by the transition, and deterioration in pwMS’ ability to pursue 
meaningful activities and goals. Frustration has also been reported in 
response to the diagnosis of RRMS (e.g. Edwards et al., 2008; Dennison et 
al., 2010), although this was reported to stem from disappointment at how the 
diagnosis was communicated.   This study builds on previous results, by 
reporting additional frustration arising from a lack of disease modifying 
treatments for SPMS, and delays in service provision.   
    
How do pwMS cope with the transition? 
In summary of question two, the results indicated a wide range of cognitive 
and behavioural responses to the transition to SPMS.  Some of these were 
described as helpful by participants in coping with the transition, in enabling 
pwMS to adjust and move forward with their lives in spite of the transition. 
Other coping strategies were referred to as suboptimal, or even maladaptive 
however, perhaps inadvertently leading to increased distress and difficulty in 
the long term.  The responses of pwMS to the transition will now be discussed 
in relation to Dennison et al.’s (2009) model of adjustment, and other theory 
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and research. 
Avoidance 
Some pwMS responded to the transition via avoidant emotion-focused coping, 
which, according to Dennison et al.’s (2009) model, is associated with poor 
adjustment outcomes.  Prior to the reclassification some pwMS attempted to 
ignore the changes in their disease pattern, or denied that these changes 
were due to SPMS.  Attributing these changes to causes other than SPMS 
may have reflected a process of ‘displacement’ described by Miceli and 
Castelfranchi (2005), whereby individuals attempt to transfer anxiety 
stemming from uncertainty onto more definite and controllable objects.  This 
may enable people to direct their attention away from threats which they 
sense, but which are deemed too frightening to face, onto more controllable, 
less overwhelming sources.  Threats to one’s self-worth, such as those which 
impact on one’s ability to pursue goals from which one derives self-esteem, 
are particularly threatening, according to Miceli and Castelfranchi.  The 
irreversible deterioration in physical and cognitive abilities associated with 
SPMS may have been highly threatening to pwMS in this regard. This may 
have been underpinned by Western societal values and ideals regarding 
strength, health, and independence, which are in direct opposition to the 
nature of disability (Murphy, 1995).  As a consequence, pwMS may have 
displaced their anxiety onto less threatening, more controllable explanations, 
such as the effects of a relapse or insufficient physiotherapy.   
Such responses may also have represented pwMS’ efforts to repress 
thoughts about the possibility of SPMS.  A body of literature has highlighted 
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individual variability in people’s responses to threat, including a tendency 
towards denial, or ‘repression’, of potential threat (e.g. Lomont, 1965; Lazarus 
& Alfert, 1965).  ‘Soldiering on’ among some pwMS may have reflected such 
individual variability. Research has indicated that although ‘repressers’ may 
report low levels of anxiety, they demonstrate higher levels of autonomic 
disturbance than individuals with a low tendency towards denial (Lomont, 
1965).   
Following the reclassification, some pwMS attempted to ignore the reality of 
SPMS and its implications. This finding was not demonstrated by Hourihan 
(2013), although accounts of individuals refusing to admit the losses resulting 
from their chronic illness do exist (Albrecht, 1992; Herzlich, 1973; Radley & 
Green, 1987).  This response may have reflected a process of ‘struggling 
against illness’ (Charmaz, 1995, p. 663), where people refuse to accept the 
irreversibility of the losses they have suffered as a result of chronic illness.  
According to Charmaz (1995), individuals may ignore their illness when it 
exerts minimal effects on their life, when they can control its effects, or when 
other goals take precedence over their illness.  As one’s illness progresses 
however, people may increasingly struggle to ignore its implications.  In 
response, some pwMS demonstrated resistance against the progression of 
their MS, and strove to identify ways of alleviating this.  This is reflected by 
Charmaz (1995), who highlighted how some individuals with chronic illness 
may hold onto the hope of regaining lost health and functioning in spite of the 
unlikelihood or impossibility of this.  According to Charmaz, struggling against 
one’s illness may reflect resistance against incorporating one’s disability into 
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one’s sense of self, which hinders adjustment to one’s condition.  This 
resonates with literature regarding prolonged grief, which acknowledges the 
normative nature of responses, such as protest and denial, against unwanted 
losses (Bowlby, 1961; Goodall et al., 2003), but argues that if prolonged, such 
responses may inhibit adaptation and lead to chronic dysfunction (Prigerson 
et al., 2013). 
Escapism through drugs and alcohol was used by some pwMS in response to 
the transition, and may have further reflected the difficulty they faced in 
accepting the irreversibility of their condition. Murphy (1995) argued that 
people with physical disabilities may experience a range of negative emotions 
as a result of not meeting internalised cultural ideals.  This was reflected by 
participants’ descriptions of feeling distressed and overwhelmed in response 
to new stages of disability.  It is possible that substance use provided pwMS 
with a temporary means of escape from such difficult emotions.  Coping 
through avoidance and/or escape has been shown to be related to poor 
outcomes for psychological well-being and quality of life in MS (McCabe, 
McKern, & McDonald, 2004; McCabe, 2006).   
Cognitive appraisal 
There was some variation in pwMS’ appraisals of the meaning and 
implications of having SPMS. According to Dennison et al.’s (2009) model, an 
individual’s appraisal of MS has consequences for their adjustment to the 
condition. Appraisal, in this context, is defined as one’s interpretation of a 
stressor, its associated degree of threat, challenge and controllability (Lazarus 
& Folkman, 1984). For some, SPMS was viewed as an unstoppable force 
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against which one was entirely powerless. This appeared to be associated 
with a loss of self-efficacy and a sense of giving up, or assuming an entirely 
passive stance towards disease progression.  This is likely to have stemmed 
from the nature of SPMS which, in contrast with RRMS, is associated with 
irreversible deterioration and withdrawal of treatment.  Indeed, low self-
efficacy has been shown to be linked with a reduction or ceasing of one’s 
efforts to persist in the face of obstacles (Bandura & Schunk, 1981).  Similarly, 
illness representations comprising beliefs of lack of personal control over the 
illness, and perceptions of severe illness consequences have been shown to 
be associated with worse adjustment in MS (Moss-Morris, Weinman, Petrie, 
Horne, & Cameron, 2002).  Furthermore, helplessness has been shown to be 
a strong predictor of depression in MS, even after controlling for disease 
severity (Shnek et al., 1997; Shnek et al., 1995).   
By contrast, viewing SPMS as a mere label in the context of an overall 
progressive condition may have enabled pwMS to draw upon their existing 
experiences and resources, and apply these to coping with the transition.  
Although Dennison et al.’s (2009) model regarded positive reappraisal as 
beneficial for adjustment to MS, this specific appraisal was not included in 
their model, given its relevance to the transition itself. This finding was not 
demonstrated by Hourihan (2013), and appears to be unique to the current 
study. Such an appraisal of one’s condition may have reflected a degree of 
adjustment to MS preceding the reclassification, which will now be discussed. 
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Acceptance 
A key finding was that pwMS’ prior adjustment to life with MS may have 
buffered pwMS against the impact of the reclassification.  This was in contrast 
to the initial diagnosis of MS, prior to which pwMS would have had no 
experience of living with, and adjusting to, MS.  This finding was not reported 
by Hourihan (2013), or included in Dennison et al.’s (2009) model, and 
appears to be unique to the current study.  While this may have been due to 
knowledge about MS and familiarity with MS services, it may also have 
reflected a process of adjustment to the disease in advance of the transition to 
SPMS.  According to Charmaz (1995) adapting to chronic illness involves 
altering oneself and one’s life to accommodate its associated changes and 
losses, and creating a new sense of self which accounts for one’s degree of 
impairment.  Charmaz highlighted how, after many years of attempting to 
ignore or struggle against one’s illness, some, but not all, people begin a 
process of adapting to illness.  This process may have enabled pwMS to 
adjust to the reclassification, given previous accommodation and altering of 
their sense of self in line with their MS.  
Adaptation to, and acceptance of, one’s condition are closely related 
concepts, according to Charmaz (1995).  Several participants described 
reaching a point of acceptance of their condition, either in advance of, or 
following, the reclassification.  Acceptance of disability, which is often viewed 
as a marker of psychological adjustment (Antonak & Livneh, 1995; Charmaz, 
1991; Li & Moore, 1998), has been shown to be associated with better quality 
of life and health outcomes in MS (Burton, 1995; Stuifbergen, Seraphine, & 
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Roberts, 2000).  In light of this, acceptance of one’s illness was described in 
Dennison et al.’s (2009) model as related to successful adjustment in MS.  
This association may be understood in light of a link between higher levels of 
acceptance and health-promoting behaviours, resulting in greater well-being 
(Stuifbergen et al., 2000).   
Some pwMS responded to the transition by adapting their lives in line with 
their degree of disability, such as by obtaining necessary equipment to meet 
their needs, and identifying alternative activities.  This finding was 
demonstrated by Hourihan (2013), as well as by studies exploring the 
experience of living and coping with MS in general (e.g. Reynolds & Prior, 
2003).  Like Hourihan, the current study reported a sense of lack of choice in 
relation to such adaptation.  Dennison et al. (2009) regarded acceptance of 
one’s condition, including integration of necessary changes into one’s way of 
life, as beneficial for adjustment.  Similarly, altering one’s identity and goals in 
the face of irreversible disability forms part of the overall adjustment process 
according to Charmaz (1995).  
Problem-focused strategies 
The use of problem-focused strategies (i.e. strategies aimed at reducing the 
source of stress) emerged at various points during the transition.  As 
discussed in the Introduction, Dennison et al. (2009) regarded such strategies 
as beneficial for adjustment to MS.  For instance, in response to the 
uncertainty regarding changes in their disease pattern described above, some 
pwMS attempted to prepare themselves for transitioning to SPMS, and sought 
confirmation of a SPMS diagnosis from their MS team. Such responses may 
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have represented pwMS’ attempts to reduce uncertainty, which, according to 
Miceli and Castelfranchi (2005), is intolerable, and may lead individuals to 
seek certainty, even if its implications are negative. 
As demonstrated, the transition involved a range of unwanted changes which 
were outside pwMS’ control. Charmaz (1995) proposed that adjustment 
entails ceasing one’s struggle to control one’s illness, whilst striving to 
maintain as much independence as possible.  Letting go of struggling against 
what was outside of one’s control was sometimes balanced with a focus on 
areas within one’s control, such as diet, exercise and engagement in 
physiotherapy. These may have represented problem-focused strategies, 
given their aim of reducing the rate of the inevitable deterioration in SPMS.  A 
number of studies have found that adjustment was positively correlated with 
self-efficacy regarding management of one’s MS symptoms (Riazi, 
Thompson, & Hobart, 2004; Shnek et al., 1997).  Given limited control over 
one’s SPMS, focusing on doing what one could to manage their symptoms 
may have been associated with enhanced self-efficacy, enabling adjustment.   
The role of social support 
The results highlighted the value of social support in coping with the transition. 
This was also reported by Hourihan (2013), as well as by qualitative studies 
exploring the experience of MS in general (e.g. Kirkpatrick-Pinson et al., 
2009).  A number of quantitative studies have also demonstrated a 
relationship between social support and better adjustment in MS (e.g. 
Pakenham, 1999; McCabe, 2006).  The current results also reflect Dennison 
et al.’s (2009) model, which regarded seeking social support as beneficial for 
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adjustment.  Conversely, some pwMS responded to the transition by 
withdrawing from others, and refusing their support, which may reflect a form 
of avoidance and struggling against one’s illness, discussed above. 
Optimism, hope and benefit-finding 
Cultivation of positivity, gratitude and hope emerged as another potential 
response to the transition.  Although not reflected by Hourihan’s (2013) 
findings, coping through maintaining a sense of optimism, hope and benefit-
finding has been demonstrated in relation to living with RRMS (e.g. Koopman 
& Schweitzer, 1999) and throughout the MS trajectory (e.g. Reynolds & Prior, 
2003).  Dennison et al. (2009) posited that such responses are associated 
with successful adjustment in MS. 
For instance, Charmaz (1995) argued that in spite of needing to form new 
identities which account for one’s increased restriction, individuals with 
chronic illnesses may often identify positives and value in their restricted lives.  
Similarly, Evers et al. (2001) proposed that the ability to identify benefit in 
one’s illness is associated with positive long-term outcomes.  Benefit finding is 
regarded as an adaptive coping strategy whereby people positively evaluate 
their circumstances in spite of adversity (Pakenham, 2005).  It is possible that, 
in the face of adversity, benefit finding may be culturally anticipated as a 
means of seeking maturation and growth (Tennen & Affleck, 2002).  Several 
participants described gratitude when comparing themselves to those less 
fortunate than themselves. Downward comparison theory suggests that when 
under threat, people may enhance their subjective well-being through making 
downward social comparisons (Wills, 1981). Enhancing or restoring of one’s 
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self-esteem through comparing oneself to those with greater levels of difficulty 
has been demonstrated in chronic illness (Taylor, 1983). 
Research has also demonstrated a link between optimism about the future 
and better adjustment outcomes in MS (de Ridder et al., 2000; Fournier et al., 
2002).  Such findings may be understood as a result of optimists’ tendency to 
continue with adaptive activities when confronted with adversity (Carver et al., 
1993).  According to hope theorists, positive emotions are driven by the belief 
that one can find pathways and the required motivation to achieve desired 
goals (Snyder, Rand & Sigmon, 2002).  Taylor’s (1983) cognitive theory of 
adaptation posits that optimistic beliefs about one’s prognosis are conducive 
towards good mental health, even if such beliefs are proven to be 
unrealistically optimistic.  By comparison, according to Groopman (2004), ‘true 
hope’, as opposed to naïve optimism, involves incorporating 
acknowledgement of potential threats into one’s optimistic perspective, and is 
also associated with heightened well-being.  Participants’ accounts of hope 
may have reflected a mixture of naïve and true hope, given variability in 
pwMS’ acknowledgement of the implications of SPMS.      
Making the most of one’s current circumstances, in spite of the transition, was 
described as helpful by several participants.  This included making the most of 
one’s current level of functioning and independence, which has been 
demonstrated by other studies of the experience of living with SPMS (Olsson 
et al., 2010), and MS in general (e.g. Reynolds & Prior, 2003). This finding 
was not demonstrated by Hourihan (2013), however.  A few participants 
spoke about how, in spite of transitioning to SPMS, they strove not to allow 
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their condition to take over their entire lives.  According to Charmaz (1995) 
successful adaptation to chronic illness entails living with the illness whilst not 
allowing it to entirely dominate one’s life. Successful adaptation, in this sense, 
means that individuals maintain whatever level of independence and 
autonomy that their condition permits.  Related to this, several participants 
described focusing on taking each day at a time, as opposed to worrying 
about the future, as helpful in managing the transition.  According to Dennison 
et al.’s (2009) model, catastrophizing is associated with poor adjustment 
outcomes, and has been shown to be positively correlated with depression in 
MS (Shnek et al., 1997; Shnek, Foley, LaRocca, Smith, & Halper, 1995). 
 
What are the needs of pwMS during the transition, and the barriers to 
these? 
In summary of the final research question, the results highlighted a range of 
unmet needs of pwMS throughout the transition process, including sufficient 
provision of information, both in advance of, and at the point of, 
reclassification, adequate time and care in communicating the reclassification, 
and support following the transition.  Barriers to meeting these needs 
stemmed primarily from factors related to HPs and service limitations.  The 
findings suggested that in terms of support from services, the transition may 
be a relatively neglected area compared with the initial diagnosis. These 
needs and barriers will now be discussed in turn. 
Pre-reclassification 
As reported by Hourihan (2013), whilst education across the disease 
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trajectory is recommended as best practice in MS care (NICE, 2003), 
provision of sufficient preparatory education about the transition was 
sometimes lacking. This appeared to contribute to some pwMS’ sense of 
shock on being reclassified.  A number of challenges for provision of 
preparatory education were suggested by the results. Several participants 
acknowledged how difficult it may be for some pwMS to process such news, 
particularly around the time of the initial MS diagnosis. Some suggested that 
whilst such education is important, it may be more appropriate following the 
initial MS diagnosis, once pwMS have had time to come to terms with their 
MS diagnosis.  As discussed under ‘Future Research’, careful consideration of 
the timing of such education is paramount, given the potential distress 
associated with receipt of such news.  
Additionally, many pwMS experienced a sense of delay on the part of HPs in 
providing clarification regarding the changes in their disease pattern via 
reclassification. Although this was not reported by Hourihan (2013), research 
has reported delays in receiving the initial diagnosis of MS, as pwMS seek 
clarification and legitimization of their symptoms (Edwards et al., 2008; Kralik, 
Brown, & Koch, 2001).   
Both of these findings may have been underpinned by several factors.  Whilst 
the unpredictable and variable nature of MS may have contributed to delays in 
reclassifying patients, HPs’ desire to protect pwMS against the potential 
impact of bad news may have played a role. This is reflected by research 
regarding the initial MS diagnosis which highlighted the role of uncertainty in 
diagnostic test results, and HPs’ desire to protect pwMS from the full truth 
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about their diagnosis, in contributing to delays in communication of the 
diagnosis (Elian & Dean, 1985; Mushlin et al., 1994).  HPs’ desire to protect 
pwMS from worry and distress may also have influenced provision of 
preparatory education about the transition. 
The results suggested that the process of communicating with pwMS about 
the transition was difficult for some HPs.  These findings are echoed by 
studies indicating that the process of giving bad news to patients is potentially 
stressful for HPs, and may relate to their well-being (Buckman, 1984; Holland, 
1989).  It is possible that the emotional impact of this role on HPs may have 
further influenced provision of preparatory education, and contributed to 
delays in reclassifying subsequent patients.   
Reclassification 
The manner in which the reclassification is communicated was regarded as 
important by most participants.  Research demonstrates that the quality of 
communication between patients and HPs may influence patients’ abilities to 
manage their symptoms and maximise their overall health (Buckley, Vacek, & 
Cooper, 1990; Simpson et al., 1991; Thorne, 1993).  Furthermore, the nature 
of communication from professionals regarding MS may have the potential to 
increase or mitigate fear about one’s prognosis (Thorne et al., 2004).  
Providing pwMS with a sense of hope about the future, allowing sufficient time 
and privacy for communication, continuity of care, and demonstrating 
empathy were also regarded as helpful, but sometimes lacking, by several 
participants. This echoes the results of Hourihan (2013), as well as studies 
suggesting pwMS’ desire for care and reassurance during the initial MS 
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diagnosis process (e.g. Kralik et al., 2001).  This may be important in the 
transition, given the relative lack of such support compared with the initial 
diagnosis suggested by the results, as well as the distress and hopelessness 
often associated with the transition.  It is likely that service resource limitations 
partly underpinned these findings. Reports of a lack of empathy among some 
HPs may have also arisen from a degree of emotional detachment, due to the 
difficult nature of relaying bad news to patients (Statham & Dimavicius, 1992; 
Ptacek, Fries, Eberhardt, & Ptacek, 1999).   
Since reclassification 
Some pwMS remained uncertain about the implications of SPMS following the 
reclassification, which also reflected Hourihan’s (2013) results.  These 
findings were in spite of the fact that education across the disease trajectory is 
recommended as best practice in MS care (NICE, 2003).  Immediate access 
to information following diagnosis has been reported as crucial for allaying 
pwMS’ fear about their prognosis (Thorne et al., 2004), and enabling patients 
to make sense of their illness experience and participate in active 
management of their condition (Ziebland, 2004).  Although provision of 
sufficient and accurate information about MS and its management has been 
shown to be a common problem for pwMS throughout the disease trajectory 
(Baker, 1998; Somerset, Campbell, Sharp, & Peters, 2001), the current 
results suggested a relative lack of this in relation to the reclassification, 
compared with the initial diagnosis.  
Follow-up support and signposting were also regarded as crucial, but often 
lacking by many participants. This reflects the findings of Hourhinan (2013), 
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and studies of the initial MS diagnosis (e.g. Thorne et al., 2004).  As 
suggested by Olsson et al. (2010), identifying ways to maintain engagement 
in meaningful activities is important in helping people cope with SPMS.  
Fleming-Courts et al. (2004) highlighted a need for rehabilitation at points of 
change in MS.  The current results and those of Hourihan (2013) suggested 
that compared with the initial diagnosis, follow-up support and signposting 
following the reclassification of SPMS could be particularly poor.  As 
suggested by Hourihan (2013) a sense of impotence among HPs in the face 
of SPMS may have possibly contributed to this.  The current study suggested 
that availability of a specialised clinic aimed at supporting pwMS through the 
transition may have been one potential remedy to a lack of perceived support 
surrounding the transition.  Given the emotional impact of the reclassification 
for many pwMS, providing pwMS with an option of immediate follow-up 
support following the reclassification (e.g. a debriefing session with a MS 
nurse) may have proved helpful.  Referring patients to sources of support to 
meet their physical, psychological, and practical needs was regarded as 
crucial. 
 
Theoretical Implications 
As demonstrated, many of the current results resonate with Dennison et al.’s 
(2009) model of adjustment to MS.  Additionally, a number of key findings 
have been identified which appear to be unique to the transition. Such 
findings will now be summarised in relation to Dennison’s model. 
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The process of becoming aware of changes in one’s disease pattern, and the 
experience of being reclassified, were both often associated with uncertainty, 
anxiety and distress among pwMS.  As a consequence, one could argue that 
the transition to SPMS may potentially involve two ‘critical events’ (Dennison 
et al., 2009), given their associated disruption to pwMS’ emotional equilibrium.  
The extent of the disruption associated with the reclassification arose, in part, 
from how pwMS had previously made sense of, and responded to, becoming 
aware of the changes in their disease pattern.  Greater expectations of 
transitioning to SPMS appeared to mitigate against the impact of being 
reclassified.  The likelihood of such expectations may have been influenced, 
in part, by the extent of preparatory education provided by HPs. This, in turn, 
was often influenced by HPs’ desire to protect pwMS from distress associated 
with such news.  
The extent of the disruption stemming from the reclassification was also 
influenced by the degree of pwMS’ previous adjustment to MS. Prior 
adjustment to MS appeared to buffer pwMS against the impact of the 
reclassification.  Although Dennison et al. (2009) acknowledged the influence 
of one’s previous life experiences on one’s beliefs, values and behaviours, it 
did not include such a buffering effect. This is due to the model’s primary 
focus on the initial diagnosis of MS, prior to which pwMS would not have 
previous experiences of adjusting to MS to draw upon. Hence, an extension of 
Dennison et al.’s model in relation to the transition is proposed, which 
incorporates this buffering effect, including psychological preparation for the 
transition and acceptance of one’s MS prior to the reclassification. 
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Dennison et al. (2009) proposed that critical events initially lead to negative 
psychological consequences, such as emotional distress. However, the 
current findings demonstrated that in addition to negative emotional 
responses, the reclassification of SPMS was also sometimes accompanied by 
initial feelings of relief.  Hence, incorporation of this potential response in 
relation to the transition is proposed. 
As discussed, Dennison et al.’s model viewed positive appraisals of MS as 
beneficial for adjustment. The current findings suggested that viewing SPMS 
as a mere label within the context of an overall progressive illness may have 
enabled pwMS to draw on their existing experiences and resources when 
coping with the transition. Hence, this particular appraisal appears to be 
uniquely relevant to the transition.  
 
Implications for Clinical Practice 
A key finding was the variation in pwMS’ appraisal of the transition to SPMS. 
As a result clinicians ought to explore individual appraisals of the transition, 
given the consequences of such appraisals for pwMS’ coping responses to 
the transition.  Additionally, in light of the buffering effect that previous 
adjustment to MS had against the impact of the transition, it would be helpful 
to explore pwMS’ existing resources and coping strategies.  This could enable 
supporting pwMS to draw upon such resources in coping with the transition. 
Fraser, Kee and Minick (2006) highlighted the value of recognising and 
building upon patients’ existing experiences and coping mechanisms for 
managing chronic illness. Such input may potentially enable pwMS to 
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reappraise the transition as merely another label in the context of an overall 
progressive illness, and lead to a sense of empowerment through recognising 
the experiences and resources that they have already developed in coping 
with MS.  
Given that peer support was regarded by some participants as potentially 
helpful in coping with the transition, provision of peer support interventions in 
this context may prove useful. Some evidence indicates the potential value of 
peer support for pwMS’ quality of life and depression levels (e.g. Mohr, Burke, 
Beckner & Merluzzi, 2005). However, other research suggests that peer 
support (e.g. support groups, telephone support) may place those with better 
mental health at risk for deterioration in such groups (Uccelli, Mohr, Battaglia, 
Zagami, & Mohr, 2004). Whilst peer support interventions may benefit those 
with affective problems (Schwartz, 1999), groups aimed at developing pwMS’ 
coping skills may prove more beneficial for pwMS with fewer affective 
problems (Schwartz, 1999). 
CBT has emerged as an effective approach for treating mood disorders in MS 
(e.g. Mohr, Boudewyn, Goodkin, Bostrom, & Epstein, 2001).  As suggested by 
Dennison et al. (2009), it is recommended that when working with pwMS 
clinicians ought to remain mindful of the coping responses associated with 
successful and unsuccessful adjustment. For instance, given the potential for 
apathy and withdrawal as a result of the transition to SPMS, aspects of CBT 
such as modified behavioural activation and challenging unhelpful appraisals 
and cognitive errors may prove useful.  
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PwMS’ avoidance of, and struggling against, the transition may mirror the 
concept of ‘experiential avoidance’ (Hayes, Wilson, Gifford, Follette & 
Strosahl, 1996), which involves deliberate attempts to avoid or escape 
unpleasant private experiences.  Such responses become problematic when 
they interfere with one’s ability to engage in behaviours that are in line with 
one’s values, according to Hayes et al. (1996). Therapeutic approaches such 
as Acceptance and Commitment Therapy (ACT; Hayes, Strosahl & Wilson, 
1999) may facilitate a reduction in unhelpful experiential avoidance, through 
enabling clients to live in line with their values in spite of unwanted 
experiences.  Preliminary evidence supports the usefulness of ACT in 
enhancing pwMS’ psychological well-being (e.g. Nordin & Rorsman, 2012).  
Given increasing restriction in their ability to pursue goals as a result of the 
transition, identifying pwMS’ broader values and enabling them to pursue 
these via alternative avenues in line with their disability, may prove valuable.  
Furthermore, in light of the potential for catastrophizing about the future in 
response to the uncertainty associated with the transition, approaches such 
as ACT (Hayes et al., 1996), and mindfulness (Kabat-Zinn, 1990) may enable 
pwMS to gain contact with the present moment and lessen such cognitive 
processes.  Mindfulness approaches have also emerged as beneficial for 
pwMS’ quality of life and well-being (e.g. Grossman et al., 2010). 
The results highlighted a number of issues related to HPs which may have 
posed barriers to meeting the needs of pwMS during the transition.  As a 
consequence, HPs may benefit from psycho-education regarding the 
psychological impact of the transition on pwMS. This could include education 
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about the potential variation in pwMS’ responses to the transition, in order to 
overcome any biases or misunderstandings among HPs.  Furthermore, HPs 
may benefit from training around sensitive and appropriate communication of 
the reclassification. Given the impact that delivering the news of the 
reclassification can have on HPs themselves, and how this may potentially 
impact on their subsequent interactions with patients, they may also benefit 
from emotional support, such as education about coping skills (Ptacek et al., 
1999), or supportive counselling (Levenstein, 1987). 
 
Critical Review 
The aim of this study was to gain rich insight into the experiences of pwMS 
during the transition to SPMS.  As a result of the limited sample size and 
cross-sectional nature of this study, the generalisability of the results in 
relation to the wider MS population cannot be determined, and causality 
cannot be inferred.  However, consistency between the accounts of pwMS 
and HPs, and between many of the current findings and existing research 
suggest a degree of applicability of the current results. 
Given that participants were recruited purposively, participants were 
essentially self-selecting, which may have led to further bias. Whilst the 
results demonstrated divergence, it is possible that the degree of 
heterogeneity of experiences was compromised due to individuals choosing 
not to participate. Consequently, it could have been useful to record the 
number of potential participants that were approached in order to potentially 
establish reasons underlying individuals’ choices not to participate. 
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The fact that participant accounts were generated retrospectively may have 
affected participants’ recall of events. However, as the majority of pwMS were 
recruited within 12 months of being reclassified with SPMS, this hopefully 
reduced recall bias somewhat. 
Service-user involvement in the development of the interview schedule 
enabled generation of questions that were relevant, sufficiently open, and 
ordered appropriately.  Furthermore, the use of semi-structured interviews 
allowed participants to generate rich, and detailed accounts.  As with all semi-
structured interviews there may have been a potential for participants to 
generate socially desirable responses (Brink, 1989).  However, several 
participants indicated that they had benefited from being listened to, and often 
brought up sensitive issues themselves. This suggests that the interviews 
created a sufficiently safe, empathic environment which hopefully reduced 
socially desirable responses. 
Inclusion of HPs enabled generation of a broad range of data.  Comparison of 
pwMS’ and HPs’ accounts may have further highlighted barriers to meeting 
the needs of pwMS during the transition.  Guest et al. (2006) argued that in 
order to establish differences between groups in qualitative research, a 
minimum of twelve participants per groups is required.  The time constraints 
of this project did not allow for recruitment of sufficient numbers of pwMS and 
HPs to carry out such a comparison.  
Member validation checks, where the researcher checks their analysis with 
the participants is often recommended in order to maintain quality in 
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qualitative research (Yardley, 2000). Given time and resource constraints 
however, this was not possible.  Instead the validity of the analysis was 
checked through peer analysis of interview transcripts, which enabled cross 
validation, as well as integrating peer and supervisor feedback into theme 
organisation and titles.  Peer and supervisor review of the themes is also 
likely to have contributed to greater internal coherence and consistency within 
themes (Braun & Clarke, 2006). 
Braun and Clarke (2006) highlighted a number of potential pitfalls in TA, 
including failure to analyse the data beyond its surface content, and use of the 
interview schedule questions as the ‘themes’ that are reported. This study 
was strengthened by its degree of interpretation of the data, such as through 
linking it with existing literature, as well as its use of participants’ language in 
the construction of theme labels.  Other potential pitfalls may include 
insufficient examples of data in support of each theme, and a lack of 
consistency between the analytic claims and the data itself (Braun & Clarke, 
2006).  As demonstrated by the Results section, a substantial number of 
participant quotes were provided in support of each theme.  Furthermore, the 
process of reviewing the themes in relation to the entire dataset (discussed in 
the Methods section) is likely to have strengthened the degree of consistency 
between the data and the interpretive claims made.   
 
Future research 
In light of the limitations, prospective, longitudinal studies examining whether 
psychological coping factors precede and predict successful and unsuccessful 
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coping with the transition to SPMS would be useful.  In particular, studies 
which investigate multiple psychological factors may enable identification of 
the most powerful psychological predictors of coping success.  Identification 
of interactions between psychological factors and other factors, such as 
demographics, illness severity, and so forth, could allow identification of 
direct, mediator and moderator influences. The substantial time and resources 
required for such a study are acknowledged. 
In light of the needs of pwMS highlighted by this study, examining the benefit 
of specific forms of interventions aimed at enhancing supportive mechanisms 
and addressing unmet needs throughout the transition would be useful.  For 
instance, examining the impact of preparatory education about the transition 
(e.g. a booklet) on the well-being of pwMS who later undergo the transition 
could be useful.  Although the current results suggested that it may be 
appropriate to provide such education following the initial MS diagnosis, the 
optimal timing of such education requires further investigation, given the 
potential for distress arising from this news.  Additionally, the helpfulness of 
specific forms of follow-up support following the reclassification, such as 
providing pwMS with the option of an immediate debriefing session with a MS 
nurse, and provision of peer support interventions, could be useful. Finally, 
the impact of provision of specialist clinics aimed at addressing the specific 
needs of pwMS throughout the transition is warranted. 
Finally, the accounts of a number of participants highlighted a number of 
challenges posed to family members by the transition. Such accounts were 
not included in the final analysis, given the nature of the research questions. 
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However, these accounts highlighted the value of research exploring the 
experiences and needs of pwMS’ family members, in order to identify means 
of better supporting them through this process. 
 
Conclusions 
The present study explored the experiences of transitioning from RRMS to 
SPMS, including the coping and needs associated with this transition. Nine 
pwMS and seven HPs were interviewed and transcripts were analysed using 
TA. 
In summary, although not a discreet stage in itself, the transition to SPMS 
involved moving from uncertainty regarding subtle changes in pwMS’ disease 
pattern, towards confirmation of their disease status. Such confirmation often 
served as a turning point for pwMS, leading to heightened acknowledgement 
of their condition. The reclassification was associated with a range of 
emotional responses, including shock and fear about one’s prognosis.  The 
transition posed a number of challenges for the well-being of pwMS, including 
a reduction in treatment options, increasing restriction and isolation, and 
uncertainty regarding one’s projected rate of deterioration.  Prior adjustment 
to MS and expectations of being reclassified appeared to buffer some pwMS 
against the impact of the reclassification.  PwMS appeared to cope with the 
transition via a wide range of responses. These included cognitive and 
behavioural responses, which may have inadvertently increased the extent to 
which some pwMS struggled with the transition.  In spite of the transition, 
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some pwMS demonstrated a capacity to move forward with their lives in spite 
of the transition, which often involved a degree of acceptance of their 
condition. 
This study highlighted a number of potential avenues for better supporting 
pwMS through the transition. Appropriate preparation for the transition, and 
provision of adequate information and support were regarded as crucial, but 
often lacking.  The extent to which the needs of pwMS were met often 
stemmed from limitations to service resources and factors relating to HPs 
themselves.  Overall, the results suggested that the transition to SPMS is a 
common, yet relatively neglected area, warranting further investigation. 
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APPENDIX A – PARTICIPANT INVITATION LETTER (PWMS VERSION) 
 
Version 1.1, dated 31/03/2014 
[Hospital Logo] 
 
       
 
Department of Clinical Psychology 
Royal Holloway, University of London 
Egham 
Surrey 
TW20 0EX 
 
Website: www.rhul.ac.uk 
 
PARTICIPANT INVITATION LETTER 
(PwMS version) 
 
To whom this may concern, 
 
Re: Invitation to take part in an interview study about the experience of transitioning from 
Relapsing Remitting Multiple Sclerosis to Secondary Progressive Multiple Sclerosis. 
 
Emer O’Loughlin, a Trainee Clinical Psychologist is conducting research looking at the 
experience of people who have recently transitioned from Relapsing Remitting Multiple 
Sclerosis (RRMS) to Secondary Progressive Multiple Sclerosis (SPMS). This study aims to 
develop a better understanding of the experiences and needs of people who are making 
this transition, as well as the perceived barriers to their needs being met at this time. We 
would like to invite you to take part in this project.  We feel that this research is important 
because if we can better understand the experiences and needs of people who are making 
this transition, it will highlight information which will enable services to provide improved 
support to people at this time. 
 
The study will be carried out by Emer O’Loughlin, who is a Trainee Clinical Psychologist at 
Royal Holloway, University of London. The research is being overseen by Susan Hourihan, 
Clinical Specialist Occupational Therapist, and Afsane Riazi, Senior Lecturer in Health 
Psychology, Royal Holloway, University of London.  We hope that up to 20 adults (10 people 
with MS and 10 health professionals working with people with MS) will be able to meet to 
be interviewed individually about these issues and to fill in one brief questionnaire. Your 
clinician thinks you may be suitable to take part in this study and so along with this letter, 
you have been given a Participant Information sheet which describes the study in more 
detail. 
 
Please take time to read the following carefully. If you are interested in taking part in the 
study or have any questions please contact Emer O’Loughlin using the contact details 
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provided on the participant information sheet.  Alternatively, if you would prefer for Emer 
O’Loughlin to contact you instead, then please complete the participant reply slip at the end 
of the participant information sheet, and return it using the prepaid envelope.   
 
Whilst we’d be grateful for your help, taking part in the research is entirely voluntary and 
your decision will not impact upon services you receive from [name of hospital] in any way.  
Thank you for giving this letter your consideration. 
 
Yours sincerely, 
 
 
 
Emer O’Loughlin 
 
Trainee Clinical Psychologist 
Royal Holloway, University of London 
 
  
 164 
 
APPENDIX B – PARTICIPANT INVITATION LETTER (HP VERSION) 
 
Version 1.1, dated 31/03/2014 
         
[Hospital logo] 
 
 
 
Department of Clinical Psychology 
Royal Holloway, University of London 
Egham 
Surrey 
TW20 0EX 
 
Website: www.rhul.ac.uk 
 
PARTICIPANT INVITATION LETTER 
(HPs version) 
To whom this may concern, 
 
Re: Invitation to take part in an interview study about the experience of transitioning from 
Relapsing Remitting Multiple Sclerosis to Secondary Progressive Multiple Sclerosis. 
 
Emer O’Loughlin, a Trainee Clinical Psychologist is conducting research looking at the 
experience of people who have recently transitioned from Relapsing Remitting Multiple 
Sclerosis (RRMS) to Secondary Progressive Multiple Sclerosis (SPMS). This study aims to 
develop a better understanding of the experiences and needs of people who are making 
this transition, as well as the perceived barriers to their needs being met at this time. We 
would like to invite you to take part in this project.  We feel that this research is important 
because if we can better understand the experiences and needs of people who are making 
this transition, it will highlight information which will enable services to provide improved 
support to people at this time. 
 
The study will be carried out by Emer O’Loughlin, who is a Trainee Clinical Psychologist at 
Royal Holloway, University of London. The research is being overseen by Susan Hourihan, 
Clinical Specialist Occupational Therapist, and Dr Jeremy Chataway, Consultant Neurologist.   
We hope that up to 20 adults (10 people with MS and 10 health professionals working with 
people with MS) will be able to meet to be interviewed individually about these issues and 
to fill in one brief questionnaire.  
Please take time to read the following carefully.  If you are interested in taking part in this 
study, please contact Emer on 01784 414012 (please note: this is a shared phone number. 
If leaving a voice message, please state that it is intended for Emer O’Loughlin). 
Alternatively, if you would prefer Emer to contact you instead, please complete the 
participant reply slip at the end of the participant information sheet, and return it using the 
prepaid envelope provided. 
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Whilst we’d be grateful for your help, taking part in the research is entirely voluntary and 
you under no obligation to take part.  Thank you for giving this letter your consideration. 
 
Yours sincerely, 
 
 
Emer O’Loughlin 
 
Trainee Clinical Psychologist 
Royal Holloway, University of London 
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APPENDIX C – INFORMATION SHEET (PWMS VERSION) 
 
Version 1.2, dated 17/07/2014 
         [Hospital logo] 
 
 
Department of Clinical Psychology 
Royal Holloway, University of London 
Egham 
Surrey 
TW20 0EX 
 
Website: www.rhul.ac.uk 
 
 
PARTICIPANT INFORMATION SHEET  
(PWMS Version) 
‘Qualitative study of the experience of transitioning from Relapsing Remitting Multiple 
Sclerosis to Secondary Progressive Multiple Sclerosis’ 
 
We would like to invite you to take part in a psychology research study.  Before you decide, 
you need to understand why the research is being done and what it would involve for you.  
Please take time to read the following information carefully and talk to others about the 
study to help you decide if you wish to take part (such as your family, friends, your MS 
specialist team, or the researcher). 
 
Part 1 tells you the purpose of this study and what is involved should you decide to take 
part. 
 
Part 2 gives you more detailed information about the conduct of the study. 
 
Please contact us if there is anything that is not clear or if you would like more information 
(please see contact details at the end of this Information Sheet). 
 
Part 1 
 
What is the purpose of the study? 
The main aim of the study is to gain insight into how people cope with the transition from 
Relapsing Remitting Multiple Sclerosis (RRMS) to Secondary Progressive Multiple Sclerosis 
(SPMS), what their needs are during this time, and to identify any barriers to their needs 
being met. This information will be gained through interviewing both people with MS and 
specialist healthcare professionals working with people with MS.  If we can understand more 
about how people experience this transition, it will help clinicians to provide people with the 
best support. 
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Who is organising and conducting the research? 
The research is being overseen by Susan Hourihan, Clinical Specialist Occupational Therapist, 
and Dr Jeremy Chataway, Consultant Neurologist, from [name of hospital].   The study is 
being carried out by Emer O’Loughlin who is a Trainee Clinical Psychologist at Royal 
Holloway, University of London.  It will also be supervised by Dr Afsane Riazi, who is a Senior 
Lecturer in Health Psychology at Royal Holloway. 
 
Why have I been invited to take part? 
We would like to speak to people who have transitioned from RRMS to SPMS within the last 
two years.  We hope to interview up to 10 people with MS in total, as well as up to 10 
specialist MS health professionals. 
 
Do I have to take part? 
Taking part in this study is voluntary and entirely your choice.  Your decision will not affect 
the standard of care you receive from the NHS. If you decide that you would like to take 
part, you will be asked to sign a consent form to show you have agreed to take part and will 
be given a copy of this. You can change your mind at any time and stop participating in the 
study. You do not need to give a reason for this. This would also not affect the standard of 
care you receive or any future treatment. 
 
What will happen to me if I take part? 
If you decide to take part, Emer will meet you on one occasion for approximately 60 minutes 
at a location which is convenient for you, such as your home.  The length of the interview 
will vary depending on how much you feel you wish to say.  The meeting will be arranged to 
take place at a time that is mutually convenient. 
 
At the meeting, you will be asked to fill out a brief questionnaire asking you to provide some 
background information, which will include questions such as your age, when you were first 
diagnosed with MS, and when you received a reclassification of SPMS.  Then an interview 
will take place, in which you will be asked questions about your experience of transitioning 
from RRMS to SPMS. The sorts of questions that may be asked are about how you coped 
with this transition, what your needs were at this time, and if you think there were any 
barriers to your needs being met at this time.  There are no right or wrong answers, and you 
are free to decline to answer any question you do not feel happy to answer.  If you give 
consent, the interview will be audio recorded and only the researcher (Emer O’Loughlin) and 
an assistant transcriber will be allowed to listen to the recordings.  All information that may 
identify you will be removed from the recordings before being provided to the assistant 
transcriber.  The recording will only be used for the purposes of this research and will be 
destroyed after this purpose is met. Some of your comments may be directly quoted when 
the research is written up; however, each comment will be completely anonymous. If you 
disclose something that suggests you or others are at risk, the researcher is obliged to act in 
accordance with NHS protocol and respond to the concerns raised. If the researcher felt you 
would benefit from medical or psychological input, this would be discussed with you and the 
researcher would recommend that the appropriate person at the hospital contact your GP. 
After the study has finished, the researcher will send you a brief summary of the findings 
from the research. 
 
Expenses and payments 
Taking part in this study is voluntary and you will not be paid for your participation. 
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What are the possible risks and benefits of taking part? 
Risks: There are no direct risks from taking part, although some people may feel 
uncomfortable talking about their experiences.  This is an understandable reaction to 
discussing a personal subject.  However you will not have to say anything you do not want 
to.  If you become distressed at any time, you can take a break or decide to stop talking 
altogether.  You will also be given time at the end to compose yourself if you need.  If you 
feel you need to speak to someone after the meeting, suggestions will be made to help you 
with this.   
 
Benefits: We cannot promise the study will help you but it is hoped that by taking part in this 
research, you will be providing valuable information regarding your experiences of 
transitioning from RRMS to SPMS.  This would be extremely helpful, because understanding 
the experiences and needs of people who are making this transition will help us better 
support patients in the future who are going through the transition. 
 
What if there is a problem about taking part in the study? 
Any complaint about the way you have been treated during the study will be addressed.  
Detailed information on this is provided later in this Information Sheet (please see Part 2). 
 
Will my taking part in the study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will be handled in 
confidence. Detailed information on this is provided later in this Information Sheet (see Part 
2). 
 
If the information in Part 1 has interested you and you are considering participation, please 
read the additional information in Part 2 before making any decision. 
 
Part 2 
 
What will happen if I later change my mind and don’t want to carry on with the study? 
Even after you’ve decided to take part, you can change your mind and withdraw from the 
study at any time and do not need to give a reason. The researcher will give you her contact 
number so even after the interview you can let her know if you have changed your mind or 
wish to have parts of the interview taken out. Again you do not need to give a reason for 
this. Any data that you do not want included will be destroyed. Choosing to withdraw from 
the study at any time will not affect the care you receive from the hospital in any way.  
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to either Emer 
O’Loughlin (Researcher) or Afsane Riazi (Research Supervisor) who will do their best to 
answer your questions (their contact details are provided at the end of this Information 
Sheet).  If you remain unhappy and wish to complain formally, you can do this: please 
contact: 
 
Patient Advice & Liaison Service ([name of Hospital Trust]),  
[Address] 
 
Alternatively, please contact the study’s local collaborator:  
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Susan Hourihan,  
Clinical Specialist Occupational Therapist  
[Hospital name and address] 
Tel: XXXXXXXXX 
 
You may also make a complaint to the study’s sponsor: 
Department of Clinical Psychology,  
Royal Holloway,  
University of London,  
Egham,  
Surrey, 
TW20 0EX 
Tel: 017 8444 3851 
 
Royal Holloway, University of London, is providing negligent indemnity cover for this 
research.  In the unlikely event that something does go wrong, you may have grounds for 
legal action for compensation but you have to pay your own legal costs.  The normal NHS 
complaints mechanisms will still be available to you. 
 
Will my taking part in this study be kept confidential? 
Yes, we will follow ethical and legal guidelines, and all information about you will be kept 
strictly confidential and known only to the researchers.  With your permission, a letter will 
be written to your GP and MS team informing them that you took part in the study.  Also a 
copy of the consent form you sign will be kept securely in a locked cabinet. 
 
All data collected during the course of the study will be held in accordance with the Data 
Protection Act (1998). This means that we keep it safely and cannot reveal it to other 
people, without your permission. Any questionnaires that you fill in, the tape recording of 
the interview and transcripts of the interview will be given an identification number. So only 
the researcher will know whose data belongs to whom. The interview will be anonymous 
since any identifiable information will be deleted when the researcher listens to and 
transcribes the interview tape. You will not be identified in any report or publication of the 
results of the research.  
 
All anonymised paper copies of information that you provide will be kept securely in a 
locked filing cabinet that only Emer O’Loughlin and Afsane Riazi (Research Supervisor) have 
access to.  Similarly, the electronic audio recordings of the interview and any other 
electronic information such as the interview transcripts will be saved on an encrypted 
memory stick.  On completion of the research, all of the interview tapes will be wiped clean, 
but transcripts of the interviews will be stored securely for up to 5 years. 
 
Disclosure of information gained from the study will be shared only in exceptional 
circumstances.  If the researcher is concerned about any risk of harm either to yourself or 
anyone else, then she is legally obliged to share this information with the appropriate 
people, (a contact person for your MS team, and your GP).  The researcher will always try to 
discuss these concerns with you first, before doing anything. 
 
What will happen to the results of the research study? 
The results of the study will be written up as part of a Doctorate in Clinical Psychology. 
Anonymised quotes from your interview may be used in the final report to help explain the 
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key findings. The research may also be published in a journal, or presented at a scientific 
conference. You will not be able to be identified from any of these. 
You will also be sent a summary of the research findings.  
 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, called a Research 
Ethics Committee, to protect your safety, rights, well-being and dignity. This study has been 
reviewed and given favourable opinion by Nottingham 2 Research Ethics Committee. 
 
The study has also been reviewed and gained approval from the Research Ethics Committee 
at Royal Holloway, University of London. 
 
Contacts for further information  
If you would like further information about taking part, please do not hesitate to contact 
Emer O’Loughlin, Afsane Riazi or Susan Hourihan.  Contact details are below. 
 
Contact detail for further information or to take part 
Emer O’Loughlin, Trainee Clinical Psychologist 
Department of Clinical Psychology 
Royal Holloway, University of London 
Egham Hill 
Egham, 
Surrey 
TW20 0EX 
Tel: 01784 414012 (Please note: if leaving a voice message, please state that it is 
intended for Emer O’Loughlin). 
 
Afsane Riazi, Senior Lecturer in Health Psychology  
Department of Psychology 
Royal Holloway, University of London 
Egham Hill 
Egham 
Surrey 
TW20 0EX 
Tel: 01784 443601  
 
Susan Hourihan, Clinical Specialist Occupational Therapist  
[Hospital name and address] 
Tel: XXXXXXXXX 
 
If you are interested in taking part? 
If you would like to take part, please contact Emer O’Loughlin (primary researcher) 
using the contact details provided above. Alternatively, if you would prefer for 
Emer O’Loughlin to contact you instead, then please complete the participant reply 
slip below and return it using the prepaid envelope.  Emer O’Loughlin will then call 
you, and will answer any further questions that you may have about the study.  If, 
at this stage, you are still willing to participate in this study, Emer O’Loughlin will 
speak with you about arranging a convenient time to meet. 
 
Thank you for taking the time to read this. 
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(Tear off Slip)   PARTICIPANT REPLY SLIP 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
Qualitative study of the experience of transitioning from Relapsing Remitting Multiple 
Sclerosis to Secondary Progressive Multiple Sclerosis 
Please tick the box to show your response and give your contact details.  
 
I have read the Participant Information Sheet and I would like to take part in  
this study. I am happy to be contacted to arrange a time to meet with Emer O’Loughlin 
 
My name is:   _______________________________________ 
 
I would like to be contacted by (telephone, email, post?)_____________________ 
 
My telephone/mobile number is:
 _______________________________________ 
 
My email address is  _______________________________________ 
 
My address is:   _______________________________________ 
     
_______________________________________ 
     
_______________________________________ 
 
Please return this reply slip in the pre-paid envelope, or alternatively you can contact Emer 
O’Loughlin on 01784 414012 (Please note: if leaving a voice message, please state that it is 
intended for Emer O’Loughlin). 
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APPENDIX D – INFORMATION SHEET (HP VERSION) 
 
Version 1.2, dated 17/07/2014 
 
         [Hospital logo] 
 
 
 
Department of Clinical Psychology 
Royal Holloway, University of London 
Egham 
Surrey 
TW20 0EX 
 
Website: www.rhul.ac.uk 
 
 
PARTICIPANT INFORMATION SHEET  
(HPs Version) 
‘Qualitative study of the experience of transitioning from Relapsing Remitting Multiple 
Sclerosis to Secondary Progressive Multiple Sclerosis’ 
 
We would like to invite you to take part in a psychology research study.  Before you decide, 
you need to understand why the research is being done and what it would involve for you.  
Please take time to read the following information carefully and talk to others about the 
study to help you decide if you wish to take part (such as your family, friends, colleagues, or 
the researcher). 
 
Part 1 tells you the purpose of this study and what is involved should you decide to take 
part. 
 
Part 2 gives you more detailed information about the conduct of the study. 
 
Please contact us if there is anything that is not clear or if you would like more information 
(please see contact details at the end of this Information Sheet). 
 
Part 1 
 
What is the purpose of the study? 
The main aim of the study is to gain insight into how people cope with the transition from 
Relapsing Remitting Multiple Sclerosis (RRMS) to Secondary Progressive Multiple Sclerosis 
(SPMS), what their needs are during this time, and to identify any barriers to their needs 
being met. This information will be gained through interviewing both people with MS and 
specialist healthcare professionals working with people with MS.  If we can understand more 
about this transition, it will help clinicians to provide people with the best support. 
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Who is organising and conducting the research? 
The research is being overseen by Susan Hourihan, Clinical Specialist Occupational Therapist, 
and Dr Jeremy Chataway, Consultant Neurologist, from [name of hospital].  The study is 
being carried out by Emer O’Loughlin who is a Trainee Clinical Psychologist at Royal 
Holloway, University of London.  It will also be supervised by Dr Afsane Riazi, who is a Senior 
Lecturer in Health Psychology at Royal Holloway. 
 
Why have I been invited to take part? 
In addition to interviewing up to 10 people with MS we would like to speak to up to 10 
health professionals who work with people with MS.  This is in order to facilitate the 
development of a more comprehensive understanding of this subject than would be 
achieved through interviewing people with MS only. 
 
Do I have to take part? 
Taking part in this study is voluntary and entirely your choice.  If you decide that you would 
like to take part, you will be asked to sign a consent form to show you have agreed to take 
part and will be given a copy of this. You can change your mind at any time and stop 
participating in the study. You do not need to give a reason for this.  
 
What will happen to me if I take part? 
If you decide to take part Emer will meet you on one occasion for approximately 60 minutes 
at [name of hospital].  The length of the interview will vary depending on how much you feel 
you wish to say.  The meeting will be arranged to take place at a time that is mutually 
convenient. 
 
At the meeting, you will be asked to fill out one brief questionnaire asking you to provide 
some background information, which will include questions such as your age, profession, 
and how long you have been working with people with MS for.  Then an interview will take 
place, in which you will be asked questions about your views of the experience of 
transitioning from RRMS to SPMS. The sorts of questions that may be asked are about how 
think patients cope with this transition, what their needs are at this time, and if you think 
there are any barriers to their needs being met at this time.  There are no right or wrong 
answers, and you are free to decline to answer any question you do not feel happy to 
answer.  If you give consent, the interview will be audio recorded and only the researcher 
(Emer O’Loughlin) and an assistant transcriber will be allowed to listen to the recordings.  All 
information that may identify you will be removed from the recordings before being 
provided to the assistant transcriber.  The recording will only be used for the purposes of 
this research and will be destroyed after this purpose is met. Some of your comments may 
be directly quoted when the research is written up; however, each comment will be 
completely anonymous. 
 
After the study has finished, the researcher will send you a brief summary of the findings 
from the research. 
 
Expenses and payments 
Taking part in this study is voluntary and you will not be paid for your participation. 
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What are the possible risks and benefits of taking part? 
Risks: There are no direct risks from taking part, although some people may feel 
uncomfortable talking about these issues. You are not required to discuss anything that you 
do not wish to, and can stop at any time.   
 
Benefits: We cannot promise the study will help you but it is hoped that by taking part in this 
research, you will be providing valuable information regarding the experience of 
transitioning from RRMS to SPMS.  This would be extremely helpful, because understanding 
the experiences and needs of people who are making this transition will help us better 
support patients in the future who are going through the transition. 
 
What if there is a problem about taking part in the study? 
Any complaint about the way you have been treated during the study will be addressed.  
Detailed information on this is provided later in this Information Sheet (please see Part 2). 
 
Will my taking part in the study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will be handled in 
confidence. Detailed information on this is provided later in this Information Sheet (see Part 
2). 
 
If the information in Part 1 has interested you and you are considering participation, please 
read the additional information in Part 2 before making any decision. 
 
Part 2 
 
What will happen if I later change my mind and don’t want to carry on with the study? 
Even after you’ve decided to take part, you can change your mind and withdraw from the 
study at any time and do not need to give a reason. The researcher will give you her contact 
number so even after the interview you can let her know if you have changed your mind or 
wish to have parts of the interview taken out. Again you do not need to give a reason for 
this. Any data that you do not want included will be destroyed. You can choose to withdraw 
from the study at any time.  
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to either Emer 
O’Loughlin (Researcher) or Afsane Riazi (Research Supervisor) who will do their best to 
answer your questions (their contact details are provided at the end of this Information 
Sheet).  If you remain unhappy and wish to complain formally, you can do this: please 
contact the Department of Clinical Psychology, Royal Holloway, University of London. 
 
Royal Holloway, University of London, is providing negligent indemnity cover for this 
research.  In the unlikely event that something does go wrong, you may have grounds for 
legal action for compensation but you have to pay your own legal costs.   
 
Will my taking part in this study be kept confidential? 
Yes, we will follow ethical and legal guidelines, and all information about you will be kept 
strictly confidential and known only to the researchers.   A copy of the consent form you sign 
will be kept securely in a locked cabinet. 
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All data collected during the course of the study will be held in accordance with the Data 
Protection Act (1998). This means that we keep it safely and cannot reveal it to other 
people, without your permission. Any questionnaires that you fill in, the tape recording of 
the interview and transcripts of the interview will be given an identification number. So only 
the researcher will know whose data belongs to whom. The interview will be anonymous 
since any identifiable information will be deleted when the researcher listens to and 
transcribes the interview tape. You will not be identified in any report or publication of the 
results of the research.  
 
All anonymised paper copies of information that you provide will be kept securely in a 
locked filing cabinet that only Emer O’Loughlin and Afsane Riazi (Research Supervisor) have 
access to.  Similarly, the electronic audio recordings of the interview and any other 
electronic information such as the interview transcripts will be saved on an encrypted 
memory stick.  On completion of the research, all of the interview tapes will be wiped clean, 
but transcripts of the interviews will be stored for up to 5 years. 
 
Disclosure of information gained from the study will be shared only in exceptional 
circumstances.  If the researcher is concerned about any risk of harm either to yourself or 
anyone else, then she is legally obliged to share this information with the appropriate 
people.  The researcher will always try to discuss these concerns with you first, before doing 
anything. 
 
What will happen to the results of the research study? 
The results of the study will be written up as part of a Doctorate in Clinical Psychology. 
Anonymised quotes from your interview may be used in the final report to help explain the 
key findings. The research may also be published in a journal, or presented at a scientific 
conference. You will not be able to be identified from any of these. 
 
You will also be sent a summary of the research findings.  
 
Who has reviewed the study?  
This study has been reviewed and given favourable opinion by Nottingham 2 Research Ethics 
Committee. 
 
The study has also been reviewed and gained approval from the Research Ethics Committee 
at Royal Holloway, University of London. 
 
Contacts for further information  
If you would like further information about taking part, please do not hesitate to contact 
Emer O’Loughlin, Afsane Riazi or Susan Hourihan.  Contact details are below. 
 
Contact details for further information or to take part 
Emer O’Loughlin, Trainee Clinical Psychologist 
Department of Clinical Psychology 
Royal Holloway, University of London 
Egham Hill 
Egham, 
Surrey 
TW20 0EX 
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Tel: 01784 414012 (Please note: if leaving a voice message, please state that it is 
intended for Emer O’Loughlin). 
 
Afsane Riazi, Senior Lecturer in Health Psychology  
Department of Psychology 
Royal Holloway, University of London 
Egham Hill 
Egham 
Surrey 
TW20 0EX 
Tel: 01784 443601  
 
Susan Hourihan, Clinical Specialist Occupational Therapist  
[Hospital name and address] 
Tel: XXXXXXXX 
 
If you are interested in taking part? 
If you would like to take part, please contact Emer O’Loughlin using the contact 
details provided above. Alternatively, if you would prefer Emer O’Loughlin to 
contact you instead, then please complete the participant reply slip below and 
return it using the prepaid envelope.  Emer O’Loughlin will then call you, and will 
answer any further questions that you may have about the study.  If, at this stage, 
you are still willing to participate in this study, Emer O’Loughlin will speak with you 
about arranging a convenient time to meet.  Please ask your line manager to sign 
the confirmation letter provided with this information sheet and bring this with you 
to the interview. 
 
Thank you for taking the time to read this. 
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(Tear off Slip)   PARTICIPANT REPLY SLIP 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
Qualitative study of the experience of transitioning from Relapsing Remitting Multiple 
Sclerosis to Secondary Progressive Multiple Sclerosis 
Please tick the box to show your response and give your contact details.  
 
I have read the Participant Information Sheet and I would like to take part in  
this study. I am happy to be contacted to arrange a time to meet with Emer O’Loughlin 
 
My name is:   _______________________________________ 
 
I would like to be contacted by (telephone, email, post?)_____________________ 
 
My telephone/mobile number is:
 _______________________________________ 
 
My email address is  _______________________________________ 
 
My address is:   _______________________________________ 
     
_______________________________________ 
     
_______________________________________ 
 
Please return this reply slip in the pre-paid envelope, or alternatively you can contact Emer 
O’Loughlin on 01784 414012 (Please note: if leaving a voice message, please state that it is 
intended for Emer O’Loughlin). 
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APPENDIX E – NHS RESEARCH ETHICS COMMITTEE LETTER 
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APPENDIX F – RHUL BOARD OF ETHICS EMAIL 
 
From: Psychology-Webmaster@rhul.ac.uk 
To: nxjt019@rhul.ac.uk; Riazi, Afsane; 
Cc: PSY-EthicsAdmin@rhul.ac.uk; Leman, Patrick; Lock, Annette; umjt001@rhul.ac.uk; 
Subject: 2014/045 Ethics Form Approved 
 
Date: Mon 28/04/2014 14:26 
 
 
Application Details: View the form click here   Revise the form click here 
  
 
Applicant Name: Emer O'Loughlin 
  
 
Application title: 
Qualitative study of the experience of transitioning from 
Relapsing Remitting MS (RRMS) to Secondary Progressive MS 
(SPMS) 
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APPENDIX G – R & D ETHICS LETTER
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APPENDIX H – NHS ETHICS AMENDMENT APPROVAL LETTER 
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APPENDIX I – CONSENT FORM (PWMS VERSION) 
 
Version 1.1, dated 31/03/2014 
      [Hospital logo] 
       
 
Department of Clinical Psychology 
Royal Holloway, University of London 
Egham 
Surrey 
TW20 0EX 
 
Website: www.rhul.ac.uk 
 
CONSENT FORM 
(PwMS version) 
 
Qualitative study of the experience of transitioning from Relapsing Remitting Multiple 
Sclerosis to Secondary Progressive Multiple Sclerosis 
 
Patient Identification Number for this study:  
 
Name of researcher 
Emer O’Loughlin (Trainee Clinical Psychologist) 
Doctorate in Clinical Psychology 
Royal Holloway, University of London 
Egham 
Surrey TW20 0EX 
 
Tel: 01784414012 (Please note: if leaving a voice message, please state that it is intended for 
Emer O’Loughlin) 
Please initial box 
I confirm that I have read and I understand the participant information 
sheet for the above study and that I have been given the opportunity 
to ask any questions. 
 
 
I understand that I am under no obligation to participate in this study. 
It is entirely voluntary and I can withdraw at any time, without giving a 
reason and that this will not affect any aspect of my care at the 
hospital. 
 
 
I consent to an audio recording of the interview being made and 
understand that it will be destroyed after the purpose of the research 
is complete.  
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I understand that an assistant transcriber may assist with the process 
of transcribing the interview.  In this case, I understand that all 
information that could identify me will be removed from the audio 
recording prior to it being provided to the assistant transcriber. 
 
 
I am aware and understand that the researcher, Emer O’Loughlin, may 
publish direct quotations said by me during the interview, but that 
these will be anonymised. 
 
 
I understand that all names, places and anything that could identify me 
will be removed. 
 
 
I agree to my GP being informed about my participation in the study. 
 
 
 
I agree to my MS team being informed about my participation in the 
study. 
 
 
 
I agree to take part in the above study. 
 
 
 
 
_______________________    _________________ ___________________________ 
Name of participant:   Date   Signature of participant: 
(Print name) 
 
_______________________    _________________ ___________________________ 
Name of Researcher:   Date   Signature of researcher: 
(Print name) 
 
When completed: 1 for participant; 1 for researcher file; 1 for medical records 
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APPENDIX J – CONSENT FORM (HP VERSION) 
 
Version 1.1, dated 31/03/2014 
     [Hospital logo] 
      
 
Department of Clinical Psychology 
Royal Holloway, University of London 
Egham 
Surrey 
TW20 0EX 
 
Website: www.rhul.ac.uk 
 
CONSENT FORM  
(HPs Version) 
 
Qualitative study of the experience of transitioning from Relapsing Remitting Multiple 
Sclerosis to Secondary Progressive Multiple Sclerosis 
 
Participant Identification Number for this study:  
 
Name of researcher 
Emer O’Loughlin (Trainee Clinical Psychologist) 
Doctorate in Clinical Psychology 
Royal Holloway, University of London 
Egham 
Surrey TW20 0EX 
 
Tel: 01784414012 (Please note: if leaving a voice message, please state that it is intended for 
Emer O’Loughlin) 
Please initial box 
I confirm that I have read and I understand the participant information 
sheet for the above study and that I have been given the opportunity 
to ask any questions. 
 
 
I understand that I am under no obligation to participate in this study. 
It is entirely voluntary and I can withdraw at any time, without giving a 
reason. 
 
 
I consent to an audio recording of the interview being made and 
understand that it will be destroyed after the purpose of the research 
is complete.  
 
 
I understand that an assistant transcriber may assist with the process  
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of transcribing the interview.  In this case, I understand that all 
information that could identify me will be removed from the audio 
recording prior to it being provided to the assistant transcriber. 
 
 
I am aware and understand that the researcher, Emer O’Loughlin, may 
publish direct quotations said by me during the interview, but that 
these will be anonymised. 
 
 
I understand that all names, places and anything that could identify me 
will be removed. 
 
 
 
I agree to take part in the above study. 
 
 
 
 
_______________________    _________________ ___________________________ 
Name of participant   Date   Signature of participant 
(Print name) 
 
_______________________    _________________ ___________________________ 
Name of Researcher:   Date   Signature of researcher: 
(Print name) 
 
When completed: 1 for participant; 1 for researcher site file 
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APPENDIX K – GP INFORMATION LETTER 
 
Version 1.1, dated 31/03/2014 
 
[Hospital logo] 
 
 
Department of Clinical Psychology 
Royal Holloway, University of London 
Egham 
Surrey 
TW20 0EX 
 
Website: www.rhul.ac.uk 
 
 
GP ADDRESS 
XXXXXXXXXXX 
XXXXXXXXX 
XXXXXX 
XXX 
 
Dear Dr. XXXX,  
 
Re. Patient’s Name 
Address XXXX 
 
I am writing to inform you that the above patient who is seen with XXXX clinic will be taking part in a 
research project. The aim of the research is to explore the experiences of people who have 
transitioned from Relapsing Remitting Multiple Sclerosis (RRMS) to Secondary Progressive Multiple 
Sclerosis (SPMS), including how they cope with this transition, their needs at this time, and any 
perceived barriers to their needs being met. Enclosed is the Participant Information sheet for further 
details.  
 
We feel this research is important to help us gain a deeper understanding of what it is like for people 
who are transitioning from RRMS to SPMS, to explore the issues they face and ways of coping that 
they find more or less helpful.  
 
The study will be carried out by Emer O’Loughlin, Trainee Clinical Psychologist at Royal Holloway, 
University of London as part of her Doctoral thesis and Susan Hourihan (Clinical Specialist 
Occupational Therapist) and Dr Afsane Riazi (Senior lecturer in Health Psychology).  
 
Yours Sincerely,  
 
 
Emer O’Loughlin 
Trainee Clinical Psychologist 
 191 
 
APPENDIX L – DEBRIEFING SHEET (PWMS VERSION) 
 
Version 1.1, dated 31/03/2014 
         [Hospital logo]
                                             
 
 
Debriefing Sheet 
(PWMS version) 
 
The experience of transitioning from Relapsing Remitting to Secondary 
Progressive MS 
 
Thank you very much for making this study possible. This study aimed to 
explore the experience of people with multiple sclerosis who have recently 
been told that their diagnosis of Relapsing Remitting Multiple Sclerosis 
(RRMS) has progressed on to the more progressive form of the disease 
known as Secondary Progressive Multiple Sclerosis (SPMS).  
 
I was interested in gaining an in-depth understanding of: 
1. Your experience of moving from a diagnosis RRMS to a diagnosis of 
SPMS; 
2. Your perceptions of needs and supports at time of diagnosis of 
SPMS. 
 
While existing research has investigated the experience of being diagnosed 
with RRMS and, the experience of living with established disability, there 
has been little investigation of the period of transition between RRMS and 
SPMS.  
It is hoped that this study will lead to a deeper understanding of the issues 
that pwMS experience as they move from RRMS to SPMS in order that 
Health Care Professionals better support the needs of such individuals 
during this process. 
 
Sources of comfort and help If talking about your experiences has left you 
feeling down, you may appreciate the following sources of support:  
 
1. The most immediate sources of comfort and help are likely to be your 
own family and friends.  
2. There are also a number of national organisations who can also offer you 
support. For example:  
 
 MS Society UK (http://www.mssociety.org.uk) is the leading UK charity for 
people with Multiple Sclerosis and their families, providing information, help 
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and support. Their helpline workers are fully trained, and many have MS or are 
affected by it personally. They can provide information, will help to explore your 
options with you and can listen if you feel down. The information they provide is 
always up to date and backed by evidence. The helpline is open from 9am to 
9pm Monday to Friday (except bank holidays). They can be contacted on 0808 
800 8000 or email helpline@mssociety.org.uk 
 
 The Samaritans (http://www.samaritans.org). The Samaritans is a 
helpline which is open 24 hours a day is staffed by trained volunteers 
who will listen in confidence to anyone in any type of emotional 
distress, without judging or telling people what to do and will help you 
explore options. They can be contacted on telephone 08457 909090. 
 
3. You are welcome to contact me again to discuss any aspect of your 
participation in this study, to share any concerns you might have or to ask 
questions.  
 
Contact details: 
 
Emer O’Loughlin 
Trainee Clinical Psychologist 
Department of Clinical Psychology 
Royal Holloway, University of London 
Egham 
Surrey 
TW20 0EX  
 
Tel: 01784 414012 (Please note: if leaving a voice message, please state 
that it is intended for Emer O’Loughlin) 
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APPENDIX M – DEBRIEFING SHEET (HP VERSION) 
 
Version 1.1, dated 31/03/2014 
         [Hospital logo] 
               
 
 
 
Debriefing Sheet  
(HPs Version) 
 
The experience of transitioning from relapsing remitting to secondary 
progressive MS 
 
Thank you very much for making this study possible. This study aimed to 
explore the experience of people with multiple sclerosis who have recently 
been told that their diagnosis of Relapsing Remitting Multiple Sclerosis 
(RRMS) has progressed on to the more progressive form of the disease 
known as Secondary Progressive Multiple Sclerosis (SPMS).  
 
I was interested in gaining an in-depth understanding of: 
3. Your experience of moving from a diagnosis RRMS to a diagnosis of 
SPMS; 
4. Your perceptions of needs and supports at time of diagnosis of 
SPMS. 
 
While existing research has investigated the experience of being diagnosed 
with RRMS and, the experience of living with established disability, there 
has been little investigation of the period of transition between RRMS and 
SPMS. It is hoped that this study will lead to a deeper understanding of the 
issues that pwMS experience as they move from RRMS to SPMS in order 
that Healthcare Professionals better support the needs of such individuals 
during this process. 
 
You are welcome to contact me again to discuss any aspect of your 
participation in this study, to share any concerns you might have or to ask 
questions.  
 
Contact details: 
 
Emer O’Loughlin 
Trainee Clinical Psychologist 
Department of Clinical Psychology 
Royal Holloway, University of London 
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Egham 
Surrey 
TW20 0EX  
Tel: 01784 414012 (Please note: if leaving a voice message, please state 
that it is intended for Emer O’Loughlin) 
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APPENDIX N – SEMI-STRUCTURED INTERVIEW SCHEDULE (PWMS 
VERSION) 
 
Version 1.1, dated 31/03/2014 
 
Draft Interview Schedule – for PWMS 
 Informed consent, recording it, withdraw, confidentiality. Any questions? 
 I’m not going to say much - like a one sided conversation. 
 Tell me stories/detail about your experiences. 
 There are no right or wrong answers; I am only interested in what is important for 
you. 
 You are the expert of your experience. 
 As much detail as possible to bring your story to life for me. 
 Take your time in thinking and talking 
 Demographic questionnaire first 
 
- Warm up questions – Can you tell me when you received your initial diagnosis of 
MS? Can you tell me when you received your subsequent re-classification of SPMS? 
 
- Before receiving a re-classification of SPMS, had you noticed any changes in your 
condition?  If so, what did you make of this? 
Prompt: Had you noticed any changes in your physical symptoms (e.g. fatigue, vision, 
balance, stiffness/spasms)? Did you think anything about this?  
- Can you tell me what it was it like to receive a re-classification of SPMS (following a 
previous diagnosis of RRMS)? 
Prompt: How did you feel? How expected/unexpected was it? What sense did you 
make of this news?  
 
- In what way has this transition impacted on your life (e.g. work, home-life etc.)? 
 
- In what way was the experience of the transition from RRMS to SPMS similar or 
different to other stages of the disease? 
For example in what way was this transition similar or different to the receipt of the 
original diagnosis? 
 
- How did you deal with the impact of this re-classification? 
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Prompt: Were there certain things that you did to try to cope with it, or ways that 
you tried to think about it? Were there any coping strategies that you used? 
 
- Were there ways of dealing with it, or coping strategies, it that you found to be 
helpful? 
 
- Were there other ways of dealing with it, or coping strategies, that you found to be 
less helpful or unhelpful? 
 
- Is there anything that was, or would have been, helpful before receiving a re-
classification of SPMS? 
Prompt: Are there any ways that services could have informed or supported you 
better?   
 
- Is there anything that was, or would have been, helpful in the way the news of your 
re-classification was communicated to you? 
Prompt: How supported or unsupported by services did you feel? What was 
helpful/unhelpful? Is there anything you would suggest should have been done 
differently? 
 
- Is there anything that was, or would have been, helpful following receipt of this 
news? 
Prompt: How supported or unsupported by services did you feel? What was 
helpful/unhelpful? Is there anything you would suggest should have been done 
differently? 
 
- Do you think there were any barriers to services meeting your needs during this 
transition? If so, what were they? 
 
- Was there anything you expected me to ask, that I didn’t? Anything you’d like to 
add? 
 
- What has it been like discussing these issues today?  
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APPENDIX 0 –SEMI-STRUCTURED INTERVIEW SCHEDULE (HP 
VERSION) 
Version 1.1, dated 31/03/2014 
Draft Semi-Structured Interview Schedule – for HPs 
 
- Informed consent, recording it, withdraw, confidentiality. Any questions? 
- I’m not going to say much - like a one sided conversation. 
- Tell me stories/detail about the experiences of pwMS. 
- There are no right or wrong answers; I am only interested in what is important for 
pwMS. 
- Try to talk from the perspective of pwMS. 
- As much detail as possible to bring their story to life for me. 
- Take your time in thinking and talking 
- Demographic questionnaire first 
 
- Warm up question – What is your role? How long have you been working with 
PWMS?  
 
- Before receiving a re-classification of SPMS, do you think that PWMS notice any 
changes in their condition?  If so, what sense do you think they make of this? 
Prompt: Do you think that PWMS notice any changes in their physical symptoms?  Do 
you think they think anything about this? Do they ignore it? Do they worry about it? 
 
- What do you think it is like to receive a diagnosis of SPMS (following a previous 
diagnosis of RRMS)? 
Prompt: How do you think they feel? How expected/unexpected do you think it is? 
What do you think pwMS think about the news of their reclassification? 
What sense do you think they make of this news?  
 
- In what way is the experience of the transition from RRMS to SPMS similar or 
different to other stages of MS? 
For example, in what way is this transition similar or different to the receipt of the 
original diagnosis?  
 
- How do you think pwMS deal with the impact of this re-classification? 
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Prompt: Do you think there certain things that people do to try to cope with it, or 
ways that they try to think about it?  
 
- Do you think there are ways of dealing with it or coping strategies that pwMS tend 
to find helpful? 
 
- Do you think that there other ways of dealing with it or coping strategies that pwMS 
tend find to be less helpful or unhelpful? 
 
- Do you think that PWMS would identify anything that was, or would have been, 
helpful before receiving a re-classification of SPMS? What else, in your opinion, do 
you think would be helpful? 
Prompt: Do you think there any ways that services could inform or support PWMS 
better at this time?   
 
- Do you think that PWMS would identify anything that was, or would have been 
helpful, in the way the news of their re-classification was communicated to them? 
What else, in your opinion, do you think would be helpful? 
Prompt: How supported or unsupported by services did you think PWMS feel at this 
point? What do you think is helpful/unhelpful? Is there anything you would suggest 
should be done differently? 
 
- Do you think PWMS would identify anything that was, or would have been, helpful 
following receipt of this news? What else, in your opinion, do you think would be 
helpful? 
Prompt: How supported or unsupported by services do you think PWMS feel? What 
do you think is helpful/unhelpful? Is there anything you would suggest should be 
done differently? 
 
- Do you think there are any barriers to meeting the needs of PWMS during this 
transition period? If so, what are they? 
 
- Was there anything you expected me to ask, that I didn’t? Anything you’d like to 
add? 
 
- What has it been like discussing these issues today?  
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APPENDIX P – DEMOGRAPHIC QUESTIONNAIRE (PWMS VERSION) 
 
Version 1.1, dated 31/03/2014        
  
[Hospital logo] 
                      
 
                                                                                                                               Idno 
     
 
MS Transition Study 
Socio-demographic Information 
(PWMS version) 
 
    Sex      Date of birth 
            Male      Female    
                                                            D    D          M     M             Y      Y    Y      Y 
 
                                                                          /        /        /         / 
 
Q1 Ethnic group 
          White                                        Black Carribean         Black African 
 
          Black Other                              Indian         Pakistani 
 
          Bangladeshi                             Chinese                       Other Asian group 
 
          None of these – other, please say  
         
 
Q2 Marital status 
  
         Married                                       Widowed           Divorced 
 
         Cohabiting                                  Separated           Single 
 
 
Q3 a) Number of dependents in the home 
          (not children)  
 
 
Q3 b) Number of children under 5 years 
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Q3 c) Number of children aged 5 to 16 years inclusive 
 
Q4 a) Your  occupation 
 
 
            Full-time work                         Part-time work      Permanently                      
                                                                                                                  sick/disabled 
 
            Unemployed                            Retired                           Student 
      
            Housewife                               Other 
     
                                                                                                                       
If ‘other’ please say 
 
 
 
Q4 b) Current/main employment (write housewife if appropriate)  
 
 
 
 
 
Q4 c) If currently unemployed, last full-time occupation                                           
                           
      
 
 
                                                                                                                     Organisation function/ 
                                                                                                                      nature of business 
            Number of people supervised      
 
 
 
Q5 a) Partners occupation (if not applicable please tick ‘N/A’) 
        
           N/A                      
     
 
           Full-time work                         Part-time work                    Permanently                             
                                                                                                                      sick/disabled 
 
           Unemployed                            Retired                                 Student 
 
           Housewife                               Other             
                                                                                                                                       
       If ‘other’, please say       
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Q5 b) Your partner’s current/main employment (write housewife if appropriate)  
  
            
 
 
 
 
Q5 c) If currently unemployed, what was your partner’s last full-time occupation  
               
     
 
 
 
 
 
           Number of people supervised                      Organisation function/nature of business 
  
 
 
 
 
Q6 a) Age you left full-time education                           Q6 b) Age you left part-time education 
 
 
 
 
 
Q6 c) Highest exam level 
 
        None     CSE       GCSE/O’Level   A’Level   HND     Degree    Other 
 
     If ‘other’, please specify         
 
 
 
Q6 d) Still in education  
 
        Yes – FT          Yes – PT          No 
                                   
If still in PT or FT education, title of course      
 
 
Q7 a) 
         Accommodation status 
 
            Owner-occupied                    Council/housing association          Private rental 
 
            Other rented                          Lives with parents            Other  
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        If other please specify   
 
 
 
Q7 b) Type of accommodation  
 
           Detached                                        Semi-detached                   End-terrace  
 
           Mid-terrace                                    Flat/maisonette                   Bedsitter 
 
           Hostel                                             Halls of residence              NFA 
 
           Other please specify                                                                         
                                                                                                                           
 
       Floor of main accommodation   
 
 
 
Q8 .  Roughly,  when did your MS symptoms FIRST START? ……month …… year 
 
Q9.  Roughly,  when was your MS FIRST DIAGNOSED? ……month …… year 
 
Q10.  a) Roughly,  when was your most recent relapse ?  ……month …… year 
 
 b) And how severe was it? ….Mild …..Moderate …..Severe 
     
Q11. Roughly, when did you receive a reclassification of Secondary Progressive MS? 
……month     ……year   
 
Q12.  Concerning your mobility indoors, do you:  
 …..walk unaided  
 …..use a stick or frame, or hold onto furniture or somebody  
 when walking 
 ….use a wheel chair 
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APPENDIX Q – DEMOGRAPHIC QUESTIONNAIRE (HP VERSION) 
 
Version 1.1, dated 31/03/2014 
 
      [Hospital logo] 
                     
 
                                                                                                                           Idno 
     
 
MS Transition Study 
Socio-demographic Information 
(Health Professionals version) 
 
    Sex:      Date of birth: 
         Male     Female    
                                                          D    D              M     M             Y        Y        Y      Y 
 
                                                                               /                          /          
 
Q1 Ethnic group: 
          White                                        Black Carribean         Black African 
 
          Black Other                              Indian         Pakistani 
 
          Bangladeshi                             Chinese                       Other Asian group 
 
          None of these – other, please specify:………………………………………………… 
   
Q2 a)Your occupation: 
 
            MS Specialist Consultant             
            MS Specialist Nurse                                  
            Occupational Therapist  
            Physiotherapist                        
            Psychologist   
            Other (please specify:……………………………………………………………) 
 
Q3 Number of years working with people with MS:……………………………………………  
                
Q6 Roughly number of patients you have worked with who have transitioned from RRMS to 
SPMS:     
            <10             
            11-50                                  
            >50 
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APPENDIX R – Thematic map 
(i) Initial Thematic Map 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Is this really 
happening? 
Noticing 
subtle 
changes 
Uncertainty 
Preparing 
oneself 
Limbo 
I wish 
they had 
prepared 
me 
Soldiering 
on 
Becoming 
a reality 
Shock 
Having one’s 
doom sealed 
It makes 
sense 
Turning 
point 
It’s a matter 
of trust 
It needs to be done 
in the right 
environment 
You get told and then 
you walk out the door 
How can I deal 
with this? 
Brushing 
oneself off 
and moving 
on 
Learning to 
live 
differently 
Drawing on 
support 
Focus on 
the present 
You can’t let it take 
over your entire life Staying 
positive 
Doing everything I can do 
and accepting the rest 
Living with 
increasing 
challenges 
It’s all 
downhill 
from here 
There has to be 
a way out of this 
Burying 
one’s 
head in 
the sand 
One’s world just 
shrinks 
Loss 
and 
grief 
Withdrawing 
Frustration 
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(ii) Final Thematic Map 
 
 
  
Is this 
really 
happening
? 
Becoming 
a reality 
A life of 
struggle 
Brushing 
oneself off 
and moving 
on 
Noticing a 
gradual decline 
I couldn’t really 
make sense of it 
Soldiering on 
Preparing 
oneself 
Limbo 
I wish they 
had prepared 
me 
Shock and 
devastation 
It 
makes 
sense 
It needs to be done 
in the right 
environment 
Turning 
point 
What does 
this mean? 
It’s all 
downhill from 
here 
This can’t be 
happening 
One’s world just 
shrinks 
Living with 
frustration I accepted it because I’d 
already resigned myself 
to it 
Living 
differently 
Drawing 
on 
support 
Making the 
most of it 
Doing all I can do 
and accepting 
the rest 
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APPENDIX S – Transcription extract 
 
Interview Transcript Extract Initial Coding 
I: Can you tell me when you received your subsequent reclassification of Secondary 
Progressive MS? 
 
P: I was told in 2012 I was possibly entering the secondary phase of MS. Um, then 
last year, by my usual consultant… she didn’t want to classify… she didn’t want to 
confirm that… but then this year the consultant told me that she believed I was… um, 
that I had Secondary Progressive… so it was this year. 
 
I: This year… ok. So before receiving a reclassification of Secondary Progressive MS 
had you noticed any changes in your condition? And if so, what sense did you make of 
this? 
 
P: Yes. Yes, I had very heavy legs, terrible fatigue… I would go to work and by 
lunchtime I could have just sat down and gone to sleep. Um, I was struggling with 
carrying equipment for my job because I was just so tired. I was having problems 
getting in and out of doors, and I kept thinking is it my imagination? Is it because I 
think I’ve got a progression of my MS? Am I imagining all this? So I did… definitely 
had quite a few symptoms… they were… it wasn’t really symptoms so much as just a 
gradual decline of… of my mobility. I couldn’t really understand why. 
 
I: Mmm. And tell me a little bit more about what you thought about it, or what sense 
you made of it. 
 
P: Um, well my profession is a community nurse… so it was very difficult because 
Relapsing Remitting… I always bounced back to where I was before… and this time I 
wasn’t actually getting worse, that I could notice, but it was when I was looking back 
over the year I was thinking I could walk further this time last year… I wasn’t 
toppling… I wasn’t struggling getting into doors… so I felt I was getting worse.  I felt I 
 
 
 
Told possibly entering SPMS - uncertainty 
 
Consultant reluctance to reclassify – uncertain 
 
 
 
 
 
 
Fatigue, heaviness 
Carrying on with work - struggling 
 
Is it my imagination? 
Is it due to progression? 
Gradual decline in mobility 
Confusion, uncertainty 
 
 
 
 
Bouncing back in RRMS 
 
Gradual, silent deterioration- looking back 
 
Some awareness of potential SPMS 
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did probably have Secondary Progressive MS, but I didn’t really understand what that 
was because people with Secondary Progressive MS that I knew were people I 
nursed in bed and… and in wheelchairs. So I struggled understanding what was going 
on with me. 
 
 
I: Ok. Ok, thank you. So can you tell me what it was like to receive a reclassification of 
Secondary Progressive MS? 
 
P: It actually was a relief… it was a relief because I’d been struggling at work for so 
long. I did have a blue badge, but because I wore a nurse’s uniform if I parked in a 
blue badge space quite often people would stand there and stare at me… in fact I 
had one lady who stood and watched me with her hands on her hips pointing at the 
disabled space. And my colleague who was with me said “wave your blue badge at 
her!” But obviously I didn’t. So for me it was a little bit of a relief because I kept 
imagining… well, I kept thinking I was imagining… um, that I was more tired than I 
was. It’s so… and also it was just like mist… one minute I could walk a bit further than 
another… so it would come and go. So I couldn’t really make sense of it, because it 
was here today, and then tomorrow I was a bit better… well not a bit better, but not 
quite so bad as the day before. But I also found that if I was pushing myself and 
thinking right I’ve got to walk further today because I’ve got to keep strength in my 
legs… what you don’t use you lose… I was actually getting worse, and I couldn’t make 
sense of that either. So, yes, going back to your question which… I’ve forgotten what 
it was [laughs]. 
 
I: Yeah, just… I guess, tell me about what it was like to receive that reclassification. 
 
P: Yes. It was relief. And I started then to rethink… if I am entering Secondary… well I 
am now in Secondary Progressive MS… I have got to rethink my life, because here I 
am struggling to work… I’m going to work in the mornings, and then coming home in 
the afternoons… my husband’s cooking meals, I’m not walking the dog because I’m 
so whacked out, I’m going to bed at half seven… and things that I used to do like 
SPMS associated with severe disability 
Struggling to understand changes 
 
 
 
 
 
 
 
Relief at reclassification 
 
RRMS: Misunderstood due to invisible disability 
 
 
Relief because changes not just imagined 
Symptoms like a mist - transitory 
 
 
Changes confusing due to variation/changeability 
Trying to maintain level of functioning – still 
declining 
 
Confusion, struggling to make sense of it 
 
 
 
 
Relief at reclassification 
Need to rethink one’s life 
Struggling with work 
Struggling with domestic tasks 
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singing I can’t do, because I can’t stand on stage. Um… so I think it mainly… it was a 
relief because I was able to then rethink and think well actually I can’t do all those 
things now, I know I can’t do all those things, and I’m not going to be able to do 
them. So I’ve had to redesign my social life. So I have to say relief was probably 
where I was then. 
 
I: Ok. Ok. And just about that… how expected or unexpected was it when you received 
that… that reclassification? 
 
P: Because it was… it wasn’t said to me, um, in a way that… “you are now what we 
would call in Secondary Progressive MS”… it was as if I would have known anyway, 
because it was a different consultant… so she told me… um, “have you ever”… well 
she was asking me questions…” have you had any disease modifying drugs?” and I 
said “no.” Um… “have you never had anything with this weakness?” and “have you 
ever had any drugs for your fatigue?” and I said “no.” And she said “well with 
Secondary Progressive…” So it was almost as if I knew already, or she thought I knew 
already, and I never showed any indication that I didn’t know already, because I think 
I probably did. So I just went along with that… I didn’t actually question… I went 
along with it, because I’d already questioned the consultant the year before saying 
“have I got Secondary Progressive?” and she said “I don’t like to classify it.” So, I 
suppose I knew really… so this consultant was just telling me what I knew. But it was 
a… a definite… “you have Secondary Progressive MS,” whereas before I’d never been 
told that. So… yeah. 
 
I: Mmm. Ok. So the previous consultant the year before they hadn’t wanted to 
classify you, but what did they say to you exactly? 
 
P: Gosh, I can’t remember. I had the registrar come in and check me over. And he 
wasn’t quite as thorough as my usual consultant anyway, because I had tight trousers 
on so he didn’t, um, check my legs in the same way for sensation. But when she 
came in and I was asking her… and I just said “I’m really worried because I’m not as 
strong, I’m not as good as I was,” and she said “well your reactions are the same as 
Unable to participate in hobbies 
Adjusting to loss of functioning 
Relief because one could rethink life 
Need to redesign social life 
 
 
 
 
 
Lack of continuity of care (change of consultant) – 
expectation that patient already knew 
 
 
 
 
 
Hiding shock/surprise at reclassification 
 
Some expectation of reclassification 
Reclassification significant (a shock?) despite some 
expectation of it- becoming a reality 
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Patient expressing concern about changes to 
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they were last year.” And I said “could I be entering… or could I be in Secondary 
Progressive MS?” and that’s when she said “we don’t classify it.” And I suppose I was 
a little… I came away feeling a bit… hmm, not miffed… but I came away feeling as if I 
hadn’t really achieved anything, as if that was a waste of a visit, because the thing I 
was worrying about wasn’t clarified. 
Asking if could have SPMS 
Consultant reluctance to reclassify 
 
Patient miffed at lack of clarification 
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APPENDIX T – Transcription extract: second coder 
 
I: Can you tell me when you received your subsequent reclassification of Secondary 
Progressive MS? 
P: I was told in 2012 I was possibly entering the secondary phase of MS. Um, then last 
year, by my usual consultant… she didn’t want to classify… she didn’t want to confirm 
that… but then this year the consultant told me that she believed I was… um, that I had 
Secondary Progressive… so it was this year. 
I: This year… ok. So before receiving a reclassification of Secondary Progressive MS had 
you noticed any changes in your condition? And if so, what sense did you make of this? 
P: Yes. Yes, I had very heavy legs, terrible fatigue… I would go to work and by lunchtime I 
could have just sat down and gone to sleep. Um, I was struggling with carrying 
equipment for my job because I was just so tired. I was having problems getting in and 
out of doors, and I kept thinking is it my imagination? Is it because I think I’ve got a 
progression of my MS? Am I imagining all this? So I did… definitely had quite a few 
symptoms… they were… it wasn’t really symptoms so much as just a gradual decline of… 
of my mobility. I couldn’t really understand why. 
I: Mmm. And tell me a little bit more about what you thought about it, or what sense you 
made of it. 
P: Um, well my profession is a community nurse… so it was very difficult because 
Relapsing Remitting… I always bounced back to where I was before… and this time I 
wasn’t actually getting worse, that I could notice, but it was when I was looking back over 
the year I was thinking I could walk further this time last year… I wasn’t toppling… I 
wasn’t struggling getting into doors… so I felt perhaps I was getting worse… I felt I did 
 
 
Informed possibility entering secondary phase  
Consultant didn’t want to classify/confirm 
new diagnosis 
This year reclassified by consultant 
- sense of unknown, and uncertainty – 
consultant wanting to be certain 
 
 
Experienced changes in condition – heavy 
legs, fatigue, tired 
Struggling  
Impacting job performance 
 
Questioning if changes real or in imagination  
Experienced a gradual decline in mobility  
Not understanding why experiencing decline 
 
 
 
 
Difficult experience of relapsing remitting 
Functioning always returned to normal – 
sense of time important 
Felt like wasn’t getting worse, relying on own 
perception of functioning 
Looking back over year – recalling memories 
of previous abilities – comparison to different 
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probably have Secondary Progressive MS, but I didn’t really understand what that was 
because people with Secondary Progressive MS that I knew were people I nursed in bed 
and… and in wheelchairs. So I struggled understanding what was going on with me. 
I: Ok. Ok, thank you. So can you tell me what it was like to receive a reclassification of 
Secondary Progressive MS? 
P: It actually was a relief… it was a relief because I’d been struggling at work for so long. I 
did have a blue badge, but because I wore a nurse’s uniform if I parked in a blue badge 
space quite often people would stand there and stare at me… in fact I had one lady who 
stood and watched me with her hands on her hips pointing at the disabled space. And my 
colleague who was with me said "wave your blue badge at her!" But obviously I didn’t. So 
for me it was a little bit of a relief because I kept imagining… well, I kept thinking I was 
imagining… um, that I was more tired than I was. It’s so… and also it was just like mist… 
one minute I could walk a bit further than another… so it would come and go. So I 
couldn’t really make sense of it, because it was here today, and then tomorrow I was a 
bit better… well not a bit better, but not quite so bad as the day before. But I also found 
that if I was pushing myself and thinking right I’ve got to walk further today because I’ve 
got to keep strength in my legs… what you don’t use you lose… I was actually getting 
worse, and I couldn’t make sense of that either. So, yes, going back to your question 
which… I’ve forgotten what it was [laughs]. 
I: Yeah, just… I guess, tell me about what it was like to receive that reclassification. 
P: Yes. It was relief. And I started then to rethink… if I am entering Secondary… well I am 
now in Secondary Progressive MS… I have got to rethink my life, because here I am 
struggling to work… I’m going to work in the mornings, and then coming home in the 
afternoons… my husband’s cooking meals, I’m not walking the dog because I’m so 
whacked out, I’m going to bed at half seven… and things that I used to do like singing I 
time period – provided new perspective on 
illness decline 
Impact of professional knowledge – image of 
self not matching reality of nursing profession 
A struggle to understand – struggle to apply 
knowledge/experience to own situation 
 
Reclassification a relief 
Relief because struggling for so long 
Meaning of illness and communicating illness 
– reaction of others, others judging, visibility 
of illness? 
 
Relief – doubting own perception, imaging 
deterioration 
Like mist – coming and going- transitory 
nature of deterioration – metaphor of mist – 
descending upon her, haze – feeling lost? 
 
Here today, gone tomorrow – transitory 
nature of symptoms 
Gradual decline – functioning not returning to 
same level 
 
 
 
Reaction to decline – push myself, thinking 
about the future – keeping strength in legs, 
what don’t use you lose – worry for the 
future? 
Getting worse – not understanding – couldn’t 
make sense – confusion 
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can’t do, because I can’t stand on stage. Um… so I think it mainly… it was a relief because 
I was able to then rethink and think well actually I can’t do all those things now, I know I 
can’t do all those things, and I’m not going to be able to do them. So I’ve had to redesign 
my social life. So I have to say relief was probably where I was then. 
I: Ok. Ok. And just about that… how expected or unexpected was it when you received 
that… that reclassification? 
P: Because it was… it wasn’t said to me, um, in a way that... "you are now what we would 
call in Secondary Progressive MS"… it was as if I would have known anyway, because it 
was a different consultant… so she told me… um "have you ever"… well she was asking 
me questions… "have you had any disease modifying drugs?" and I said "no."  Um... 
"have you never had anything with this weakness?" and "have you ever had any drugs for 
your fatigue?" and I said "no"… and she said "well with Secondary Progressive".. So it was 
almost as if I knew already, or she thought I knew already, and I never showed any 
indication that I didn’t know already, because I think I probably did. So I just went along 
with that… I didn’t actually question… I went along with it, because I’d already 
questioned the consultant the year before saying "have I got Secondary Progressive?" 
and she said "I don’t like to classify it." So, I suppose I knew really… so this consultant was 
just telling me what I knew. But it was a… a definite… "you have Secondary Progressive 
MS," whereas before I’d never been told that. So… yeah. 
I: Mmm. Ok. So the previous consultant the year before they hadn’t wanted to classify 
you, but what did they say to you exactly? 
P: Gosh, I can’t remember. I had the registrar come in and check me over. And he wasn’t 
quite as thorough as my usual consultant anyway, because I had tight trousers on so he 
didn’t, um, check my legs in the same way for sensation. But when she came in and I was 
asking her… and I just said "I’m really worried because I’m not as strong, I’m not as good 
Reclassification a relief 
Reclassification catalyst for rethinking life  
Impact of illness on several areas of life  
Reclassification – permission to re-evaluate – 
process of adjustment 
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Experience of a different consultant – 
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– asked questions the year before – prepared 
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Definitive diagnosis – new experience - 
certainty 
Difference between knowing and expected, 
and definite diagnosis? 
 
 
Experience of different consultants – new 
consultant not as through 
Sharing concerns with medical professionals 
Asking professionals if entering secondary 
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as I was, and she said well your reactions are the same as they were last year." And I said 
"could I be entering… or could I be in Secondary Progressive MS?" and that’s when she 
said "we don’t classify it." And I suppose I was a little… I came away feeling a bit… hmm, 
not miffed… but I came away feeling as if I hadn’t really achieved anything, as if that was 
a waste of a visit, because the thing I was worrying about wasn’t clarified.  
progressive- looking for answers, searching for 
professional opinion 
Professionals not providing concrete answers 
– difficult for patient 
Feeling like hadn’t achieved anything – 
difficult experience of medical appointments – 
difficult not receiving clarification 
Worry about reclassification 
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